#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Alterations in White Matter Microstructure and Connectivity in Young Adults with Alcohol Use Disorder
#Text=Background:
#Text=Magnetic resonance imaging (MRI) studies have shown differences in volume and structure in the brains of individuals with alcohol use disorder (AUD).
1-1	0-11	Alterations	_	
1-2	12-14	in	_	
1-3	15-20	White	_	
1-4	21-27	Matter	_	
1-5	28-42	Microstructure	_	
1-6	43-46	and	_	
1-7	47-59	Connectivity	_	
1-8	60-62	in	_	
1-9	63-68	Young	_	
1-10	69-75	Adults	_	
1-11	76-80	with	_	
1-12	81-88	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[1]	
1-13	89-92	Use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[1]	
1-14	93-101	Disorder	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[1]	
1-15	102-112	Background	_	
1-16	112-113	:	_	
1-17	114-122	Magnetic	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[2]	
1-18	123-132	resonance	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[2]	
1-19	133-140	imaging	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[2]	
1-20	141-142	(	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[2]	
1-21	142-145	MRI	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[2]	
1-22	145-146	)	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[2]	
1-23	147-154	studies	_	
1-24	155-159	have	_	
1-25	160-165	shown	_	
1-26	166-177	differences	_	
1-27	178-180	in	_	
1-28	181-187	volume	_	
1-29	188-191	and	_	
1-30	192-201	structure	_	
1-31	202-204	in	_	
1-32	205-208	the	_	
1-33	209-215	brains	_	
1-34	216-218	of	_	
1-35	219-230	individuals	_	
1-36	231-235	with	_	
1-37	236-243	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[3]	
1-38	244-247	use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[3]	
1-39	248-256	disorder	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[3]	
1-40	257-258	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[3]	
1-41	258-261	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[3]	
1-42	261-262	)	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[3]	
1-43	262-263	.	_	

#Text=Most research has focused on neuropathological effects of alcohol that appear after years of chronic alcohol misuse.
2-1	264-268	Most	_	
2-2	269-277	research	_	
2-3	278-281	has	_	
2-4	282-289	focused	_	
2-5	290-292	on	_	
2-6	293-310	neuropathological	_	
2-7	311-318	effects	_	
2-8	319-321	of	_	
2-9	322-329	alcohol	_	
2-10	330-334	that	_	
2-11	335-341	appear	_	
2-12	342-347	after	_	
2-13	348-353	years	_	
2-14	354-356	of	_	
2-15	357-364	chronic	_	
2-16	365-372	alcohol	_	
2-17	373-379	misuse	_	
2-18	379-380	.	_	

#Text=However, few studies have investigated white matter (WM) microstructure and diffusion MRI-based (DWI) connectivity during early stages of AUD.
3-1	381-388	However	_	
3-2	388-389	,	_	
3-3	390-393	few	_	
3-4	394-401	studies	_	
3-5	402-406	have	_	
3-6	407-419	investigated	_	
3-7	420-425	white	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[4]	
3-8	426-432	matter	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[4]	
3-9	433-434	(	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[4]	
3-10	434-436	WM	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[4]	
3-11	436-437	)	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[4]	
3-12	438-452	microstructure	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[4]	
3-13	453-456	and	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[4]	
3-14	457-466	diffusion	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[4]	
3-15	467-476	MRI-based	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[4]|http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[5]	
3-16	477-478	(	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[4]	
3-17	478-481	DWI	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[4]	
3-18	481-482	)	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[4]	
3-19	483-495	connectivity	_	
3-20	496-502	during	_	
3-21	503-508	early	_	
3-22	509-515	stages	_	
3-23	516-518	of	_	
3-24	519-522	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[6]	
3-25	522-523	.	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[6]	

#Text=Therefore, the goal of this work was to investigate WM integrity and structural connectivity in emerging adulthood AUD subjects using both conventional DWI metrics and a novel connectomics approach.
4-1	524-533	Therefore	_	
4-2	533-534	,	_	
4-3	535-538	the	_	
4-4	539-543	goal	_	
4-5	544-546	of	_	
4-6	547-551	this	_	
4-7	552-556	work	_	
4-8	557-560	was	_	
4-9	561-563	to	_	
4-10	564-575	investigate	_	
4-11	576-578	WM	_	
4-12	579-588	integrity	_	
4-13	589-592	and	_	
4-14	593-603	structural	_	
4-15	604-616	connectivity	_	
4-16	617-619	in	_	
4-17	620-628	emerging	_	
4-18	629-638	adulthood	_	
4-19	639-642	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[7]	
4-20	643-651	subjects	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[7]	
4-21	652-657	using	_	
4-22	658-662	both	_	
4-23	663-675	conventional	_	
4-24	676-679	DWI	_	
4-25	680-687	metrics	_	
4-26	688-691	and	_	
4-27	692-693	a	_	
4-28	694-699	novel	_	
4-29	700-712	connectomics	_	
4-30	713-721	approach	_	
4-31	721-722	.	_	

#Text=Methods:
#Text=Twenty-two AUD and eighteen controls (CON) underwent anatomical and diffusion MRI.
5-1	723-730	Methods	_	
5-2	730-731	:	_	
5-3	732-742	Twenty-two	_	
5-4	743-746	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
5-5	747-750	and	_	
5-6	751-759	eighteen	_	
5-7	760-768	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
5-8	769-770	(	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
5-9	770-773	CON	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
5-10	773-774	)	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
5-11	775-784	underwent	_	
5-12	785-795	anatomical	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[9]|http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[10]	
5-13	796-799	and	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[9]|http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[10]	
5-14	800-809	diffusion	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[9]|http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[10]	
5-15	810-813	MRI	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[9]|http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[10]|http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[11]	
5-16	813-814	.	_	

#Text=Outcome measures were scalar diffusion metrics and structural network connectomes.
6-1	815-822	Outcome	_	
6-2	823-831	measures	_	
6-3	832-836	were	_	
6-4	837-843	scalar	_	
6-5	844-853	diffusion	_	
6-6	854-861	metrics	_	
6-7	862-865	and	_	
6-8	866-876	structural	_	
6-9	877-884	network	_	
6-10	885-896	connectomes	_	
6-11	896-897	.	_	

#Text=Tract Based Spatial Statistics was used to investigate group differences in diffusion measures.
7-1	898-903	Tract	_	
7-2	904-909	Based	_	
7-3	910-917	Spatial	_	
7-4	918-928	Statistics	_	
7-5	929-932	was	_	
7-6	933-937	used	_	
7-7	938-940	to	_	
7-8	941-952	investigate	_	
7-9	953-958	group	_	
7-10	959-970	differences	_	
7-11	971-973	in	_	
7-12	974-983	diffusion	_	
7-13	984-992	measures	_	
7-14	992-993	.	_	

#Text=Structural connectomes were used as input into a community structure procedure to obtain a co-classification index matrix (an indicator of community association strength) for each subject.
8-1	994-1004	Structural	_	
8-2	1005-1016	connectomes	_	
8-3	1017-1021	were	_	
8-4	1022-1026	used	_	
8-5	1027-1029	as	_	
8-6	1030-1035	input	_	
8-7	1036-1040	into	_	
8-8	1041-1042	a	_	
8-9	1043-1052	community	_	
8-10	1053-1062	structure	_	
8-11	1063-1072	procedure	_	
8-12	1073-1075	to	_	
8-13	1076-1082	obtain	_	
8-14	1083-1084	a	_	
8-15	1085-1102	co-classification	_	
8-16	1103-1108	index	_	
8-17	1109-1115	matrix	_	
8-18	1116-1117	(	_	
8-19	1117-1119	an	_	
8-20	1120-1129	indicator	_	
8-21	1130-1132	of	_	
8-22	1133-1142	community	_	
8-23	1143-1154	association	_	
8-24	1155-1163	strength	_	
8-25	1163-1164	)	_	
8-26	1165-1168	for	_	
8-27	1169-1173	each	_	
8-28	1174-1181	subject	_	
8-29	1181-1182	.	_	

#Text=Differences in co-classification and structural connectivity (indexed by streamline density) were assessed via the Network Based Statistics Toolbox.
9-1	1183-1194	Differences	_	
9-2	1195-1197	in	_	
9-3	1198-1215	co-classification	_	
9-4	1216-1219	and	_	
9-5	1220-1230	structural	_	
9-6	1231-1243	connectivity	_	
9-7	1244-1245	(	_	
9-8	1245-1252	indexed	_	
9-9	1253-1255	by	_	
9-10	1256-1266	streamline	_	
9-11	1267-1274	density	_	
9-12	1274-1275	)	_	
9-13	1276-1280	were	_	
9-14	1281-1289	assessed	_	
9-15	1290-1293	via	_	
9-16	1294-1297	the	_	
9-17	1298-1305	Network	_	
9-18	1306-1311	Based	_	
9-19	1312-1322	Statistics	_	
9-20	1323-1330	Toolbox	_	
9-21	1330-1331	.	_	

#Text=Results:
#Text=AUD had higher FA values throughout the major WM tracts, but also had lower FA values in WM tracts in the cerebellum and right insula (pTFCE < 0.05).
10-1	1332-1339	Results	_	
10-2	1339-1340	:	_	
10-3	1341-1344	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
10-4	1345-1348	had	_	
10-5	1349-1355	higher	_	
10-6	1356-1358	FA	_	
10-7	1359-1365	values	_	
10-8	1366-1376	throughout	_	
10-9	1377-1380	the	_	
10-10	1381-1386	major	_	
10-11	1387-1389	WM	_	
10-12	1390-1396	tracts	_	
10-13	1396-1397	,	_	
10-14	1398-1401	but	_	
10-15	1402-1406	also	_	
10-16	1407-1410	had	_	
10-17	1411-1416	lower	_	
10-18	1417-1419	FA	_	
10-19	1420-1426	values	_	
10-20	1427-1429	in	_	
10-21	1430-1432	WM	_	
10-22	1433-1439	tracts	_	
10-23	1440-1442	in	_	
10-24	1443-1446	the	_	
10-25	1447-1457	cerebellum	_	
10-26	1458-1461	and	_	
10-27	1462-1467	right	_	
10-28	1468-1474	insula	_	
10-29	1475-1476	(	_	
10-30	1476-1481	pTFCE	_	
10-31	1482-1483	<	_	
10-32	1484-1488	0.05	_	
10-33	1488-1489	)	_	
10-34	1489-1490	.	_	

#Text=Mean diffusivity was generally lower in the AUD group (pTFCE < 0.05).
11-1	1491-1495	Mean	_	
11-2	1496-1507	diffusivity	_	
11-3	1508-1511	was	_	
11-4	1512-1521	generally	_	
11-5	1522-1527	lower	_	
11-6	1528-1530	in	_	
11-7	1531-1534	the	_	
11-8	1535-1538	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[12]	
11-9	1539-1544	group	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[12]	
11-10	1545-1546	(	_	
11-11	1546-1551	pTFCE	_	
11-12	1552-1553	<	_	
11-13	1554-1558	0.05	_	
11-14	1558-1559	)	_	
11-15	1559-1560	.	_	

#Text=AUD had lower co-classification of nodes between ventral attention and default mode networks, and higher co-classification between nodes of visual, default mode, and somatomotor networks.
12-1	1561-1564	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
12-2	1565-1568	had	_	
12-3	1569-1574	lower	_	
12-4	1575-1592	co-classification	_	
12-5	1593-1595	of	_	
12-6	1596-1601	nodes	_	
12-7	1602-1609	between	_	
12-8	1610-1617	ventral	_	
12-9	1618-1627	attention	_	
12-10	1628-1631	and	_	
12-11	1632-1639	default	_	
12-12	1640-1644	mode	_	
12-13	1645-1653	networks	_	
12-14	1653-1654	,	_	
12-15	1655-1658	and	_	
12-16	1659-1665	higher	_	
12-17	1666-1683	co-classification	_	
12-18	1684-1691	between	_	
12-19	1692-1697	nodes	_	
12-20	1698-1700	of	_	
12-21	1701-1707	visual	_	
12-22	1707-1708	,	_	
12-23	1709-1716	default	_	
12-24	1717-1721	mode	_	
12-25	1721-1722	,	_	
12-26	1723-1726	and	_	
12-27	1727-1738	somatomotor	_	
12-28	1739-1747	networks	_	
12-29	1747-1748	.	_	

#Text=Additionally, AUD had higher fiber density between an adjacent pair of nodes within the default mode network.
13-1	1749-1761	Additionally	_	
13-2	1761-1762	,	_	
13-3	1763-1766	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
13-4	1767-1770	had	_	
13-5	1771-1777	higher	_	
13-6	1778-1783	fiber	_	
13-7	1784-1791	density	_	
13-8	1792-1799	between	_	
13-9	1800-1802	an	_	
13-10	1803-1811	adjacent	_	
13-11	1812-1816	pair	_	
13-12	1817-1819	of	_	
13-13	1820-1825	nodes	_	
13-14	1826-1832	within	_	
13-15	1833-1836	the	_	
13-16	1837-1844	default	_	
13-17	1845-1849	mode	_	
13-18	1850-1857	network	_	
13-19	1857-1858	.	_	

#Text=Conclusion:
#Text=Our results indicate that emerging adulthood AUD subjects may have differential patterns of FA and distinct differences in structural connectomes compared to CON.
14-1	1859-1869	Conclusion	_	
14-2	1869-1870	:	_	
14-3	1871-1874	Our	_	
14-4	1875-1882	results	_	
14-5	1883-1891	indicate	_	
14-6	1892-1896	that	_	
14-7	1897-1905	emerging	_	
14-8	1906-1915	adulthood	_	
14-9	1916-1919	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[13]	
14-10	1920-1928	subjects	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[13]	
14-11	1929-1932	may	_	
14-12	1933-1937	have	_	
14-13	1938-1950	differential	_	
14-14	1951-1959	patterns	_	
14-15	1960-1962	of	_	
14-16	1963-1965	FA	_	
14-17	1966-1969	and	_	
14-18	1970-1978	distinct	_	
14-19	1979-1990	differences	_	
14-20	1991-1993	in	_	
14-21	1994-2004	structural	_	
14-22	2005-2016	connectomes	_	
14-23	2017-2025	compared	_	
14-24	2026-2028	to	_	
14-25	2029-2032	CON	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
14-26	2032-2033	.	_	

#Text=These data suggest that such alterations in microstructure and structural connectivity may uniquely characterize early stages of AUD and/or a predisposition for development of AUD.
15-1	2034-2039	These	_	
15-2	2040-2044	data	_	
15-3	2045-2052	suggest	_	
15-4	2053-2057	that	_	
15-5	2058-2062	such	_	
15-6	2063-2074	alterations	_	
15-7	2075-2077	in	_	
15-8	2078-2092	microstructure	_	
15-9	2093-2096	and	_	
15-10	2097-2107	structural	_	
15-11	2108-2120	connectivity	_	
15-12	2121-2124	may	_	
15-13	2125-2133	uniquely	_	
15-14	2134-2146	characterize	_	
15-15	2147-2152	early	_	
15-16	2153-2159	stages	_	
15-17	2160-2162	of	_	
15-18	2163-2166	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
15-19	2167-2170	and	_	
15-20	2170-2171	/	_	
15-21	2171-2173	or	_	
15-22	2174-2175	a	_	
15-23	2176-2190	predisposition	_	
15-24	2191-2194	for	_	
15-25	2195-2206	development	_	
15-26	2207-2209	of	_	
15-27	2210-2213	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
15-28	2213-2214	.	_	

#Text=Introduction
#Text=Alcohol use disorder (AUD) is the most common addictive disorder and is associated with significant morbidity, mortality, social, and economic burden.
16-1	2215-2227	Introduction	_	
16-2	2228-2235	Alcohol	_	
16-3	2236-2239	use	_	
16-4	2240-2248	disorder	_	
16-5	2249-2250	(	_	
16-6	2250-2253	AUD	_	
16-7	2253-2254	)	_	
16-8	2255-2257	is	_	
16-9	2258-2261	the	_	
16-10	2262-2266	most	_	
16-11	2267-2273	common	_	
16-12	2274-2283	addictive	_	
16-13	2284-2292	disorder	_	
16-14	2293-2296	and	_	
16-15	2297-2299	is	_	
16-16	2300-2310	associated	_	
16-17	2311-2315	with	_	
16-18	2316-2327	significant	_	
16-19	2328-2337	morbidity	_	
16-20	2337-2338	,	_	
16-21	2339-2348	mortality	_	
16-22	2348-2349	,	_	
16-23	2350-2356	social	_	
16-24	2356-2357	,	_	
16-25	2358-2361	and	_	
16-26	2362-2370	economic	_	
16-27	2371-2377	burden	_	
16-28	2377-2378	.	_	

#Text=Despite decades of research, a complete understanding of the disease processes remains incomplete, which hinders the development of successful treatments for AUD.
17-1	2379-2386	Despite	_	
17-2	2387-2394	decades	_	
17-3	2395-2397	of	_	
17-4	2398-2406	research	_	
17-5	2406-2407	,	_	
17-6	2408-2409	a	_	
17-7	2410-2418	complete	_	
17-8	2419-2432	understanding	_	
17-9	2433-2435	of	_	
17-10	2436-2439	the	_	
17-11	2440-2447	disease	_	
17-12	2448-2457	processes	_	
17-13	2458-2465	remains	_	
17-14	2466-2476	incomplete	_	
17-15	2476-2477	,	_	
17-16	2478-2483	which	_	
17-17	2484-2491	hinders	_	
17-18	2492-2495	the	_	
17-19	2496-2507	development	_	
17-20	2508-2510	of	_	
17-21	2511-2521	successful	_	
17-22	2522-2532	treatments	_	
17-23	2533-2536	for	_	
17-24	2537-2540	AUD	_	
17-25	2540-2541	.	_	

#Text=One strategy to aid in our knowledge is to study younger individuals with AUD in order to better characterize the brain during the earliest stages of the disorder.
18-1	2542-2545	One	_	
18-2	2546-2554	strategy	_	
18-3	2555-2557	to	_	
18-4	2558-2561	aid	_	
18-5	2562-2564	in	_	
18-6	2565-2568	our	_	
18-7	2569-2578	knowledge	_	
18-8	2579-2581	is	_	
18-9	2582-2584	to	_	
18-10	2585-2590	study	_	
18-11	2591-2598	younger	_	
18-12	2599-2610	individuals	_	
18-13	2611-2615	with	_	
18-14	2616-2619	AUD	_	
18-15	2620-2622	in	_	
18-16	2623-2628	order	_	
18-17	2629-2631	to	_	
18-18	2632-2638	better	_	
18-19	2639-2651	characterize	_	
18-20	2652-2655	the	_	
18-21	2656-2661	brain	_	
18-22	2662-2668	during	_	
18-23	2669-2672	the	_	
18-24	2673-2681	earliest	_	
18-25	2682-2688	stages	_	
18-26	2689-2691	of	_	
18-27	2692-2695	the	_	
18-28	2696-2704	disorder	_	
18-29	2704-2705	.	_	

#Text=Additionally, AUD is a significant health problem in young adults.
19-1	2706-2718	Additionally	_	
19-2	2718-2719	,	_	
19-3	2720-2723	AUD	_	
19-4	2724-2726	is	_	
19-5	2727-2728	a	_	
19-6	2729-2740	significant	_	
19-7	2741-2747	health	_	
19-8	2748-2755	problem	_	
19-9	2756-2758	in	_	
19-10	2759-2764	young	_	
19-11	2765-2771	adults	_	
19-12	2771-2772	.	_	

#Text=According to the 2016 National Survey on Drug Use and Health (NSDUH), 12% of individuals aged 21– 25 years old report heavy alcohol use (binge drinking on five or more days in the past month), yet only 5.6% of those 35 and older report heavy alcohol use (NSDUH, 2016).
20-1	2773-2782	According	_	
20-2	2783-2785	to	_	
20-3	2786-2789	the	_	
20-4	2790-2794	2016	_	
20-5	2795-2803	National	_	
20-6	2804-2810	Survey	_	
20-7	2811-2813	on	_	
20-8	2814-2818	Drug	_	
20-9	2819-2822	Use	_	
20-10	2823-2826	and	_	
20-11	2827-2833	Health	_	
20-12	2834-2835	(	_	
20-13	2835-2840	NSDUH	_	
20-14	2840-2841	)	_	
20-15	2841-2842	,	_	
20-16	2843-2846	12%	_	
20-17	2847-2849	of	_	
20-18	2850-2861	individuals	_	
20-19	2862-2866	aged	_	
20-20	2867-2869	21	_	
20-21	2869-2870	–	_	
20-22	2871-2873	25	_	
20-23	2874-2879	years	_	
20-24	2880-2883	old	_	
20-25	2884-2890	report	_	
20-26	2891-2896	heavy	_	
20-27	2897-2904	alcohol	_	
20-28	2905-2908	use	_	
20-29	2909-2910	(	_	
20-30	2910-2915	binge	_	
20-31	2916-2924	drinking	_	
20-32	2925-2927	on	_	
20-33	2928-2932	five	_	
20-34	2933-2935	or	_	
20-35	2936-2940	more	_	
20-36	2941-2945	days	_	
20-37	2946-2948	in	_	
20-38	2949-2952	the	_	
20-39	2953-2957	past	_	
20-40	2958-2963	month	_	
20-41	2963-2964	)	_	
20-42	2964-2965	,	_	
20-43	2966-2969	yet	_	
20-44	2970-2974	only	_	
20-45	2975-2979	5.6%	_	
20-46	2980-2982	of	_	
20-47	2983-2988	those	_	
20-48	2989-2991	35	_	
20-49	2992-2995	and	_	
20-50	2996-3001	older	_	
20-51	3002-3008	report	_	
20-52	3009-3014	heavy	_	
20-53	3015-3022	alcohol	_	
20-54	3023-3026	use	_	
20-55	3027-3028	(	_	
20-56	3028-3033	NSDUH	_	
20-57	3033-3034	,	_	
20-58	3035-3039	2016	_	
20-59	3039-3040	)	_	
20-60	3040-3041	.	_	

#Text=Furthermore, among college aged students (age 18–25), studies show that between 10 – 20% meet the criteria for an alcohol use disorder; however, in the general population, only around 5% meet the criteria for AUD (, NSDUH, 2016).
21-1	3042-3053	Furthermore	_	
21-2	3053-3054	,	_	
21-3	3055-3060	among	_	
21-4	3061-3068	college	_	
21-5	3069-3073	aged	_	
21-6	3074-3082	students	_	
21-7	3083-3084	(	_	
21-8	3084-3087	age	_	
21-9	3088-3090	18	_	
21-10	3090-3091	–	_	
21-11	3091-3093	25	_	
21-12	3093-3094	)	_	
21-13	3094-3095	,	_	
21-14	3096-3103	studies	_	
21-15	3104-3108	show	_	
21-16	3109-3113	that	_	
21-17	3114-3121	between	_	
21-18	3122-3124	10	_	
21-19	3125-3126	–	_	
21-20	3127-3130	20%	_	
21-21	3131-3135	meet	_	
21-22	3136-3139	the	_	
21-23	3140-3148	criteria	_	
21-24	3149-3152	for	_	
21-25	3153-3155	an	_	
21-26	3156-3163	alcohol	_	
21-27	3164-3167	use	_	
21-28	3168-3176	disorder	_	
21-29	3176-3177	;	_	
21-30	3178-3185	however	_	
21-31	3185-3186	,	_	
21-32	3187-3189	in	_	
21-33	3190-3193	the	_	
21-34	3194-3201	general	_	
21-35	3202-3212	population	_	
21-36	3212-3213	,	_	
21-37	3214-3218	only	_	
21-38	3219-3225	around	_	
21-39	3226-3228	5%	_	
21-40	3229-3233	meet	_	
21-41	3234-3237	the	_	
21-42	3238-3246	criteria	_	
21-43	3247-3250	for	_	
21-44	3251-3254	AUD	_	
21-45	3255-3256	(	_	
21-46	3256-3257	,	_	
21-47	3258-3263	NSDUH	_	
21-48	3263-3264	,	_	
21-49	3265-3269	2016	_	
21-50	3269-3270	)	_	
21-51	3270-3271	.	_	

#Text=These epidemiological reports demonstrate that AUD in young adults is already a significant problem.
22-1	3272-3277	These	_	
22-2	3278-3293	epidemiological	_	
22-3	3294-3301	reports	_	
22-4	3302-3313	demonstrate	_	
22-5	3314-3318	that	_	
22-6	3319-3322	AUD	_	
22-7	3323-3325	in	_	
22-8	3326-3331	young	_	
22-9	3332-3338	adults	_	
22-10	3339-3341	is	_	
22-11	3342-3349	already	_	
22-12	3350-3351	a	_	
22-13	3352-3363	significant	_	
22-14	3364-3371	problem	_	
22-15	3371-3372	.	_	

#Text=Although a growing body of literature exists on the effects of drinking (and risk for AUD) on adolescent (age 13–17) brains (also, see below), little is known about brain structure in young adults (~18–25 years old) with AUD.
23-1	3373-3381	Although	_	
23-2	3382-3383	a	_	
23-3	3384-3391	growing	_	
23-4	3392-3396	body	_	
23-5	3397-3399	of	_	
23-6	3400-3410	literature	_	
23-7	3411-3417	exists	_	
23-8	3418-3420	on	_	
23-9	3421-3424	the	_	
23-10	3425-3432	effects	_	
23-11	3433-3435	of	_	
23-12	3436-3444	drinking	_	
23-13	3445-3446	(	_	
23-14	3446-3449	and	_	
23-15	3450-3454	risk	_	
23-16	3455-3458	for	_	
23-17	3459-3462	AUD	_	
23-18	3462-3463	)	_	
23-19	3464-3466	on	_	
23-20	3467-3477	adolescent	_	
23-21	3478-3479	(	_	
23-22	3479-3482	age	_	
23-23	3483-3485	13	_	
23-24	3485-3486	–	_	
23-25	3486-3488	17	_	
23-26	3488-3489	)	_	
23-27	3490-3496	brains	_	
23-28	3497-3498	(	_	
23-29	3498-3502	also	_	
23-30	3502-3503	,	_	
23-31	3504-3507	see	_	
23-32	3508-3513	below	_	
23-33	3513-3514	)	_	
23-34	3514-3515	,	_	
23-35	3516-3522	little	_	
23-36	3523-3525	is	_	
23-37	3526-3531	known	_	
23-38	3532-3537	about	_	
23-39	3538-3543	brain	_	
23-40	3544-3553	structure	_	
23-41	3554-3556	in	_	
23-42	3557-3562	young	_	
23-43	3563-3569	adults	_	
23-44	3570-3571	(	_	
23-45	3571-3572	~	_	
23-46	3572-3574	18	_	
23-47	3574-3575	–	_	
23-48	3575-3577	25	_	
23-49	3578-3583	years	_	
23-50	3584-3587	old	_	
23-51	3587-3588	)	_	
23-52	3589-3593	with	_	
23-53	3594-3597	AUD	_	
23-54	3597-3598	.	_	

#Text=Late adolescence/emerging adulthood is a critical neurodevelopmental window that involves maturation of reward-related regions and cortical areas involved with executive function (for review see).
24-1	3599-3603	Late	_	
24-2	3604-3615	adolescence	_	
24-3	3615-3616	/	_	
24-4	3616-3624	emerging	_	
24-5	3625-3634	adulthood	_	
24-6	3635-3637	is	_	
24-7	3638-3639	a	_	
24-8	3640-3648	critical	_	
24-9	3649-3667	neurodevelopmental	_	
24-10	3668-3674	window	_	
24-11	3675-3679	that	_	
24-12	3680-3688	involves	_	
24-13	3689-3699	maturation	_	
24-14	3700-3702	of	_	
24-15	3703-3717	reward-related	_	
24-16	3718-3725	regions	_	
24-17	3726-3729	and	_	
24-18	3730-3738	cortical	_	
24-19	3739-3744	areas	_	
24-20	3745-3753	involved	_	
24-21	3754-3758	with	_	
24-22	3759-3768	executive	_	
24-23	3769-3777	function	_	
24-24	3778-3779	(	_	
24-25	3779-3782	for	_	
24-26	3783-3789	review	_	
24-27	3790-3793	see	_	
24-28	3793-3794	)	_	
24-29	3794-3795	.	_	

#Text=As this age group enters a collegiate environment, the potential for greater exposure to alcohol increases.
25-1	3796-3798	As	_	
25-2	3799-3803	this	_	
25-3	3804-3807	age	_	
25-4	3808-3813	group	_	
25-5	3814-3820	enters	_	
25-6	3821-3822	a	_	
25-7	3823-3833	collegiate	_	
25-8	3834-3845	environment	_	
25-9	3845-3846	,	_	
25-10	3847-3850	the	_	
25-11	3851-3860	potential	_	
25-12	3861-3864	for	_	
25-13	3865-3872	greater	_	
25-14	3873-3881	exposure	_	
25-15	3882-3884	to	_	
25-16	3885-3892	alcohol	_	
25-17	3893-3902	increases	_	
25-18	3902-3903	.	_	

#Text=In turn, this increases the vulnerability for development of AUD and potential concomitant adverse consequences on brain development during this time period.
26-1	3904-3906	In	_	
26-2	3907-3911	turn	_	
26-3	3911-3912	,	_	
26-4	3913-3917	this	_	
26-5	3918-3927	increases	_	
26-6	3928-3931	the	_	
26-7	3932-3945	vulnerability	_	
26-8	3946-3949	for	_	
26-9	3950-3961	development	_	
26-10	3962-3964	of	_	
26-11	3965-3968	AUD	_	
26-12	3969-3972	and	_	
26-13	3973-3982	potential	_	
26-14	3983-3994	concomitant	_	
26-15	3995-4002	adverse	_	
26-16	4003-4015	consequences	_	
26-17	4016-4018	on	_	
26-18	4019-4024	brain	_	
26-19	4025-4036	development	_	
26-20	4037-4043	during	_	
26-21	4044-4048	this	_	
26-22	4049-4053	time	_	
26-23	4054-4060	period	_	
26-24	4060-4061	.	_	

#Text=Thus, there is a critical need to better understand the effects of AUD on the brain in younger individuals, as this may ultimately facilitate the ability to identify those at risk for sustained AUD.
27-1	4062-4066	Thus	_	
27-2	4066-4067	,	_	
27-3	4068-4073	there	_	
27-4	4074-4076	is	_	
27-5	4077-4078	a	_	
27-6	4079-4087	critical	_	
27-7	4088-4092	need	_	
27-8	4093-4095	to	_	
27-9	4096-4102	better	_	
27-10	4103-4113	understand	_	
27-11	4114-4117	the	_	
27-12	4118-4125	effects	_	
27-13	4126-4128	of	_	
27-14	4129-4132	AUD	_	
27-15	4133-4135	on	_	
27-16	4136-4139	the	_	
27-17	4140-4145	brain	_	
27-18	4146-4148	in	_	
27-19	4149-4156	younger	_	
27-20	4157-4168	individuals	_	
27-21	4168-4169	,	_	
27-22	4170-4172	as	_	
27-23	4173-4177	this	_	
27-24	4178-4181	may	_	
27-25	4182-4192	ultimately	_	
27-26	4193-4203	facilitate	_	
27-27	4204-4207	the	_	
27-28	4208-4215	ability	_	
27-29	4216-4218	to	_	
27-30	4219-4227	identify	_	
27-31	4228-4233	those	_	
27-32	4234-4236	at	_	
27-33	4237-4241	risk	_	
27-34	4242-4245	for	_	
27-35	4246-4255	sustained	_	
27-36	4256-4259	AUD	_	
27-37	4259-4260	.	_	

#Text=In turn, such knowledge could permit development of interventions to prevent extensive damage and/or persistence of AUD throughout adulthood.
28-1	4261-4263	In	_	
28-2	4264-4268	turn	_	
28-3	4268-4269	,	_	
28-4	4270-4274	such	_	
28-5	4275-4284	knowledge	_	
28-6	4285-4290	could	_	
28-7	4291-4297	permit	_	
28-8	4298-4309	development	_	
28-9	4310-4312	of	_	
28-10	4313-4326	interventions	_	
28-11	4327-4329	to	_	
28-12	4330-4337	prevent	_	
28-13	4338-4347	extensive	_	
28-14	4348-4354	damage	_	
28-15	4355-4358	and	_	
28-16	4358-4359	/	_	
28-17	4359-4361	or	_	
28-18	4362-4373	persistence	_	
28-19	4374-4376	of	_	
28-20	4377-4380	AUD	_	
28-21	4381-4391	throughout	_	
28-22	4392-4401	adulthood	_	
28-23	4401-4402	.	_	

#Text=Diffusion weighted imaging (DWI) is a neuroimaging technique that allows a non-invasive investigation of white matter (WM) microstructure.
29-1	4403-4412	Diffusion	_	
29-2	4413-4421	weighted	_	
29-3	4422-4429	imaging	_	
29-4	4430-4431	(	_	
29-5	4431-4434	DWI	_	
29-6	4434-4435	)	_	
29-7	4436-4438	is	_	
29-8	4439-4440	a	_	
29-9	4441-4453	neuroimaging	_	
29-10	4454-4463	technique	_	
29-11	4464-4468	that	_	
29-12	4469-4475	allows	_	
29-13	4476-4477	a	_	
29-14	4478-4490	non-invasive	_	
29-15	4491-4504	investigation	_	
29-16	4505-4507	of	_	
29-17	4508-4513	white	_	
29-18	4514-4520	matter	_	
29-19	4521-4522	(	_	
29-20	4522-4524	WM	_	
29-21	4524-4525	)	_	
29-22	4526-4540	microstructure	_	
29-23	4540-4541	.	_	

#Text=In preclinical studies, it is well known that alcohol leads to myelination injury.
30-1	4542-4544	In	_	
30-2	4545-4556	preclinical	_	
30-3	4557-4564	studies	_	
30-4	4564-4565	,	_	
30-5	4566-4568	it	_	
30-6	4569-4571	is	_	
30-7	4572-4576	well	_	
30-8	4577-4582	known	_	
30-9	4583-4587	that	_	
30-10	4588-4595	alcohol	_	
30-11	4596-4601	leads	_	
30-12	4602-4604	to	_	
30-13	4605-4616	myelination	_	
30-14	4617-4623	injury	_	
30-15	4623-4624	.	_	

#Text=Similarly, DWI studies have demonstrated that AUD is associated with deleterious effects on WM microstructure in recently detoxified individuals who reported, on average, two decades of alcohol use.
31-1	4625-4634	Similarly	_	
31-2	4634-4635	,	_	
31-3	4636-4639	DWI	_	
31-4	4640-4647	studies	_	
31-5	4648-4652	have	_	
31-6	4653-4665	demonstrated	_	
31-7	4666-4670	that	_	
31-8	4671-4674	AUD	_	
31-9	4675-4677	is	_	
31-10	4678-4688	associated	_	
31-11	4689-4693	with	_	
31-12	4694-4705	deleterious	_	
31-13	4706-4713	effects	_	
31-14	4714-4716	on	_	
31-15	4717-4719	WM	_	
31-16	4720-4734	microstructure	_	
31-17	4735-4737	in	_	
31-18	4738-4746	recently	_	
31-19	4747-4757	detoxified	_	
31-20	4758-4769	individuals	_	
31-21	4770-4773	who	_	
31-22	4774-4782	reported	_	
31-23	4782-4783	,	_	
31-24	4784-4786	on	_	
31-25	4787-4794	average	_	
31-26	4794-4795	,	_	
31-27	4796-4799	two	_	
31-28	4800-4807	decades	_	
31-29	4808-4810	of	_	
31-30	4811-4818	alcohol	_	
31-31	4819-4822	use	_	
31-32	4822-4823	.	_	

#Text=While widespread deficits in WM tracts have been observed, damage has most consistently been demonstrated in the corpus callosum, frontal forceps, internal and external capsules, fornix, superior cingulate and longitudinal fasciculi.
32-1	4824-4829	While	_	
32-2	4830-4840	widespread	_	
32-3	4841-4849	deficits	_	
32-4	4850-4852	in	_	
32-5	4853-4855	WM	_	
32-6	4856-4862	tracts	_	
32-7	4863-4867	have	_	
32-8	4868-4872	been	_	
32-9	4873-4881	observed	_	
32-10	4881-4882	,	_	
32-11	4883-4889	damage	_	
32-12	4890-4893	has	_	
32-13	4894-4898	most	_	
32-14	4899-4911	consistently	_	
32-15	4912-4916	been	_	
32-16	4917-4929	demonstrated	_	
32-17	4930-4932	in	_	
32-18	4933-4936	the	_	
32-19	4937-4943	corpus	_	
32-20	4944-4952	callosum	_	
32-21	4952-4953	,	_	
32-22	4954-4961	frontal	_	
32-23	4962-4969	forceps	_	
32-24	4969-4970	,	_	
32-25	4971-4979	internal	_	
32-26	4980-4983	and	_	
32-27	4984-4992	external	_	
32-28	4993-5001	capsules	_	
32-29	5001-5002	,	_	
32-30	5003-5009	fornix	_	
32-31	5009-5010	,	_	
32-32	5011-5019	superior	_	
32-33	5020-5029	cingulate	_	
32-34	5030-5033	and	_	
32-35	5034-5046	longitudinal	_	
32-36	5047-5056	fasciculi	_	
32-37	5056-5057	.	_	

#Text=However, data on the consequences of alcohol misuse on WM integrity in college-age individuals (18–24 years of age) are extremely limited and equivocal.
33-1	5058-5065	However	_	
33-2	5065-5066	,	_	
33-3	5067-5071	data	_	
33-4	5072-5074	on	_	
33-5	5075-5078	the	_	
33-6	5079-5091	consequences	_	
33-7	5092-5094	of	_	
33-8	5095-5102	alcohol	_	
33-9	5103-5109	misuse	_	
33-10	5110-5112	on	_	
33-11	5113-5115	WM	_	
33-12	5116-5125	integrity	_	
33-13	5126-5128	in	_	
33-14	5129-5140	college-age	_	
33-15	5141-5152	individuals	_	
33-16	5153-5154	(	_	
33-17	5154-5156	18	_	
33-18	5156-5157	–	_	
33-19	5157-5159	24	_	
33-20	5160-5165	years	_	
33-21	5166-5168	of	_	
33-22	5169-5172	age	_	
33-23	5172-5173	)	_	
33-24	5174-5177	are	_	
33-25	5178-5187	extremely	_	
33-26	5188-5195	limited	_	
33-27	5196-5199	and	_	
33-28	5200-5209	equivocal	_	
33-29	5209-5210	.	_	

#Text=At a 2-year follow-up, 20–21 year-old binge drinkers had no changes in DTI-based metrics over time, and were not different from controls.
34-1	5211-5213	At	_	
34-2	5214-5215	a	_	
34-3	5216-5217	2	_	
34-4	5217-5218	-	_	
34-5	5218-5222	year	_	
34-6	5223-5232	follow-up	_	
34-7	5232-5233	,	_	
34-8	5234-5236	20	_	
34-9	5236-5237	–	_	
34-10	5237-5239	21	_	
34-11	5240-5248	year-old	_	
34-12	5249-5254	binge	_	
34-13	5255-5263	drinkers	_	
34-14	5264-5267	had	_	
34-15	5268-5270	no	_	
34-16	5271-5278	changes	_	
34-17	5279-5281	in	_	
34-18	5282-5291	DTI-based	_	
34-19	5292-5299	metrics	_	
34-20	5300-5304	over	_	
34-21	5305-5309	time	_	
34-22	5309-5310	,	_	
34-23	5311-5314	and	_	
34-24	5315-5319	were	_	
34-25	5320-5323	not	_	
34-26	5324-5333	different	_	
34-27	5334-5338	from	_	
34-28	5339-5347	controls	_	
34-29	5347-5348	.	_	

#Text=In addition, while lower FA has been reported in binge drinkers ~17 years of age, higher FA has been observed in individuals with AUD of similar age.
35-1	5349-5351	In	_	
35-2	5352-5360	addition	_	
35-3	5360-5361	,	_	
35-4	5362-5367	while	_	
35-5	5368-5373	lower	_	
35-6	5374-5376	FA	_	
35-7	5377-5380	has	_	
35-8	5381-5385	been	_	
35-9	5386-5394	reported	_	
35-10	5395-5397	in	_	
35-11	5398-5403	binge	_	
35-12	5404-5412	drinkers	_	
35-13	5413-5414	~	_	
35-14	5414-5416	17	_	
35-15	5417-5422	years	_	
35-16	5423-5425	of	_	
35-17	5426-5429	age	_	
35-18	5429-5430	,	_	
35-19	5431-5437	higher	_	
35-20	5438-5440	FA	_	
35-21	5441-5444	has	_	
35-22	5445-5449	been	_	
35-23	5450-5458	observed	_	
35-24	5459-5461	in	_	
35-25	5462-5473	individuals	_	
35-26	5474-5478	with	_	
35-27	5479-5482	AUD	_	
35-28	5483-5485	of	_	
35-29	5486-5493	similar	_	
35-30	5494-5497	age	_	
35-31	5497-5498	.	_	

#Text=Thus, additional work is needed to better understand the ramifications of hazardous drinking in college-age young adults.
36-1	5499-5503	Thus	_	
36-2	5503-5504	,	_	
36-3	5505-5515	additional	_	
36-4	5516-5520	work	_	
36-5	5521-5523	is	_	
36-6	5524-5530	needed	_	
36-7	5531-5533	to	_	
36-8	5534-5540	better	_	
36-9	5541-5551	understand	_	
36-10	5552-5555	the	_	
36-11	5556-5569	ramifications	_	
36-12	5570-5572	of	_	
36-13	5573-5582	hazardous	_	
36-14	5583-5591	drinking	_	
36-15	5592-5594	in	_	
36-16	5595-5606	college-age	_	
36-17	5607-5612	young	_	
36-18	5613-5619	adults	_	
36-19	5619-5620	.	_	

#Text=Studies that employ DWI typically adopt a diffusion tensor model and quantify WM integrity utilizing fractional anisotropy (FA), which is a metric that represents the degree anisotropy of water diffusion.
37-1	5621-5628	Studies	_	
37-2	5629-5633	that	_	
37-3	5634-5640	employ	_	
37-4	5641-5644	DWI	_	
37-5	5645-5654	typically	_	
37-6	5655-5660	adopt	_	
37-7	5661-5662	a	_	
37-8	5663-5672	diffusion	_	
37-9	5673-5679	tensor	_	
37-10	5680-5685	model	_	
37-11	5686-5689	and	_	
37-12	5690-5698	quantify	_	
37-13	5699-5701	WM	_	
37-14	5702-5711	integrity	_	
37-15	5712-5721	utilizing	_	
37-16	5722-5732	fractional	_	
37-17	5733-5743	anisotropy	_	
37-18	5744-5745	(	_	
37-19	5745-5747	FA	_	
37-20	5747-5748	)	_	
37-21	5748-5749	,	_	
37-22	5750-5755	which	_	
37-23	5756-5758	is	_	
37-24	5759-5760	a	_	
37-25	5761-5767	metric	_	
37-26	5768-5772	that	_	
37-27	5773-5783	represents	_	
37-28	5784-5787	the	_	
37-29	5788-5794	degree	_	
37-30	5795-5805	anisotropy	_	
37-31	5806-5808	of	_	
37-32	5809-5814	water	_	
37-33	5815-5824	diffusion	_	
37-34	5824-5825	.	_	

#Text=In the WM, lower FA values are indicative of less restriction in water movement, which suggests a disruption in the microstructural environment.
38-1	5826-5828	In	_	
38-2	5829-5832	the	_	
38-3	5833-5835	WM	_	
38-4	5835-5836	,	_	
38-5	5837-5842	lower	_	
38-6	5843-5845	FA	_	
38-7	5846-5852	values	_	
38-8	5853-5856	are	_	
38-9	5857-5867	indicative	_	
38-10	5868-5870	of	_	
38-11	5871-5875	less	_	
38-12	5876-5887	restriction	_	
38-13	5888-5890	in	_	
38-14	5891-5896	water	_	
38-15	5897-5905	movement	_	
38-16	5905-5906	,	_	
38-17	5907-5912	which	_	
38-18	5913-5921	suggests	_	
38-19	5922-5923	a	_	
38-20	5924-5934	disruption	_	
38-21	5935-5937	in	_	
38-22	5938-5941	the	_	
38-23	5942-5957	microstructural	_	
38-24	5958-5969	environment	_	
38-25	5969-5970	.	_	

#Text=In addition to FA, the full diffusion tensor shape can also be described with other scalar metrics such as mean, axial, and radial diffusivity (MD, AD, and RD, respectively).
39-1	5971-5973	In	_	
39-2	5974-5982	addition	_	
39-3	5983-5985	to	_	
39-4	5986-5988	FA	_	
39-5	5988-5989	,	_	
39-6	5990-5993	the	_	
39-7	5994-5998	full	_	
39-8	5999-6008	diffusion	_	
39-9	6009-6015	tensor	_	
39-10	6016-6021	shape	_	
39-11	6022-6025	can	_	
39-12	6026-6030	also	_	
39-13	6031-6033	be	_	
39-14	6034-6043	described	_	
39-15	6044-6048	with	_	
39-16	6049-6054	other	_	
39-17	6055-6061	scalar	_	
39-18	6062-6069	metrics	_	
39-19	6070-6074	such	_	
39-20	6075-6077	as	_	
39-21	6078-6082	mean	_	
39-22	6082-6083	,	_	
39-23	6084-6089	axial	_	
39-24	6089-6090	,	_	
39-25	6091-6094	and	_	
39-26	6095-6101	radial	_	
39-27	6102-6113	diffusivity	_	
39-28	6114-6115	(	_	
39-29	6115-6117	MD	_	
39-30	6117-6118	,	_	
39-31	6119-6121	AD	_	
39-32	6121-6122	,	_	
39-33	6123-6126	and	_	
39-34	6127-6129	RD	_	
39-35	6129-6130	,	_	
39-36	6131-6143	respectively	_	
39-37	6143-6144	)	_	
39-38	6144-6145	.	_	

#Text=Chronic alcohol misuse has been associated with a reduction in DWI-based measures of WM integrity, whereas, in adolescent populations, higher measurements of WM integrity are typically reported, which are thought to reflect a predisposition to development of alcohol use disorder.
40-1	6146-6153	Chronic	_	
40-2	6154-6161	alcohol	_	
40-3	6162-6168	misuse	_	
40-4	6169-6172	has	_	
40-5	6173-6177	been	_	
40-6	6178-6188	associated	_	
40-7	6189-6193	with	_	
40-8	6194-6195	a	_	
40-9	6196-6205	reduction	_	
40-10	6206-6208	in	_	
40-11	6209-6218	DWI-based	_	
40-12	6219-6227	measures	_	
40-13	6228-6230	of	_	
40-14	6231-6233	WM	_	
40-15	6234-6243	integrity	_	
40-16	6243-6244	,	_	
40-17	6245-6252	whereas	_	
40-18	6252-6253	,	_	
40-19	6254-6256	in	_	
40-20	6257-6267	adolescent	_	
40-21	6268-6279	populations	_	
40-22	6279-6280	,	_	
40-23	6281-6287	higher	_	
40-24	6288-6300	measurements	_	
40-25	6301-6303	of	_	
40-26	6304-6306	WM	_	
40-27	6307-6316	integrity	_	
40-28	6317-6320	are	_	
40-29	6321-6330	typically	_	
40-30	6331-6339	reported	_	
40-31	6339-6340	,	_	
40-32	6341-6346	which	_	
40-33	6347-6350	are	_	
40-34	6351-6358	thought	_	
40-35	6359-6361	to	_	
40-36	6362-6369	reflect	_	
40-37	6370-6371	a	_	
40-38	6372-6386	predisposition	_	
40-39	6387-6389	to	_	
40-40	6390-6401	development	_	
40-41	6402-6404	of	_	
40-42	6405-6412	alcohol	_	
40-43	6413-6416	use	_	
40-44	6417-6425	disorder	_	
40-45	6425-6426	.	_	

#Text=Few studies have sought to investigate the effects of alcohol on WM microstructure in emerging adulthood (ages 18–24), when persistent hazardous drinking behaviors are typically established.
41-1	6427-6430	Few	_	
41-2	6431-6438	studies	_	
41-3	6439-6443	have	_	
41-4	6444-6450	sought	_	
41-5	6451-6453	to	_	
41-6	6454-6465	investigate	_	
41-7	6466-6469	the	_	
41-8	6470-6477	effects	_	
41-9	6478-6480	of	_	
41-10	6481-6488	alcohol	_	
41-11	6489-6491	on	_	
41-12	6492-6494	WM	_	
41-13	6495-6509	microstructure	_	
41-14	6510-6512	in	_	
41-15	6513-6521	emerging	_	
41-16	6522-6531	adulthood	_	
41-17	6532-6533	(	_	
41-18	6533-6537	ages	_	
41-19	6538-6540	18	_	
41-20	6540-6541	–	_	
41-21	6541-6543	24	_	
41-22	6543-6544	)	_	
41-23	6544-6545	,	_	
41-24	6546-6550	when	_	
41-25	6551-6561	persistent	_	
41-26	6562-6571	hazardous	_	
41-27	6572-6580	drinking	_	
41-28	6581-6590	behaviors	_	
41-29	6591-6594	are	_	
41-30	6595-6604	typically	_	
41-31	6605-6616	established	_	
41-32	6616-6617	.	_	

#Text=Increased understanding of the neurobiological consequences of AUD in this critical development period could bridge the gap between findings from adolescent and adult AUD research.
42-1	6618-6627	Increased	_	
42-2	6628-6641	understanding	_	
42-3	6642-6644	of	_	
42-4	6645-6648	the	_	
42-5	6649-6664	neurobiological	_	
42-6	6665-6677	consequences	_	
42-7	6678-6680	of	_	
42-8	6681-6684	AUD	_	
42-9	6685-6687	in	_	
42-10	6688-6692	this	_	
42-11	6693-6701	critical	_	
42-12	6702-6713	development	_	
42-13	6714-6720	period	_	
42-14	6721-6726	could	_	
42-15	6727-6733	bridge	_	
42-16	6734-6737	the	_	
42-17	6738-6741	gap	_	
42-18	6742-6749	between	_	
42-19	6750-6758	findings	_	
42-20	6759-6763	from	_	
42-21	6764-6774	adolescent	_	
42-22	6775-6778	and	_	
42-23	6779-6784	adult	_	
42-24	6785-6788	AUD	_	
42-25	6789-6797	research	_	
42-26	6797-6798	.	_	

#Text=Additionally, most DWI studies have been conducted in detoxified/abstinent AUD subjects; therefore, the present study makes a further contribution to the limited body of knowledge on WM microstructural differences in currently drinking, non-treatment seeking AUD subjects.
43-1	6799-6811	Additionally	_	
43-2	6811-6812	,	_	
43-3	6813-6817	most	_	
43-4	6818-6821	DWI	_	
43-5	6822-6829	studies	_	
43-6	6830-6834	have	_	
43-7	6835-6839	been	_	
43-8	6840-6849	conducted	_	
43-9	6850-6852	in	_	
43-10	6853-6863	detoxified	_	
43-11	6863-6864	/	_	
43-12	6864-6873	abstinent	_	
43-13	6874-6877	AUD	_	
43-14	6878-6886	subjects	_	
43-15	6886-6887	;	_	
43-16	6888-6897	therefore	_	
43-17	6897-6898	,	_	
43-18	6899-6902	the	_	
43-19	6903-6910	present	_	
43-20	6911-6916	study	_	
43-21	6917-6922	makes	_	
43-22	6923-6924	a	_	
43-23	6925-6932	further	_	
43-24	6933-6945	contribution	_	
43-25	6946-6948	to	_	
43-26	6949-6952	the	_	
43-27	6953-6960	limited	_	
43-28	6961-6965	body	_	
43-29	6966-6968	of	_	
43-30	6969-6978	knowledge	_	
43-31	6979-6981	on	_	
43-32	6982-6984	WM	_	
43-33	6985-7000	microstructural	_	
43-34	7001-7012	differences	_	
43-35	7013-7015	in	_	
43-36	7016-7025	currently	_	
43-37	7026-7034	drinking	_	
43-38	7034-7035	,	_	
43-39	7036-7049	non-treatment	_	
43-40	7050-7057	seeking	_	
43-41	7058-7061	AUD	_	
43-42	7062-7070	subjects	_	
43-43	7070-7071	.	_	

#Text=While DWI is in widespread use in research and clinical examinations of WM microstructural defects, traditional metrics (e.g., FA) may not be sensitive enough to detect structural differences in early AUD.
44-1	7072-7077	While	_	
44-2	7078-7081	DWI	_	
44-3	7082-7084	is	_	
44-4	7085-7087	in	_	
44-5	7088-7098	widespread	_	
44-6	7099-7102	use	_	
44-7	7103-7105	in	_	
44-8	7106-7114	research	_	
44-9	7115-7118	and	_	
44-10	7119-7127	clinical	_	
44-11	7128-7140	examinations	_	
44-12	7141-7143	of	_	
44-13	7144-7146	WM	_	
44-14	7147-7162	microstructural	_	
44-15	7163-7170	defects	_	
44-16	7170-7171	,	_	
44-17	7172-7183	traditional	_	
44-18	7184-7191	metrics	_	
44-19	7192-7193	(	_	
44-20	7193-7196	e.g	_	
44-21	7196-7197	.	_	
44-22	7197-7198	,	_	
44-23	7199-7201	FA	_	
44-24	7201-7202	)	_	
44-25	7203-7206	may	_	
44-26	7207-7210	not	_	
44-27	7211-7213	be	_	
44-28	7214-7223	sensitive	_	
44-29	7224-7230	enough	_	
44-30	7231-7233	to	_	
44-31	7234-7240	detect	_	
44-32	7241-7251	structural	_	
44-33	7252-7263	differences	_	
44-34	7264-7266	in	_	
44-35	7267-7272	early	_	
44-36	7273-7276	AUD	_	
44-37	7276-7277	.	_	

#Text=However, network science-based connectomics methodology may offer a novel insight into microstructural deficits in early AUD.
45-1	7278-7285	However	_	
45-2	7285-7286	,	_	
45-3	7287-7294	network	_	
45-4	7295-7308	science-based	_	
45-5	7309-7321	connectomics	_	
45-6	7322-7333	methodology	_	
45-7	7334-7337	may	_	
45-8	7338-7343	offer	_	
45-9	7344-7345	a	_	
45-10	7346-7351	novel	_	
45-11	7352-7359	insight	_	
45-12	7360-7364	into	_	
45-13	7365-7380	microstructural	_	
45-14	7381-7389	deficits	_	
45-15	7390-7392	in	_	
45-16	7393-7398	early	_	
45-17	7399-7402	AUD	_	
45-18	7402-7403	.	_	

#Text=These methods are applied to data obtained from DWI tractography-modeled brain networks of nodes (regions) and edges (connections).
46-1	7404-7409	These	_	
46-2	7410-7417	methods	_	
46-3	7418-7421	are	_	
46-4	7422-7429	applied	_	
46-5	7430-7432	to	_	
46-6	7433-7437	data	_	
46-7	7438-7446	obtained	_	
46-8	7447-7451	from	_	
46-9	7452-7455	DWI	_	
46-10	7456-7476	tractography-modeled	_	
46-11	7477-7482	brain	_	
46-12	7483-7491	networks	_	
46-13	7492-7494	of	_	
46-14	7495-7500	nodes	_	
46-15	7501-7502	(	_	
46-16	7502-7509	regions	_	
46-17	7509-7510	)	_	
46-18	7511-7514	and	_	
46-19	7515-7520	edges	_	
46-20	7521-7522	(	_	
46-21	7522-7533	connections	_	
46-22	7533-7534	)	_	
46-23	7534-7535	.	_	

#Text=One such network method is modularity, which represents the degree of segregation of a network into groups of interconnected nodes called communities.
47-1	7536-7539	One	_	
47-2	7540-7544	such	_	
47-3	7545-7552	network	_	
47-4	7553-7559	method	_	
47-5	7560-7562	is	_	
47-6	7563-7573	modularity	_	
47-7	7573-7574	,	_	
47-8	7575-7580	which	_	
47-9	7581-7591	represents	_	
47-10	7592-7595	the	_	
47-11	7596-7602	degree	_	
47-12	7603-7605	of	_	
47-13	7606-7617	segregation	_	
47-14	7618-7620	of	_	
47-15	7621-7622	a	_	
47-16	7623-7630	network	_	
47-17	7631-7635	into	_	
47-18	7636-7642	groups	_	
47-19	7643-7645	of	_	
47-20	7646-7660	interconnected	_	
47-21	7661-7666	nodes	_	
47-22	7667-7673	called	_	
47-23	7674-7685	communities	_	
47-24	7685-7686	.	_	

#Text=Putative differences in community structure between emerging adult AUD subjects and healthy individuals may represent a predisposition or an early consequence of AUD that has yet to be investigated.
48-1	7687-7695	Putative	_	
48-2	7696-7707	differences	_	
48-3	7708-7710	in	_	
48-4	7711-7720	community	_	
48-5	7721-7730	structure	_	
48-6	7731-7738	between	_	
48-7	7739-7747	emerging	_	
48-8	7748-7753	adult	_	
48-9	7754-7757	AUD	_	
48-10	7758-7766	subjects	_	
48-11	7767-7770	and	_	
48-12	7771-7778	healthy	_	
48-13	7779-7790	individuals	_	
48-14	7791-7794	may	_	
48-15	7795-7804	represent	_	
48-16	7805-7806	a	_	
48-17	7807-7821	predisposition	_	
48-18	7822-7824	or	_	
48-19	7825-7827	an	_	
48-20	7828-7833	early	_	
48-21	7834-7845	consequence	_	
48-22	7846-7848	of	_	
48-23	7849-7852	AUD	_	
48-24	7853-7857	that	_	
48-25	7858-7861	has	_	
48-26	7862-7865	yet	_	
48-27	7866-7868	to	_	
48-28	7869-7871	be	_	
48-29	7872-7884	investigated	_	
48-30	7884-7885	.	_	

#Text=The purpose of the present study was to investigate the WM integrity in young adults with or without AUD using both traditional metrics and a novel community detection approach.
49-1	7886-7889	The	_	
49-2	7890-7897	purpose	_	
49-3	7898-7900	of	_	
49-4	7901-7904	the	_	
49-5	7905-7912	present	_	
49-6	7913-7918	study	_	
49-7	7919-7922	was	_	
49-8	7923-7925	to	_	
49-9	7926-7937	investigate	_	
49-10	7938-7941	the	_	
49-11	7942-7944	WM	_	
49-12	7945-7954	integrity	_	
49-13	7955-7957	in	_	
49-14	7958-7963	young	_	
49-15	7964-7970	adults	_	
49-16	7971-7975	with	_	
49-17	7976-7978	or	_	
49-18	7979-7986	without	_	
49-19	7987-7990	AUD	_	
49-20	7991-7996	using	_	
49-21	7997-8001	both	_	
49-22	8002-8013	traditional	_	
49-23	8014-8021	metrics	_	
49-24	8022-8025	and	_	
49-25	8026-8027	a	_	
49-26	8028-8033	novel	_	
49-27	8034-8043	community	_	
49-28	8044-8053	detection	_	
49-29	8054-8062	approach	_	
49-30	8062-8063	.	_	

#Text=We hypothesized that, similar to older cohorts, younger AUD subjects would display significant differences in WM microstructure and altered connectivity due to the development of and/or consequences of AUD.
50-1	8064-8066	We	_	
50-2	8067-8079	hypothesized	_	
50-3	8080-8084	that	_	
50-4	8084-8085	,	_	
50-5	8086-8093	similar	_	
50-6	8094-8096	to	_	
50-7	8097-8102	older	_	
50-8	8103-8110	cohorts	_	
50-9	8110-8111	,	_	
50-10	8112-8119	younger	_	
50-11	8120-8123	AUD	_	
50-12	8124-8132	subjects	_	
50-13	8133-8138	would	_	
50-14	8139-8146	display	_	
50-15	8147-8158	significant	_	
50-16	8159-8170	differences	_	
50-17	8171-8173	in	_	
50-18	8174-8176	WM	_	
50-19	8177-8191	microstructure	_	
50-20	8192-8195	and	_	
50-21	8196-8203	altered	_	
50-22	8204-8216	connectivity	_	
50-23	8217-8220	due	_	
50-24	8221-8223	to	_	
50-25	8224-8227	the	_	
50-26	8228-8239	development	_	
50-27	8240-8242	of	_	
50-28	8243-8246	and	_	
50-29	8246-8247	/	_	
50-30	8247-8249	or	_	
50-31	8250-8262	consequences	_	
50-32	8263-8265	of	_	
50-33	8266-8269	AUD	_	
50-34	8269-8270	.	_	

#Text=Materials and Methods
#Text=Subjects
#Text=All study procedures were approved by the Institutional Review Board at Indiana University.
51-1	8271-8280	Materials	http://www.case.edu/ProvCaRe/provcare#StudyMethod[14]	
51-2	8281-8284	and	http://www.case.edu/ProvCaRe/provcare#StudyMethod[14]	
51-3	8285-8292	Methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod[14]	
51-4	8293-8301	Subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-5	8302-8305	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-6	8306-8311	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-7	8312-8322	procedures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-8	8323-8327	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-9	8328-8336	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-10	8337-8339	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-11	8340-8343	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-12	8344-8357	Institutional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-13	8358-8364	Review	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-14	8365-8370	Board	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-15	8371-8373	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-16	8374-8381	Indiana	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-17	8382-8392	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-18	8392-8393	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	

#Text=Informed consent was obtained from all subjects prior to study.
52-1	8394-8402	Informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-2	8403-8410	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-3	8411-8414	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-4	8415-8423	obtained	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-5	8424-8428	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-6	8429-8432	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-7	8433-8441	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-8	8442-8447	prior	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-9	8448-8450	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-10	8451-8456	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
52-11	8456-8457	.	_	

#Text=Twenty-two subjects with alcohol use disorder (AUD) and eighteen healthy controls (CON) were recruited from the community as part of a larger study as described in.
53-1	8458-8468	Twenty-two	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
53-2	8469-8477	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
53-3	8478-8482	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
53-4	8483-8490	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[17]	
53-5	8491-8494	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[17]	
53-6	8495-8503	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[17]	
53-7	8504-8505	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[17]	
53-8	8505-8508	AUD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[17]	
53-9	8508-8509	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[17]	
53-10	8510-8513	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
53-11	8514-8522	eighteen	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
53-12	8523-8530	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[18]	
53-13	8531-8539	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[18]	
53-14	8540-8541	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[18]	
53-15	8541-8544	CON	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[18]	
53-16	8544-8545	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
53-17	8546-8550	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
53-18	8551-8560	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
53-19	8561-8565	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
53-20	8566-8569	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
53-21	8570-8579	community	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
53-22	8580-8582	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
53-23	8583-8587	part	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
53-24	8588-8590	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
53-25	8591-8592	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
53-26	8593-8599	larger	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
53-27	8600-8605	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
53-28	8606-8608	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
53-29	8609-8618	described	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
53-30	8619-8621	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
53-31	8621-8622	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	

#Text=To qualify, participants had to be 18 – 30 years old, have at least 6th grade level of English comprehension, had consumed alcohol previously, and had no history of psychiatric illness or head trauma.
54-1	8623-8625	To	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-2	8626-8633	qualify	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-3	8633-8634	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-4	8635-8647	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-5	8648-8651	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-6	8652-8654	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-7	8655-8657	be	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-8	8658-8660	18	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-9	8661-8662	–	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-10	8663-8665	30	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-11	8666-8671	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-12	8672-8675	old	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-13	8675-8676	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-14	8677-8681	have	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-15	8682-8684	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-16	8685-8690	least	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-17	8691-8694	6th	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-18	8695-8700	grade	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-19	8701-8706	level	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-20	8707-8709	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-21	8710-8717	English	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-22	8718-8731	comprehension	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-23	8731-8732	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-24	8733-8736	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-25	8737-8745	consumed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-26	8746-8753	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-27	8754-8764	previously	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-28	8764-8765	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-29	8766-8769	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-30	8770-8773	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-31	8774-8776	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-32	8777-8784	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-33	8785-8787	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-34	8788-8799	psychiatric	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-35	8800-8807	illness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-36	8808-8810	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-37	8811-8815	head	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-38	8816-8822	trauma	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
54-39	8822-8823	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	

#Text=AUD subjects had a current lifetime diagnosis of AUD.
55-1	8824-8827	AUD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[20]	
55-2	8828-8836	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[20]	
55-3	8837-8840	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
55-4	8841-8842	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
55-5	8843-8850	current	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
55-6	8851-8859	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
55-7	8860-8869	diagnosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
55-8	8870-8872	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
55-9	8873-8876	AUD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[21]	
55-10	8876-8877	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	

#Text=Four AUD participants also had a past lifetime diagnosis of a Substance Use Disorder other than alcohol; one AUD participant met criteria for marijuana use disorder.
56-1	8878-8882	Four	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-2	8883-8886	AUD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[22]	
56-3	8887-8899	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-4	8900-8904	also	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-5	8905-8908	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-6	8909-8910	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-7	8911-8915	past	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-8	8916-8924	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-9	8925-8934	diagnosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-10	8935-8937	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-11	8938-8939	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-12	8940-8949	Substance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]|http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorder[23]	
56-13	8950-8953	Use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]|http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorder[23]	
56-14	8954-8962	Disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]|http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorder[23]	
56-15	8963-8968	other	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-16	8969-8973	than	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-17	8974-8981	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-18	8981-8982	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-19	8983-8986	one	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-20	8987-8990	AUD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[24]	
56-21	8991-9002	participant	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-22	9003-9006	met	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-23	9007-9015	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-24	9016-9019	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-25	9020-9029	marijuana	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-26	9030-9033	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-27	9034-9042	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
56-28	9042-9043	.	_	

#Text=Severity of lifetime alcohol problems was measured using the Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA), as the total count of all positive responses to all SSAGA questions in the Alcohol Diagnosis section.
57-1	9044-9052	Severity	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-2	9053-9055	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-3	9056-9064	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-4	9065-9072	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-5	9073-9081	problems	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-6	9082-9085	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-7	9086-9094	measured	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-8	9095-9100	using	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-9	9101-9104	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-10	9105-9120	Semi-Structured	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]|http://maven.renci.org/NeuroBridge/neurobridge#Semi-StructuredAssessmentfortheGeneticsofAlcoholism[26]	
57-11	9121-9131	Assessment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]|http://maven.renci.org/NeuroBridge/neurobridge#Semi-StructuredAssessmentfortheGeneticsofAlcoholism[26]	
57-12	9132-9135	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]|http://maven.renci.org/NeuroBridge/neurobridge#Semi-StructuredAssessmentfortheGeneticsofAlcoholism[26]	
57-13	9136-9139	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]|http://maven.renci.org/NeuroBridge/neurobridge#Semi-StructuredAssessmentfortheGeneticsofAlcoholism[26]	
57-14	9140-9148	Genetics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]|http://maven.renci.org/NeuroBridge/neurobridge#Semi-StructuredAssessmentfortheGeneticsofAlcoholism[26]	
57-15	9149-9151	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]|http://maven.renci.org/NeuroBridge/neurobridge#Semi-StructuredAssessmentfortheGeneticsofAlcoholism[26]	
57-16	9152-9162	Alcoholism	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]|http://maven.renci.org/NeuroBridge/neurobridge#Semi-StructuredAssessmentfortheGeneticsofAlcoholism[26]	
57-17	9163-9164	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]|http://maven.renci.org/NeuroBridge/neurobridge#Semi-StructuredAssessmentfortheGeneticsofAlcoholism[26]	
57-18	9164-9169	SSAGA	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]|http://maven.renci.org/NeuroBridge/neurobridge#Semi-StructuredAssessmentfortheGeneticsofAlcoholism[26]	
57-19	9169-9170	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]|http://maven.renci.org/NeuroBridge/neurobridge#Semi-StructuredAssessmentfortheGeneticsofAlcoholism[26]	
57-20	9170-9171	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]|http://maven.renci.org/NeuroBridge/neurobridge#Semi-StructuredAssessmentfortheGeneticsofAlcoholism[26]	
57-21	9172-9174	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-22	9175-9178	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-23	9179-9184	total	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-24	9185-9190	count	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-25	9191-9193	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-26	9194-9197	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-27	9198-9206	positive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-28	9207-9216	responses	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-29	9217-9219	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-30	9220-9223	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-31	9224-9229	SSAGA	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-32	9230-9239	questions	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-33	9240-9242	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-34	9243-9246	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-35	9247-9254	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-36	9255-9264	Diagnosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-37	9265-9272	section	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	
57-38	9272-9273	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]	

#Text=The score range across all subjects was 0–99.
58-1	9274-9277	The	_	
58-2	9278-9283	score	_	
58-3	9284-9289	range	_	
58-4	9290-9296	across	_	
58-5	9297-9300	all	_	
58-6	9301-9309	subjects	_	
58-7	9310-9313	was	_	
58-8	9314-9315	0	_	
58-9	9315-9316	–	_	
58-10	9316-9318	99	_	
58-11	9318-9319	.	_	

#Text=Recent alcohol consumption was quantified as the total number of self-reported drinks in the last 2 weeks.
59-1	9320-9326	Recent	_	
59-2	9327-9334	alcohol	_	
59-3	9335-9346	consumption	_	
59-4	9347-9350	was	_	
59-5	9351-9361	quantified	_	
59-6	9362-9364	as	_	
59-7	9365-9368	the	_	
59-8	9369-9374	total	_	
59-9	9375-9381	number	_	
59-10	9382-9384	of	_	
59-11	9385-9398	self-reported	_	
59-12	9399-9405	drinks	_	
59-13	9406-9408	in	_	
59-14	9409-9412	the	_	
59-15	9413-9417	last	_	
59-16	9418-9419	2	_	
59-17	9420-9425	weeks	_	
59-18	9425-9426	.	_	

#Text=Prior to study day, subjects were asked to abstain from alcohol for 12 hours.
60-1	9427-9432	Prior	_	
60-2	9433-9435	to	_	
60-3	9436-9441	study	_	
60-4	9442-9445	day	_	
60-5	9445-9446	,	_	
60-6	9447-9455	subjects	_	
60-7	9456-9460	were	_	
60-8	9461-9466	asked	_	
60-9	9467-9469	to	_	
60-10	9470-9477	abstain	_	
60-11	9478-9482	from	_	
60-12	9483-9490	alcohol	_	
60-13	9491-9494	for	_	
60-14	9495-9497	12	_	
60-15	9498-9503	hours	_	
60-16	9503-9504	.	_	

#Text=A breath alcohol test confirmed sobriety on scan day (Alco-Sensor IV, Intoximeters, St.
61-1	9505-9506	A	_	
61-2	9507-9513	breath	_	
61-3	9514-9521	alcohol	_	
61-4	9522-9526	test	_	
61-5	9527-9536	confirmed	_	
61-6	9537-9545	sobriety	_	
61-7	9546-9548	on	_	
61-8	9549-9553	scan	_	
61-9	9554-9557	day	_	
61-10	9558-9559	(	_	
61-11	9559-9570	Alco-Sensor	_	
61-12	9571-9573	IV	_	
61-13	9573-9574	,	_	
61-14	9575-9587	Intoximeters	_	
61-15	9587-9588	,	_	
61-16	9589-9591	St	_	
61-17	9591-9592	.	_	

#Text=Louis, MO).
62-1	9593-9598	Louis	_	
62-2	9598-9599	,	_	
62-3	9600-9602	MO	_	
62-4	9602-9603	)	_	
62-5	9603-9604	.	_	

#Text=Imaging
#Text=Data were acquired on a Siemens 3T Trio-Tim (Siemens, Erlangen, Germany).
63-1	9605-9612	Imaging	http://maven.renci.org/NeuroBridge/neurobridge#NeuroImagingProtocol[27]	
63-2	9613-9617	Data	http://maven.renci.org/NeuroBridge/neurobridge#NeuroImagingProtocol[27]	
63-3	9618-9622	were	http://maven.renci.org/NeuroBridge/neurobridge#NeuroImagingProtocol[27]	
63-4	9623-9631	acquired	http://maven.renci.org/NeuroBridge/neurobridge#NeuroImagingProtocol[27]	
63-5	9632-9634	on	_	
63-6	9635-9636	a	_	
63-7	9637-9644	Siemens	_	
63-8	9645-9647	3T	_	
63-9	9648-9656	Trio-Tim	_	
63-10	9657-9658	(	_	
63-11	9658-9665	Siemens	_	
63-12	9665-9666	,	_	
63-13	9667-9675	Erlangen	_	
63-14	9675-9676	,	_	
63-15	9677-9684	Germany	_	
63-16	9684-9685	)	_	
63-17	9685-9686	.	_	

#Text=Diffusion weighted data were collected with a single-shell (b=1000 s/mm2) 2D acquisition; 64 diffusion directions and 8 b = 0 volumes; A-P phase encoding; 128×128 matrix; 72 slices; 2 × 2 × 2 mm3 voxels, iPAT factor = 2.
64-1	9687-9696	Diffusion	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[28]	
64-2	9697-9705	weighted	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[28]	
64-3	9706-9710	data	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[28]	
64-4	9711-9715	were	_	
64-5	9716-9725	collected	_	
64-6	9726-9730	with	_	
64-7	9731-9732	a	_	
64-8	9733-9745	single-shell	_	
64-9	9746-9747	(	_	
64-10	9747-9748	b	_	
64-11	9748-9749	=	_	
64-12	9749-9753	1000	_	
64-13	9754-9755	s	_	
64-14	9755-9756	/	_	
64-15	9756-9759	mm2	_	
64-16	9759-9760	)	_	
64-17	9761-9763	2D	_	
64-18	9764-9775	acquisition	_	
64-19	9775-9776	;	_	
64-20	9777-9779	64	_	
64-21	9780-9789	diffusion	_	
64-22	9790-9800	directions	_	
64-23	9801-9804	and	_	
64-24	9805-9806	8	_	
64-25	9807-9808	b	_	
64-26	9809-9810	=	_	
64-27	9811-9812	0	_	
64-28	9813-9820	volumes	_	
64-29	9820-9821	;	_	
64-30	9822-9825	A-P	_	
64-31	9826-9831	phase	_	
64-32	9832-9840	encoding	_	
64-33	9840-9841	;	_	
64-34	9842-9845	128	_	
64-35	9845-9846	×	_	
64-36	9846-9849	128	_	
64-37	9850-9856	matrix	_	
64-38	9856-9857	;	_	
64-39	9858-9860	72	_	
64-40	9861-9867	slices	_	
64-41	9867-9868	;	_	
64-42	9869-9870	2	_	
64-43	9871-9872	×	_	
64-44	9873-9874	2	_	
64-45	9875-9876	×	_	
64-46	9877-9878	2	_	
64-47	9879-9882	mm3	_	
64-48	9883-9889	voxels	_	
64-49	9889-9890	,	_	
64-50	9891-9895	iPAT	_	
64-51	9896-9902	factor	_	
64-52	9903-9904	=	_	
64-53	9905-9906	2	_	
64-54	9906-9907	.	_	

#Text=A T1-weighted 3D anatomic sequence was also acquired (Field of view = 192×168 matrix, 160 sagittal slices, and 1.3 × 1.3 × 1.3 mm3 voxels).
65-1	9908-9909	A	_	
65-2	9910-9912	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[29]	
65-3	9912-9913	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[29]	
65-4	9913-9921	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[29]	
65-5	9922-9924	3D	_	
65-6	9925-9933	anatomic	_	
65-7	9934-9942	sequence	_	
65-8	9943-9946	was	_	
65-9	9947-9951	also	_	
65-10	9952-9960	acquired	_	
65-11	9961-9962	(	_	
65-12	9962-9967	Field	_	
65-13	9968-9970	of	_	
65-14	9971-9975	view	_	
65-15	9976-9977	=	_	
65-16	9978-9981	192	_	
65-17	9981-9982	×	_	
65-18	9982-9985	168	_	
65-19	9986-9992	matrix	_	
65-20	9992-9993	,	_	
65-21	9994-9997	160	_	
65-22	9998-10006	sagittal	_	
65-23	10007-10013	slices	_	
65-24	10013-10014	,	_	
65-25	10015-10018	and	_	
65-26	10019-10022	1.3	_	
65-27	10023-10024	×	_	
65-28	10025-10028	1.3	_	
65-29	10029-10030	×	_	
65-30	10031-10034	1.3	_	
65-31	10035-10038	mm3	_	
65-32	10039-10045	voxels	_	
65-33	10045-10046	)	_	
65-34	10046-10047	.	_	

#Text=Image processing
#Text=An in-house Matlab-based pipeline that utilizes FSL (Version 5.0.9) and Camino was applied for image processing.
66-1	10048-10053	Image	_	
66-2	10054-10064	processing	_	
66-3	10065-10067	An	_	
66-4	10068-10076	in-house	_	
66-5	10077-10089	Matlab-based	_	
66-6	10090-10098	pipeline	_	
66-7	10099-10103	that	_	
66-8	10104-10112	utilizes	_	
66-9	10113-10116	FSL	_	
66-10	10117-10118	(	_	
66-11	10118-10125	Version	_	
66-12	10126-10131	5.0.9	_	
66-13	10131-10132	)	_	
66-14	10133-10136	and	_	
66-15	10137-10143	Camino	_	
66-16	10144-10147	was	_	
66-17	10148-10155	applied	_	
66-18	10156-10159	for	_	
66-19	10160-10165	image	_	
66-20	10166-10176	processing	_	
66-21	10176-10177	.	_	

#Text=Each subjects’ anatomic T1-weighted image was denoised, skull stripped (FSL bet), and segmented according to tissue-type (FSL FAST).
67-1	10178-10182	Each	_	
67-2	10183-10191	subjects	_	
67-3	10191-10192	’	_	
67-4	10193-10201	anatomic	_	
67-5	10202-10204	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[30]	
67-6	10204-10205	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[30]	
67-7	10205-10213	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[30]	
67-8	10214-10219	image	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[30]	
67-9	10220-10223	was	_	
67-10	10224-10232	denoised	_	
67-11	10232-10233	,	_	
67-12	10234-10239	skull	_	
67-13	10240-10248	stripped	_	
67-14	10249-10250	(	_	
67-15	10250-10253	FSL	_	
67-16	10254-10257	bet	_	
67-17	10257-10258	)	_	
67-18	10258-10259	,	_	
67-19	10260-10263	and	_	
67-20	10264-10273	segmented	_	
67-21	10274-10283	according	_	
67-22	10284-10286	to	_	
67-23	10287-10298	tissue-type	_	
67-24	10299-10300	(	_	
67-25	10300-10303	FSL	_	
67-26	10304-10308	FAST	_	
67-27	10308-10309	)	_	
67-28	10309-10310	.	_	

#Text=Diffusion weighted data were first denoised with local principal component analysis filter, then the eight b0 volumes were registered to the first volume and averaged.
68-1	10311-10320	Diffusion	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[31]	
68-2	10321-10329	weighted	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[31]	
68-3	10330-10334	data	http://maven.renci.org/NeuroBridge/neurobridge#DiffusionWeightedImaging[31]	
68-4	10335-10339	were	_	
68-5	10340-10345	first	_	
68-6	10346-10354	denoised	_	
68-7	10355-10359	with	_	
68-8	10360-10365	local	_	
68-9	10366-10375	principal	_	
68-10	10376-10385	component	_	
68-11	10386-10394	analysis	_	
68-12	10395-10401	filter	_	
68-13	10401-10402	,	_	
68-14	10403-10407	then	_	
68-15	10408-10411	the	_	
68-16	10412-10417	eight	_	
68-17	10418-10420	b0	_	
68-18	10421-10428	volumes	_	
68-19	10429-10433	were	_	
68-20	10434-10444	registered	_	
68-21	10445-10447	to	_	
68-22	10448-10451	the	_	
68-23	10452-10457	first	_	
68-24	10458-10464	volume	_	
68-25	10465-10468	and	_	
68-26	10469-10477	averaged	_	
68-27	10477-10478	.	_	

#Text=The data were then corrected for motion, eddy currents, and registered to each subject’s anatomic space.
69-1	10479-10482	The	_	
69-2	10483-10487	data	_	
69-3	10488-10492	were	_	
69-4	10493-10497	then	_	
69-5	10498-10507	corrected	_	
69-6	10508-10511	for	_	
69-7	10512-10518	motion	_	
69-8	10518-10519	,	_	
69-9	10520-10524	eddy	_	
69-10	10525-10533	currents	_	
69-11	10533-10534	,	_	
69-12	10535-10538	and	_	
69-13	10539-10549	registered	_	
69-14	10550-10552	to	_	
69-15	10553-10557	each	_	
69-16	10558-10565	subject	_	
69-17	10565-10566	’	_	
69-18	10566-10567	s	_	
69-19	10568-10576	anatomic	_	
69-20	10577-10582	space	_	
69-21	10582-10583	.	_	

#Text=This image processing procedure has been previously published in detail elsewhere.
70-1	10584-10588	This	_	
70-2	10589-10594	image	_	
70-3	10595-10605	processing	_	
70-4	10606-10615	procedure	_	
70-5	10616-10619	has	_	
70-6	10620-10624	been	_	
70-7	10625-10635	previously	_	
70-8	10636-10645	published	_	
70-9	10646-10648	in	_	
70-10	10649-10655	detail	_	
70-11	10656-10665	elsewhere	_	
70-12	10665-10666	.	_	

#Text=At each voxel, tensor estimation was done with multi-tensor fitting in Camino in which voxels were classified as isotropic, anisotropic Gaussian (single tensor), or nonGaussian (multi-tensor).
71-1	10667-10669	At	_	
71-2	10670-10674	each	_	
71-3	10675-10680	voxel	_	
71-4	10680-10681	,	_	
71-5	10682-10688	tensor	_	
71-6	10689-10699	estimation	_	
71-7	10700-10703	was	_	
71-8	10704-10708	done	_	
71-9	10709-10713	with	_	
71-10	10714-10726	multi-tensor	_	
71-11	10727-10734	fitting	_	
71-12	10735-10737	in	_	
71-13	10738-10744	Camino	_	
71-14	10745-10747	in	_	
71-15	10748-10753	which	_	
71-16	10754-10760	voxels	_	
71-17	10761-10765	were	_	
71-18	10766-10776	classified	_	
71-19	10777-10779	as	_	
71-20	10780-10789	isotropic	_	
71-21	10789-10790	,	_	
71-22	10791-10802	anisotropic	_	
71-23	10803-10811	Gaussian	_	
71-24	10812-10813	(	_	
71-25	10813-10819	single	_	
71-26	10820-10826	tensor	_	
71-27	10826-10827	)	_	
71-28	10827-10828	,	_	
71-29	10829-10831	or	_	
71-30	10832-10843	nonGaussian	_	
71-31	10844-10845	(	_	
71-32	10845-10857	multi-tensor	_	
71-33	10857-10858	)	_	
71-34	10858-10859	.	_	

#Text=Scalar metrics of diffusion including FA, MD, AD, and RD were derived from tensor data.
72-1	10860-10866	Scalar	_	
72-2	10867-10874	metrics	_	
72-3	10875-10877	of	_	
72-4	10878-10887	diffusion	_	
72-5	10888-10897	including	_	
72-6	10898-10900	FA	_	
72-7	10900-10901	,	_	
72-8	10902-10904	MD	_	
72-9	10904-10905	,	_	
72-10	10906-10908	AD	_	
72-11	10908-10909	,	_	
72-12	10910-10913	and	_	
72-13	10914-10916	RD	_	
72-14	10917-10921	were	_	
72-15	10922-10929	derived	_	
72-16	10930-10934	from	_	
72-17	10935-10941	tensor	_	
72-18	10942-10946	data	_	
72-19	10946-10947	.	_	

#Text=Streamline tractography was carried out in Camino with Fiber Assignment by Continuous Tracking algorithm in each subject’s anatomic space.
73-1	10948-10958	Streamline	_	
73-2	10959-10971	tractography	_	
73-3	10972-10975	was	_	
73-4	10976-10983	carried	_	
73-5	10984-10987	out	_	
73-6	10988-10990	in	_	
73-7	10991-10997	Camino	_	
73-8	10998-11002	with	_	
73-9	11003-11008	Fiber	_	
73-10	11009-11019	Assignment	_	
73-11	11020-11022	by	_	
73-12	11023-11033	Continuous	_	
73-13	11034-11042	Tracking	_	
73-14	11043-11052	algorithm	_	
73-15	11053-11055	in	_	
73-16	11056-11060	each	_	
73-17	11061-11068	subject	_	
73-18	11068-11069	’	_	
73-19	11069-11070	s	_	
73-20	11071-11079	anatomic	_	
73-21	11080-11085	space	_	
73-22	11085-11086	.	_	

#Text=Relevant tractography parameters were: 1 seed per voxel at the interface of gray matter (GM) and WM (obtained from the overlap of dilated GM and WM tissue masks), with an additional seed placed if a streamline encountered a multi-tensor voxel, whereupon each streamline followed one of the tensor directions; step size 1 voxel; maximum turning angle of 45 degrees over 5 steps.
74-1	11087-11095	Relevant	_	
74-2	11096-11108	tractography	_	
74-3	11109-11119	parameters	_	
74-4	11120-11124	were	_	
74-5	11124-11125	:	_	
74-6	11126-11127	1	_	
74-7	11128-11132	seed	_	
74-8	11133-11136	per	_	
74-9	11137-11142	voxel	_	
74-10	11143-11145	at	_	
74-11	11146-11149	the	_	
74-12	11150-11159	interface	_	
74-13	11160-11162	of	_	
74-14	11163-11167	gray	_	
74-15	11168-11174	matter	_	
74-16	11175-11176	(	_	
74-17	11176-11178	GM	_	
74-18	11178-11179	)	_	
74-19	11180-11183	and	_	
74-20	11184-11186	WM	_	
74-21	11187-11188	(	_	
74-22	11188-11196	obtained	_	
74-23	11197-11201	from	_	
74-24	11202-11205	the	_	
74-25	11206-11213	overlap	_	
74-26	11214-11216	of	_	
74-27	11217-11224	dilated	_	
74-28	11225-11227	GM	_	
74-29	11228-11231	and	_	
74-30	11232-11234	WM	_	
74-31	11235-11241	tissue	_	
74-32	11242-11247	masks	_	
74-33	11247-11248	)	_	
74-34	11248-11249	,	_	
74-35	11250-11254	with	_	
74-36	11255-11257	an	_	
74-37	11258-11268	additional	_	
74-38	11269-11273	seed	_	
74-39	11274-11280	placed	_	
74-40	11281-11283	if	_	
74-41	11284-11285	a	_	
74-42	11286-11296	streamline	_	
74-43	11297-11308	encountered	_	
74-44	11309-11310	a	_	
74-45	11311-11323	multi-tensor	_	
74-46	11324-11329	voxel	_	
74-47	11329-11330	,	_	
74-48	11331-11340	whereupon	_	
74-49	11341-11345	each	_	
74-50	11346-11356	streamline	_	
74-51	11357-11365	followed	_	
74-52	11366-11369	one	_	
74-53	11370-11372	of	_	
74-54	11373-11376	the	_	
74-55	11377-11383	tensor	_	
74-56	11384-11394	directions	_	
74-57	11394-11395	;	_	
74-58	11396-11400	step	_	
74-59	11401-11405	size	_	
74-60	11406-11407	1	_	
74-61	11408-11413	voxel	_	
74-62	11413-11414	;	_	
74-63	11415-11422	maximum	_	
74-64	11423-11430	turning	_	
74-65	11431-11436	angle	_	
74-66	11437-11439	of	_	
74-67	11440-11442	45	_	
74-68	11443-11450	degrees	_	
74-69	11451-11455	over	_	
74-70	11456-11457	5	_	
74-71	11458-11463	steps	_	
74-72	11463-11464	.	_	

#Text=Streamlines terminated upon reaching another seed voxel at the GM/WM interface.
75-1	11465-11476	Streamlines	_	
75-2	11477-11487	terminated	_	
75-3	11488-11492	upon	_	
75-4	11493-11501	reaching	_	
75-5	11502-11509	another	_	
75-6	11510-11514	seed	_	
75-7	11515-11520	voxel	_	
75-8	11521-11523	at	_	
75-9	11524-11527	the	_	
75-10	11528-11530	GM	_	
75-11	11530-11531	/	_	
75-12	11531-11533	WM	_	
75-13	11534-11543	interface	_	
75-14	11543-11544	.	_	

#Text=After tracking, a length filter was applied to discard very short (<8mm) or extremely long (>180mm) streamlines.
76-1	11545-11550	After	_	
76-2	11551-11559	tracking	_	
76-3	11559-11560	,	_	
76-4	11561-11562	a	_	
76-5	11563-11569	length	_	
76-6	11570-11576	filter	_	
76-7	11577-11580	was	_	
76-8	11581-11588	applied	_	
76-9	11589-11591	to	_	
76-10	11592-11599	discard	_	
76-11	11600-11604	very	_	
76-12	11605-11610	short	_	
76-13	11611-11612	(	_	
76-14	11612-11613	<	_	
76-15	11613-11616	8mm	_	
76-16	11616-11617	)	_	
76-17	11618-11620	or	_	
76-18	11621-11630	extremely	_	
76-19	11631-11635	long	_	
76-20	11636-11637	(	_	
76-21	11637-11638	>	_	
76-22	11638-11643	180mm	_	
76-23	11643-11644	)	_	
76-24	11645-11656	streamlines	_	
76-25	11656-11657	.	_	

#Text=Throughout the processing, data were visually inspected for proper alignment and quality.
77-1	11658-11668	Throughout	_	
77-2	11669-11672	the	_	
77-3	11673-11683	processing	_	
77-4	11683-11684	,	_	
77-5	11685-11689	data	_	
77-6	11690-11694	were	_	
77-7	11695-11703	visually	_	
77-8	11704-11713	inspected	_	
77-9	11714-11717	for	_	
77-10	11718-11724	proper	_	
77-11	11725-11734	alignment	_	
77-12	11735-11738	and	_	
77-13	11739-11746	quality	_	
77-14	11746-11747	.	_	

#Text=Tract-Based Spatial Statistics (TBSS)
#Text=FA maps for each subject were generated in subjects’ anatomical space and analyzed via Tract-Based Spatial Statistics (TBSS).
78-1	11748-11759	Tract-Based	_	
78-2	11760-11767	Spatial	_	
78-3	11768-11778	Statistics	_	
78-4	11779-11780	(	_	
78-5	11780-11784	TBSS	_	
78-6	11784-11785	)	_	
78-7	11786-11788	FA	_	
78-8	11789-11793	maps	_	
78-9	11794-11797	for	_	
78-10	11798-11802	each	_	
78-11	11803-11810	subject	_	
78-12	11811-11815	were	_	
78-13	11816-11825	generated	_	
78-14	11826-11828	in	_	
78-15	11829-11837	subjects	_	
78-16	11837-11838	’	_	
78-17	11839-11849	anatomical	_	
78-18	11850-11855	space	_	
78-19	11856-11859	and	_	
78-20	11860-11868	analyzed	_	
78-21	11869-11872	via	_	
78-22	11873-11884	Tract-Based	_	
78-23	11885-11892	Spatial	_	
78-24	11893-11903	Statistics	_	
78-25	11904-11905	(	_	
78-26	11905-11909	TBSS	_	
78-27	11909-11910	)	_	
78-28	11910-11911	.	_	

#Text=These data were nonlinearly registered onto the FMRIB58 template FA image (FSL’s FNIRT).
79-1	11912-11917	These	_	
79-2	11918-11922	data	_	
79-3	11923-11927	were	_	
79-4	11928-11939	nonlinearly	_	
79-5	11940-11950	registered	_	
79-6	11951-11955	onto	_	
79-7	11956-11959	the	_	
79-8	11960-11967	FMRIB58	_	
79-9	11968-11976	template	_	
79-10	11977-11979	FA	_	
79-11	11980-11985	image	_	
79-12	11986-11987	(	_	
79-13	11987-11990	FSL	_	
79-14	11990-11991	’	_	
79-15	11991-11992	s	_	
79-16	11993-11998	FNIRT	_	
79-17	11998-11999	)	_	
79-18	11999-12000	.	_	

#Text=The mean FA volume was created and thinned to generate a skeleton representation of core WM tracts.
80-1	12001-12004	The	_	
80-2	12005-12009	mean	_	
80-3	12010-12012	FA	_	
80-4	12013-12019	volume	_	
80-5	12020-12023	was	_	
80-6	12024-12031	created	_	
80-7	12032-12035	and	_	
80-8	12036-12043	thinned	_	
80-9	12044-12046	to	_	
80-10	12047-12055	generate	_	
80-11	12056-12057	a	_	
80-12	12058-12066	skeleton	_	
80-13	12067-12081	representation	_	
80-14	12082-12084	of	_	
80-15	12085-12089	core	_	
80-16	12090-12092	WM	_	
80-17	12093-12099	tracts	_	
80-18	12099-12100	.	_	

#Text=Each subject’s FA data were then projected onto the skeleton and used for subsequent analysis.
81-1	12101-12105	Each	_	
81-2	12106-12113	subject	_	
81-3	12113-12114	’	_	
81-4	12114-12115	s	_	
81-5	12116-12118	FA	_	
81-6	12119-12123	data	_	
81-7	12124-12128	were	_	
81-8	12129-12133	then	_	
81-9	12134-12143	projected	_	
81-10	12144-12148	onto	_	
81-11	12149-12152	the	_	
81-12	12153-12161	skeleton	_	
81-13	12162-12165	and	_	
81-14	12166-12170	used	_	
81-15	12171-12174	for	_	
81-16	12175-12185	subsequent	_	
81-17	12186-12194	analysis	_	
81-18	12194-12195	.	_	

#Text=Structural Network Assembly
#Text=For each subject, we generated a structural connectivity network matrix, where the cortical nodes were based on a previously published brain parcellation.
82-1	12196-12206	Structural	_	
82-2	12207-12214	Network	_	
82-3	12215-12223	Assembly	_	
82-4	12224-12227	For	_	
82-5	12228-12232	each	_	
82-6	12233-12240	subject	_	
82-7	12240-12241	,	_	
82-8	12242-12244	we	_	
82-9	12245-12254	generated	_	
82-10	12255-12256	a	_	
82-11	12257-12267	structural	_	
82-12	12268-12280	connectivity	_	
82-13	12281-12288	network	_	
82-14	12289-12295	matrix	_	
82-15	12295-12296	,	_	
82-16	12297-12302	where	_	
82-17	12303-12306	the	_	
82-18	12307-12315	cortical	_	
82-19	12316-12321	nodes	_	
82-20	12322-12326	were	_	
82-21	12327-12332	based	_	
82-22	12333-12335	on	_	
82-23	12336-12337	a	_	
82-24	12338-12348	previously	_	
82-25	12349-12358	published	_	
82-26	12359-12364	brain	_	
82-27	12365-12377	parcellation	_	
82-28	12377-12378	.	_	

#Text=For the subcortical nodes, we implemented regions defined by for the striatum and by for the thalamus.
83-1	12379-12382	For	_	
83-2	12383-12386	the	_	
83-3	12387-12398	subcortical	_	
83-4	12399-12404	nodes	_	
83-5	12404-12405	,	_	
83-6	12406-12408	we	_	
83-7	12409-12420	implemented	_	
83-8	12421-12428	regions	_	
83-9	12429-12436	defined	_	
83-10	12437-12439	by	_	
83-11	12440-12443	for	_	
83-12	12444-12447	the	_	
83-13	12448-12456	striatum	_	
83-14	12457-12460	and	_	
83-15	12461-12463	by	_	
83-16	12464-12467	for	_	
83-17	12468-12471	the	_	
83-18	12472-12480	thalamus	_	
83-19	12480-12481	.	_	

#Text=The thalamic regions were further consolidated from 7 to 4 regions (pre-motor, primary motor, and sensory input regions were combined, and occipital and temporal regions were combined) per hemisphere to ensure sufficiently sized regions for tractography analysis.
84-1	12482-12485	The	_	
84-2	12486-12494	thalamic	_	
84-3	12495-12502	regions	_	
84-4	12503-12507	were	_	
84-5	12508-12515	further	_	
84-6	12516-12528	consolidated	_	
84-7	12529-12533	from	_	
84-8	12534-12535	7	_	
84-9	12536-12538	to	_	
84-10	12539-12540	4	_	
84-11	12541-12548	regions	_	
84-12	12549-12550	(	_	
84-13	12550-12559	pre-motor	_	
84-14	12559-12560	,	_	
84-15	12561-12568	primary	_	
84-16	12569-12574	motor	_	
84-17	12574-12575	,	_	
84-18	12576-12579	and	_	
84-19	12580-12587	sensory	_	
84-20	12588-12593	input	_	
84-21	12594-12601	regions	_	
84-22	12602-12606	were	_	
84-23	12607-12615	combined	_	
84-24	12615-12616	,	_	
84-25	12617-12620	and	_	
84-26	12621-12630	occipital	_	
84-27	12631-12634	and	_	
84-28	12635-12643	temporal	_	
84-29	12644-12651	regions	_	
84-30	12652-12656	were	_	
84-31	12657-12665	combined	_	
84-32	12665-12666	)	_	
84-33	12667-12670	per	_	
84-34	12671-12681	hemisphere	_	
84-35	12682-12684	to	_	
84-36	12685-12691	ensure	_	
84-37	12692-12704	sufficiently	_	
84-38	12705-12710	sized	_	
84-39	12711-12718	regions	_	
84-40	12719-12722	for	_	
84-41	12723-12735	tractography	_	
84-42	12736-12744	analysis	_	
84-43	12744-12745	.	_	

#Text=For all region pairs, number of streamlines and average seed surface area were extracted from the whole-brain tractogram with the Camino conmat function.
85-1	12746-12749	For	_	
85-2	12750-12753	all	_	
85-3	12754-12760	region	_	
85-4	12761-12766	pairs	_	
85-5	12766-12767	,	_	
85-6	12768-12774	number	_	
85-7	12775-12777	of	_	
85-8	12778-12789	streamlines	_	
85-9	12790-12793	and	_	
85-10	12794-12801	average	_	
85-11	12802-12806	seed	_	
85-12	12807-12814	surface	_	
85-13	12815-12819	area	_	
85-14	12820-12824	were	_	
85-15	12825-12834	extracted	_	
85-16	12835-12839	from	_	
85-17	12840-12843	the	_	
85-18	12844-12855	whole-brain	_	
85-19	12856-12866	tractogram	_	
85-20	12867-12871	with	_	
85-21	12872-12875	the	_	
85-22	12876-12882	Camino	_	
85-23	12883-12889	conmat	_	
85-24	12890-12898	function	_	
85-25	12898-12899	.	_	

#Text=The number of streamlines matrix was then thresholded to zero any values ≤ 2 to minimize the influence of false positive connections.
86-1	12900-12903	The	_	
86-2	12904-12910	number	_	
86-3	12911-12913	of	_	
86-4	12914-12925	streamlines	_	
86-5	12926-12932	matrix	_	
86-6	12933-12936	was	_	
86-7	12937-12941	then	_	
86-8	12942-12953	thresholded	_	
86-9	12954-12956	to	_	
86-10	12957-12961	zero	_	
86-11	12962-12965	any	_	
86-12	12966-12972	values	_	
86-13	12973-12974	≤	_	
86-14	12975-12976	2	_	
86-15	12977-12979	to	_	
86-16	12980-12988	minimize	_	
86-17	12989-12992	the	_	
86-18	12993-13002	influence	_	
86-19	13003-13005	of	_	
86-20	13006-13011	false	_	
86-21	13012-13020	positive	_	
86-22	13021-13032	connections	_	
86-23	13032-13033	.	_	

#Text=Finally, network edges were quantified as fiber density (number of streamlines / average seed surface of connected regions) between any pair of connected regions.
87-1	13034-13041	Finally	_	
87-2	13041-13042	,	_	
87-3	13043-13050	network	_	
87-4	13051-13056	edges	_	
87-5	13057-13061	were	_	
87-6	13062-13072	quantified	_	
87-7	13073-13075	as	_	
87-8	13076-13081	fiber	_	
87-9	13082-13089	density	_	
87-10	13090-13091	(	_	
87-11	13091-13097	number	_	
87-12	13098-13100	of	_	
87-13	13101-13112	streamlines	_	
87-14	13113-13114	/	_	
87-15	13115-13122	average	_	
87-16	13123-13127	seed	_	
87-17	13128-13135	surface	_	
87-18	13136-13138	of	_	
87-19	13139-13148	connected	_	
87-20	13149-13156	regions	_	
87-21	13156-13157	)	_	
87-22	13158-13165	between	_	
87-23	13166-13169	any	_	
87-24	13170-13174	pair	_	
87-25	13175-13177	of	_	
87-26	13178-13187	connected	_	
87-27	13188-13195	regions	_	
87-28	13195-13196	.	_	

#Text=Global metrics of network connectivity were calculated from the fiber density matrices with the Brain Connectivity Toolbox.
88-1	13197-13203	Global	_	
88-2	13204-13211	metrics	_	
88-3	13212-13214	of	_	
88-4	13215-13222	network	_	
88-5	13223-13235	connectivity	_	
88-6	13236-13240	were	_	
88-7	13241-13251	calculated	_	
88-8	13252-13256	from	_	
88-9	13257-13260	the	_	
88-10	13261-13266	fiber	_	
88-11	13267-13274	density	_	
88-12	13275-13283	matrices	_	
88-13	13284-13288	with	_	
88-14	13289-13292	the	_	
88-15	13293-13298	Brain	_	
88-16	13299-13311	Connectivity	_	
88-17	13312-13319	Toolbox	_	
88-18	13319-13320	.	_	

#Text=Community Structure (From Hierarchical Consensus Clustering)
#Text=For each subject’s structural connectivity network matrix (see above), a set of 1000 modularity partitions was generated with methodology that is part of a novel Multiresolution Consensus Clustering procedure developed by.
89-1	13321-13330	Community	_	
89-2	13331-13340	Structure	_	
89-3	13341-13342	(	_	
89-4	13342-13346	From	_	
89-5	13347-13359	Hierarchical	_	
89-6	13360-13369	Consensus	_	
89-7	13370-13380	Clustering	_	
89-8	13380-13381	)	_	
89-9	13382-13385	For	_	
89-10	13386-13390	each	_	
89-11	13391-13398	subject	_	
89-12	13398-13399	’	_	
89-13	13399-13400	s	_	
89-14	13401-13411	structural	_	
89-15	13412-13424	connectivity	_	
89-16	13425-13432	network	_	
89-17	13433-13439	matrix	_	
89-18	13440-13441	(	_	
89-19	13441-13444	see	_	
89-20	13445-13450	above	_	
89-21	13450-13451	)	_	
89-22	13451-13452	,	_	
89-23	13453-13454	a	_	
89-24	13455-13458	set	_	
89-25	13459-13461	of	_	
89-26	13462-13466	1000	_	
89-27	13467-13477	modularity	_	
89-28	13478-13488	partitions	_	
89-29	13489-13492	was	_	
89-30	13493-13502	generated	_	
89-31	13503-13507	with	_	
89-32	13508-13519	methodology	_	
89-33	13520-13524	that	_	
89-34	13525-13527	is	_	
89-35	13528-13532	part	_	
89-36	13533-13535	of	_	
89-37	13536-13537	a	_	
89-38	13538-13543	novel	_	
89-39	13544-13559	Multiresolution	_	
89-40	13560-13569	Consensus	_	
89-41	13570-13580	Clustering	_	
89-42	13581-13590	procedure	_	
89-43	13591-13600	developed	_	
89-44	13601-13603	by	_	
89-45	13603-13604	.	_	

#Text=This method samples the full resolution range of resolution of modularity across a given number of partitions.
90-1	13605-13609	This	_	
90-2	13610-13616	method	_	
90-3	13617-13624	samples	_	
90-4	13625-13628	the	_	
90-5	13629-13633	full	_	
90-6	13634-13644	resolution	_	
90-7	13645-13650	range	_	
90-8	13651-13653	of	_	
90-9	13654-13664	resolution	_	
90-10	13665-13667	of	_	
90-11	13668-13678	modularity	_	
90-12	13679-13685	across	_	
90-13	13686-13687	a	_	
90-14	13688-13693	given	_	
90-15	13694-13700	number	_	
90-16	13701-13703	of	_	
90-17	13704-13714	partitions	_	
90-18	13714-13715	.	_	

#Text=A co-classification (CA) matrix was then generated, where edge weights are the frequency with which two nodes belong to the same module across the identified ensemble of partitions.
91-1	13716-13717	A	_	
91-2	13718-13735	co-classification	_	
91-3	13736-13737	(	_	
91-4	13737-13739	CA	_	
91-5	13739-13740	)	_	
91-6	13741-13747	matrix	_	
91-7	13748-13751	was	_	
91-8	13752-13756	then	_	
91-9	13757-13766	generated	_	
91-10	13766-13767	,	_	
91-11	13768-13773	where	_	
91-12	13774-13778	edge	_	
91-13	13779-13786	weights	_	
91-14	13787-13790	are	_	
91-15	13791-13794	the	_	
91-16	13795-13804	frequency	_	
91-17	13805-13809	with	_	
91-18	13810-13815	which	_	
91-19	13816-13819	two	_	
91-20	13820-13825	nodes	_	
91-21	13826-13832	belong	_	
91-22	13833-13835	to	_	
91-23	13836-13839	the	_	
91-24	13840-13844	same	_	
91-25	13845-13851	module	_	
91-26	13852-13858	across	_	
91-27	13859-13862	the	_	
91-28	13863-13873	identified	_	
91-29	13874-13882	ensemble	_	
91-30	13883-13885	of	_	
91-31	13886-13896	partitions	_	
91-32	13896-13897	.	_	

#Text=Statistical Analyses
#Text=Group subject demographics were assessed with independent-samples t-statistic or chi-squared tests, and results at p < 0.05 were considered statistically significant.
92-1	13898-13909	Statistical	_	
92-2	13910-13918	Analyses	_	
92-3	13919-13924	Group	_	
92-4	13925-13932	subject	_	
92-5	13933-13945	demographics	_	
92-6	13946-13950	were	_	
92-7	13951-13959	assessed	_	
92-8	13960-13964	with	_	
92-9	13965-13984	independent-samples	_	
92-10	13985-13996	t-statistic	_	
92-11	13997-13999	or	_	
92-12	14000-14011	chi-squared	_	
92-13	14012-14017	tests	_	
92-14	14017-14018	,	_	
92-15	14019-14022	and	_	
92-16	14023-14030	results	_	
92-17	14031-14033	at	_	
92-18	14034-14035	p	_	
92-19	14036-14037	<	_	
92-20	14038-14042	0.05	_	
92-21	14043-14047	were	_	
92-22	14048-14058	considered	_	
92-23	14059-14072	statistically	_	
92-24	14073-14084	significant	_	
92-25	14084-14085	.	_	

#Text=Group differences in FA images from TBSS were interrogated with permutation testing in FSL’s randomise.
93-1	14086-14091	Group	_	
93-2	14092-14103	differences	_	
93-3	14104-14106	in	_	
93-4	14107-14109	FA	_	
93-5	14110-14116	images	_	
93-6	14117-14121	from	_	
93-7	14122-14126	TBSS	_	
93-8	14127-14131	were	_	
93-9	14132-14144	interrogated	_	
93-10	14145-14149	with	_	
93-11	14150-14161	permutation	_	
93-12	14162-14169	testing	_	
93-13	14170-14172	in	_	
93-14	14173-14176	FSL	_	
93-15	14176-14177	’	_	
93-16	14177-14178	s	_	
93-17	14179-14188	randomise	_	
93-18	14188-14189	.	_	

#Text=Contrasts were generated after 10,000 permutations with Threshold-Free Cluster Enhancement (TFCE) for multiple comparisons correction across all skeleton voxels.
94-1	14190-14199	Contrasts	_	
94-2	14200-14204	were	_	
94-3	14205-14214	generated	_	
94-4	14215-14220	after	_	
94-5	14221-14227	10,000	_	
94-6	14228-14240	permutations	_	
94-7	14241-14245	with	_	
94-8	14246-14260	Threshold-Free	_	
94-9	14261-14268	Cluster	_	
94-10	14269-14280	Enhancement	_	
94-11	14281-14282	(	_	
94-12	14282-14286	TFCE	_	
94-13	14286-14287	)	_	
94-14	14288-14291	for	_	
94-15	14292-14300	multiple	_	
94-16	14301-14312	comparisons	_	
94-17	14313-14323	correction	_	
94-18	14324-14330	across	_	
94-19	14331-14334	all	_	
94-20	14335-14343	skeleton	_	
94-21	14344-14350	voxels	_	
94-22	14350-14351	.	_	

#Text=Significant clusters from all contrasts were ordered by size and thresholded at the largest 1% (corresponding to > 500 voxels in size) of clusters across all comparisons (8 contrasts with a total of 1469 clusters that range 1 to 12892 voxels in size).
95-1	14352-14363	Significant	_	
95-2	14364-14372	clusters	_	
95-3	14373-14377	from	_	
95-4	14378-14381	all	_	
95-5	14382-14391	contrasts	_	
95-6	14392-14396	were	_	
95-7	14397-14404	ordered	_	
95-8	14405-14407	by	_	
95-9	14408-14412	size	_	
95-10	14413-14416	and	_	
95-11	14417-14428	thresholded	_	
95-12	14429-14431	at	_	
95-13	14432-14435	the	_	
95-14	14436-14443	largest	_	
95-15	14444-14446	1%	_	
95-16	14447-14448	(	_	
95-17	14448-14461	corresponding	_	
95-18	14462-14464	to	_	
95-19	14465-14466	>	_	
95-20	14467-14470	500	_	
95-21	14471-14477	voxels	_	
95-22	14478-14480	in	_	
95-23	14481-14485	size	_	
95-24	14485-14486	)	_	
95-25	14487-14489	of	_	
95-26	14490-14498	clusters	_	
95-27	14499-14505	across	_	
95-28	14506-14509	all	_	
95-29	14510-14521	comparisons	_	
95-30	14522-14523	(	_	
95-31	14523-14524	8	_	
95-32	14525-14534	contrasts	_	
95-33	14535-14539	with	_	
95-34	14540-14541	a	_	
95-35	14542-14547	total	_	
95-36	14548-14550	of	_	
95-37	14551-14555	1469	_	
95-38	14556-14564	clusters	_	
95-39	14565-14569	that	_	
95-40	14570-14575	range	_	
95-41	14576-14577	1	_	
95-42	14578-14580	to	_	
95-43	14581-14586	12892	_	
95-44	14587-14593	voxels	_	
95-45	14594-14596	in	_	
95-46	14597-14601	size	_	
95-47	14601-14602	)	_	
95-48	14602-14603	.	_	

#Text=FSL’s cluster tool was used to extract mean cluster FA.
96-1	14604-14607	FSL	_	
96-2	14607-14608	’	_	
96-3	14608-14609	s	_	
96-4	14610-14617	cluster	_	
96-5	14618-14622	tool	_	
96-6	14623-14626	was	_	
96-7	14627-14631	used	_	
96-8	14632-14634	to	_	
96-9	14635-14642	extract	_	
96-10	14643-14647	mean	_	
96-11	14648-14655	cluster	_	
96-12	14656-14658	FA	_	
96-13	14658-14659	.	_	

#Text=Comparisons of continuous measures of subject characteristics and global metrics of network connectivity were conducted with independent samples t-tests.
97-1	14660-14671	Comparisons	_	
97-2	14672-14674	of	_	
97-3	14675-14685	continuous	_	
97-4	14686-14694	measures	_	
97-5	14695-14697	of	_	
97-6	14698-14705	subject	_	
97-7	14706-14721	characteristics	_	
97-8	14722-14725	and	_	
97-9	14726-14732	global	_	
97-10	14733-14740	metrics	_	
97-11	14741-14743	of	_	
97-12	14744-14751	network	_	
97-13	14752-14764	connectivity	_	
97-14	14765-14769	were	_	
97-15	14770-14779	conducted	_	
97-16	14780-14784	with	_	
97-17	14785-14796	independent	_	
97-18	14797-14804	samples	_	
97-19	14805-14812	t-tests	_	
97-20	14812-14813	.	_	

#Text=Chi-squared tests were used to test for differences in categorical variables.
98-1	14814-14825	Chi-squared	_	
98-2	14826-14831	tests	_	
98-3	14832-14836	were	_	
98-4	14837-14841	used	_	
98-5	14842-14844	to	_	
98-6	14845-14849	test	_	
98-7	14850-14853	for	_	
98-8	14854-14865	differences	_	
98-9	14866-14868	in	_	
98-10	14869-14880	categorical	_	
98-11	14881-14890	variables	_	
98-12	14890-14891	.	_	

#Text=The Network Based Statistics (NBS) Toolbox was used to compare the fiber density and CA network matrices between groups.
99-1	14892-14895	The	_	
99-2	14896-14903	Network	_	
99-3	14904-14909	Based	_	
99-4	14910-14920	Statistics	_	
99-5	14921-14922	(	_	
99-6	14922-14925	NBS	_	
99-7	14925-14926	)	_	
99-8	14927-14934	Toolbox	_	
99-9	14935-14938	was	_	
99-10	14939-14943	used	_	
99-11	14944-14946	to	_	
99-12	14947-14954	compare	_	
99-13	14955-14958	the	_	
99-14	14959-14964	fiber	_	
99-15	14965-14972	density	_	
99-16	14973-14976	and	_	
99-17	14977-14979	CA	_	
99-18	14980-14987	network	_	
99-19	14988-14996	matrices	_	
99-20	14997-15004	between	_	
99-21	15005-15011	groups	_	
99-22	15011-15012	.	_	

#Text=False Discovery Rate (FDR) after 5,000 permutations was used to control for multiple comparisons.
100-1	15013-15018	False	_	
100-2	15019-15028	Discovery	_	
100-3	15029-15033	Rate	_	
100-4	15034-15035	(	_	
100-5	15035-15038	FDR	_	
100-6	15038-15039	)	_	
100-7	15040-15045	after	_	
100-8	15046-15051	5,000	_	
100-9	15052-15064	permutations	_	
100-10	15065-15068	was	_	
100-11	15069-15073	used	_	
100-12	15074-15076	to	_	
100-13	15077-15084	control	_	
100-14	15085-15088	for	_	
100-15	15089-15097	multiple	_	
100-16	15098-15109	comparisons	_	
100-17	15109-15110	.	_	

#Text=Results
#Text=Subjects Characteristics
#Text=Subject characteristics are presented in Table 1.
101-1	15111-15118	Results	_	
101-2	15119-15127	Subjects	_	
101-3	15128-15143	Characteristics	_	
101-4	15144-15151	Subject	_	
101-5	15152-15167	characteristics	_	
101-6	15168-15171	are	_	
101-7	15172-15181	presented	_	
101-8	15182-15184	in	_	
101-9	15185-15190	Table	_	
101-10	15191-15192	1	_	
101-11	15192-15193	.	_	

#Text=AUD and CON were well matched, with no significant differences in age, gender, education, or smoking status.
102-1	15194-15197	AUD	_	
102-2	15198-15201	and	_	
102-3	15202-15205	CON	_	
102-4	15206-15210	were	_	
102-5	15211-15215	well	_	
102-6	15216-15223	matched	_	
102-7	15223-15224	,	_	
102-8	15225-15229	with	_	
102-9	15230-15232	no	_	
102-10	15233-15244	significant	_	
102-11	15245-15256	differences	_	
102-12	15257-15259	in	_	
102-13	15260-15263	age	_	
102-14	15263-15264	,	_	
102-15	15265-15271	gender	_	
102-16	15271-15272	,	_	
102-17	15273-15282	education	_	
102-18	15282-15283	,	_	
102-19	15284-15286	or	_	
102-20	15287-15294	smoking	_	
102-21	15295-15301	status	_	
102-22	15301-15302	.	_	

#Text=In the AUD group, the mean age of AUD onset was 17.23 ± 1.4, and mean age at first drink was 14.82 ± 1.47, compared to 18 ± 1.91 in CON.
103-1	15303-15305	In	_	
103-2	15306-15309	the	_	
103-3	15310-15313	AUD	_	
103-4	15314-15319	group	_	
103-5	15319-15320	,	_	
103-6	15321-15324	the	_	
103-7	15325-15329	mean	_	
103-8	15330-15333	age	_	
103-9	15334-15336	of	_	
103-10	15337-15340	AUD	_	
103-11	15341-15346	onset	_	
103-12	15347-15350	was	_	
103-13	15351-15356	17.23	_	
103-14	15357-15358	±	_	
103-15	15359-15362	1.4	_	
103-16	15362-15363	,	_	
103-17	15364-15367	and	_	
103-18	15368-15372	mean	_	
103-19	15373-15376	age	_	
103-20	15377-15379	at	_	
103-21	15380-15385	first	_	
103-22	15386-15391	drink	_	
103-23	15392-15395	was	_	
103-24	15396-15401	14.82	_	
103-25	15402-15403	±	_	
103-26	15404-15408	1.47	_	
103-27	15408-15409	,	_	
103-28	15410-15418	compared	_	
103-29	15419-15421	to	_	
103-30	15422-15424	18	_	
103-31	15425-15426	±	_	
103-32	15427-15431	1.91	_	
103-33	15432-15434	in	_	
103-34	15435-15438	CON	_	
103-35	15438-15439	.	_	

#Text=Additionally, AUD reported significantly higher lifetime alcohol problem counts (p < 1 × 10−5) and total number of drinks in the two weeks prior to interview (p < 1 × 10−10) compared to CON.
104-1	15440-15452	Additionally	_	
104-2	15452-15453	,	_	
104-3	15454-15457	AUD	_	
104-4	15458-15466	reported	_	
104-5	15467-15480	significantly	_	
104-6	15481-15487	higher	_	
104-7	15488-15496	lifetime	_	
104-8	15497-15504	alcohol	_	
104-9	15505-15512	problem	_	
104-10	15513-15519	counts	_	
104-11	15520-15521	(	_	
104-12	15521-15522	p	_	
104-13	15523-15524	<	_	
104-14	15525-15526	1	_	
104-15	15527-15528	×	_	
104-16	15529-15531	10	_	
104-17	15531-15532	−	_	
104-18	15532-15533	5	_	
104-19	15533-15534	)	_	
104-20	15535-15538	and	_	
104-21	15539-15544	total	_	
104-22	15545-15551	number	_	
104-23	15552-15554	of	_	
104-24	15555-15561	drinks	_	
104-25	15562-15564	in	_	
104-26	15565-15568	the	_	
104-27	15569-15572	two	_	
104-28	15573-15578	weeks	_	
104-29	15579-15584	prior	_	
104-30	15585-15587	to	_	
104-31	15588-15597	interview	_	
104-32	15598-15599	(	_	
104-33	15599-15600	p	_	
104-34	15601-15602	<	_	
104-35	15603-15604	1	_	
104-36	15605-15606	×	_	
104-37	15607-15609	10	_	
104-38	15609-15610	−	_	
104-39	15610-15612	10	_	
104-40	15612-15613	)	_	
104-41	15614-15622	compared	_	
104-42	15623-15625	to	_	
104-43	15626-15629	CON	_	
104-44	15629-15630	.	_	

#Text=TBSS: AUD vs.
105-1	15631-15635	TBSS	_	
105-2	15635-15636	:	_	
105-3	15637-15640	AUD	_	
105-4	15641-15643	vs	_	
105-5	15643-15644	.	_	

#Text=CON
#Text=Young individuals with AUD showed higher FA values compared to CON throughout the WM skeleton (pTFCE < 0.05; Figure 1).
106-1	15645-15648	CON	_	
106-2	15649-15654	Young	_	
106-3	15655-15666	individuals	_	
106-4	15667-15671	with	_	
106-5	15672-15675	AUD	_	
106-6	15676-15682	showed	_	
106-7	15683-15689	higher	_	
106-8	15690-15692	FA	_	
106-9	15693-15699	values	_	
106-10	15700-15708	compared	_	
106-11	15709-15711	to	_	
106-12	15712-15715	CON	_	
106-13	15716-15726	throughout	_	
106-14	15727-15730	the	_	
106-15	15731-15733	WM	_	
106-16	15734-15742	skeleton	_	
106-17	15743-15744	(	_	
106-18	15744-15749	pTFCE	_	
106-19	15750-15751	<	_	
106-20	15752-15756	0.05	_	
106-21	15756-15757	;	_	
106-22	15758-15764	Figure	_	
106-23	15765-15766	1	_	
106-24	15766-15767	)	_	
106-25	15767-15768	.	_	

#Text=This apparent difference in FA is likely a function of lower RD (Figure 2C; Figure S1A) in the AUD group.
107-1	15769-15773	This	_	
107-2	15774-15782	apparent	_	
107-3	15783-15793	difference	_	
107-4	15794-15796	in	_	
107-5	15797-15799	FA	_	
107-6	15800-15802	is	_	
107-7	15803-15809	likely	_	
107-8	15810-15811	a	_	
107-9	15812-15820	function	_	
107-10	15821-15823	of	_	
107-11	15824-15829	lower	_	
107-12	15830-15832	RD	_	
107-13	15833-15834	(	_	
107-14	15834-15840	Figure	_	
107-15	15841-15843	2C	_	
107-16	15843-15844	;	_	
107-17	15845-15851	Figure	_	
107-18	15852-15855	S1A	_	
107-19	15855-15856	)	_	
107-20	15857-15859	in	_	
107-21	15860-15863	the	_	
107-22	15864-15867	AUD	_	
107-23	15868-15873	group	_	
107-24	15873-15874	.	_	

#Text=MD was also reduced in AUD (pTFCE < 0.05; Figure 2A), predominantly in areas where FA differences are absent; these differences in MD were likely due to significantly reduced AD (pTFCE < 0.05; Figure 2B).
108-1	15875-15877	MD	_	
108-2	15878-15881	was	_	
108-3	15882-15886	also	_	
108-4	15887-15894	reduced	_	
108-5	15895-15897	in	_	
108-6	15898-15901	AUD	_	
108-7	15902-15903	(	_	
108-8	15903-15908	pTFCE	_	
108-9	15909-15910	<	_	
108-10	15911-15915	0.05	_	
108-11	15915-15916	;	_	
108-12	15917-15923	Figure	_	
108-13	15924-15926	2A	_	
108-14	15926-15927	)	_	
108-15	15927-15928	,	_	
108-16	15929-15942	predominantly	_	
108-17	15943-15945	in	_	
108-18	15946-15951	areas	_	
108-19	15952-15957	where	_	
108-20	15958-15960	FA	_	
108-21	15961-15972	differences	_	
108-22	15973-15976	are	_	
108-23	15977-15983	absent	_	
108-24	15983-15984	;	_	
108-25	15985-15990	these	_	
108-26	15991-16002	differences	_	
108-27	16003-16005	in	_	
108-28	16006-16008	MD	_	
108-29	16009-16013	were	_	
108-30	16014-16020	likely	_	
108-31	16021-16024	due	_	
108-32	16025-16027	to	_	
108-33	16028-16041	significantly	_	
108-34	16042-16049	reduced	_	
108-35	16050-16052	AD	_	
108-36	16053-16054	(	_	
108-37	16054-16059	pTFCE	_	
108-38	16060-16061	<	_	
108-39	16062-16066	0.05	_	
108-40	16066-16067	;	_	
108-41	16068-16074	Figure	_	
108-42	16075-16077	2B	_	
108-43	16077-16078	)	_	
108-44	16078-16079	.	_	

#Text=Concurrently, AUD subjects exhibited lower FA values in WM tracts associated with the right insular cortex and in cerebellar WM (pTFCE < 0.05; Figure 1).
109-1	16080-16092	Concurrently	_	
109-2	16092-16093	,	_	
109-3	16094-16097	AUD	_	
109-4	16098-16106	subjects	_	
109-5	16107-16116	exhibited	_	
109-6	16117-16122	lower	_	
109-7	16123-16125	FA	_	
109-8	16126-16132	values	_	
109-9	16133-16135	in	_	
109-10	16136-16138	WM	_	
109-11	16139-16145	tracts	_	
109-12	16146-16156	associated	_	
109-13	16157-16161	with	_	
109-14	16162-16165	the	_	
109-15	16166-16171	right	_	
109-16	16172-16179	insular	_	
109-17	16180-16186	cortex	_	
109-18	16187-16190	and	_	
109-19	16191-16193	in	_	
109-20	16194-16204	cerebellar	_	
109-21	16205-16207	WM	_	
109-22	16208-16209	(	_	
109-23	16209-16214	pTFCE	_	
109-24	16215-16216	<	_	
109-25	16217-16221	0.05	_	
109-26	16221-16222	;	_	
109-27	16223-16229	Figure	_	
109-28	16230-16231	1	_	
109-29	16231-16232	)	_	
109-30	16232-16233	.	_	

#Text=Mean FA and MD values and anatomical position for clusters > 500 voxels are shown in Figures 3 and 4, respectively.
110-1	16234-16238	Mean	_	
110-2	16239-16241	FA	_	
110-3	16242-16245	and	_	
110-4	16246-16248	MD	_	
110-5	16249-16255	values	_	
110-6	16256-16259	and	_	
110-7	16260-16270	anatomical	_	
110-8	16271-16279	position	_	
110-9	16280-16283	for	_	
110-10	16284-16292	clusters	_	
110-11	16293-16294	>	_	
110-12	16295-16298	500	_	
110-13	16299-16305	voxels	_	
110-14	16306-16309	are	_	
110-15	16310-16315	shown	_	
110-16	16316-16318	in	_	
110-17	16319-16326	Figures	_	
110-18	16327-16328	3	_	
110-19	16329-16332	and	_	
110-20	16333-16334	4	_	
110-21	16334-16335	,	_	
110-22	16336-16348	respectively	_	
110-23	16348-16349	.	_	

#Text=Mean AD and RD values from clusters with significant differences in FA or MD are shown in Figures S1 and S2, respectively.
111-1	16350-16354	Mean	_	
111-2	16355-16357	AD	_	
111-3	16358-16361	and	_	
111-4	16362-16364	RD	_	
111-5	16365-16371	values	_	
111-6	16372-16376	from	_	
111-7	16377-16385	clusters	_	
111-8	16386-16390	with	_	
111-9	16391-16402	significant	_	
111-10	16403-16414	differences	_	
111-11	16415-16417	in	_	
111-12	16418-16420	FA	_	
111-13	16421-16423	or	_	
111-14	16424-16426	MD	_	
111-15	16427-16430	are	_	
111-16	16431-16436	shown	_	
111-17	16437-16439	in	_	
111-18	16440-16447	Figures	_	
111-19	16448-16450	S1	_	
111-20	16451-16454	and	_	
111-21	16455-16457	S2	_	
111-22	16457-16458	,	_	
111-23	16459-16471	respectively	_	
111-24	16471-16472	.	_	

#Text=Network Metrics of AUD vs.
112-1	16473-16480	Network	_	
112-2	16481-16488	Metrics	_	
112-3	16489-16491	of	_	
112-4	16492-16495	AUD	_	
112-5	16496-16498	vs	_	
112-6	16498-16499	.	_	

#Text=CON Structural Connectivity
#Text=Comparisons of global measures of structural connectivity showed increased network strength (pFDR < 0.02) and global efficiency (pFDR < 0.04) in AUD, while network density, degree, and clustering coefficient did not differ (Figure 5).
113-1	16500-16503	CON	_	
113-2	16504-16514	Structural	_	
113-3	16515-16527	Connectivity	_	
113-4	16528-16539	Comparisons	_	
113-5	16540-16542	of	_	
113-6	16543-16549	global	_	
113-7	16550-16558	measures	_	
113-8	16559-16561	of	_	
113-9	16562-16572	structural	_	
113-10	16573-16585	connectivity	_	
113-11	16586-16592	showed	_	
113-12	16593-16602	increased	_	
113-13	16603-16610	network	_	
113-14	16611-16619	strength	_	
113-15	16620-16621	(	_	
113-16	16621-16625	pFDR	_	
113-17	16626-16627	<	_	
113-18	16628-16632	0.02	_	
113-19	16632-16633	)	_	
113-20	16634-16637	and	_	
113-21	16638-16644	global	_	
113-22	16645-16655	efficiency	_	
113-23	16656-16657	(	_	
113-24	16657-16661	pFDR	_	
113-25	16662-16663	<	_	
113-26	16664-16668	0.04	_	
113-27	16668-16669	)	_	
113-28	16670-16672	in	_	
113-29	16673-16676	AUD	_	
113-30	16676-16677	,	_	
113-31	16678-16683	while	_	
113-32	16684-16691	network	_	
113-33	16692-16699	density	_	
113-34	16699-16700	,	_	
113-35	16701-16707	degree	_	
113-36	16707-16708	,	_	
113-37	16709-16712	and	_	
113-38	16713-16723	clustering	_	
113-39	16724-16735	coefficient	_	
113-40	16736-16739	did	_	
113-41	16740-16743	not	_	
113-42	16744-16750	differ	_	
113-43	16751-16752	(	_	
113-44	16752-16758	Figure	_	
113-45	16759-16760	5	_	
113-46	16760-16761	)	_	
113-47	16761-16762	.	_	

#Text=AUD had higher fiber density in a single connection between a node in the middle frontal gyrus and a node in the superior frontal gyrus (Figure 6A).
114-1	16763-16766	AUD	_	
114-2	16767-16770	had	_	
114-3	16771-16777	higher	_	
114-4	16778-16783	fiber	_	
114-5	16784-16791	density	_	
114-6	16792-16794	in	_	
114-7	16795-16796	a	_	
114-8	16797-16803	single	_	
114-9	16804-16814	connection	_	
114-10	16815-16822	between	_	
114-11	16823-16824	a	_	
114-12	16825-16829	node	_	
114-13	16830-16832	in	_	
114-14	16833-16836	the	_	
114-15	16837-16843	middle	_	
114-16	16844-16851	frontal	_	
114-17	16852-16857	gyrus	_	
114-18	16858-16861	and	_	
114-19	16862-16863	a	_	
114-20	16864-16868	node	_	
114-21	16869-16871	in	_	
114-22	16872-16875	the	_	
114-23	16876-16884	superior	_	
114-24	16885-16892	frontal	_	
114-25	16893-16898	gyrus	_	
114-26	16899-16900	(	_	
114-27	16900-16906	Figure	_	
114-28	16907-16909	6A	_	
114-29	16909-16910	)	_	
114-30	16910-16911	.	_	

#Text=In AUD, co-classification (CA) was greater between nodes in middle frontal and pre/postcentral gyri (Figure 6B, left), between nodes in the cuneus and the middle temporal gyrus, and between supplementary motor and middle occipital areas (Figure 6B, right).
115-1	16912-16914	In	_	
115-2	16915-16918	AUD	_	
115-3	16918-16919	,	_	
115-4	16920-16937	co-classification	_	
115-5	16938-16939	(	_	
115-6	16939-16941	CA	_	
115-7	16941-16942	)	_	
115-8	16943-16946	was	_	
115-9	16947-16954	greater	_	
115-10	16955-16962	between	_	
115-11	16963-16968	nodes	_	
115-12	16969-16971	in	_	
115-13	16972-16978	middle	_	
115-14	16979-16986	frontal	_	
115-15	16987-16990	and	_	
115-16	16991-16994	pre	_	
115-17	16994-16995	/	_	
115-18	16995-17006	postcentral	_	
115-19	17007-17011	gyri	_	
115-20	17012-17013	(	_	
115-21	17013-17019	Figure	_	
115-22	17020-17022	6B	_	
115-23	17022-17023	,	_	
115-24	17024-17028	left	_	
115-25	17028-17029	)	_	
115-26	17029-17030	,	_	
115-27	17031-17038	between	_	
115-28	17039-17044	nodes	_	
115-29	17045-17047	in	_	
115-30	17048-17051	the	_	
115-31	17052-17058	cuneus	_	
115-32	17059-17062	and	_	
115-33	17063-17066	the	_	
115-34	17067-17073	middle	_	
115-35	17074-17082	temporal	_	
115-36	17083-17088	gyrus	_	
115-37	17088-17089	,	_	
115-38	17090-17093	and	_	
115-39	17094-17101	between	_	
115-40	17102-17115	supplementary	_	
115-41	17116-17121	motor	_	
115-42	17122-17125	and	_	
115-43	17126-17132	middle	_	
115-44	17133-17142	occipital	_	
115-45	17143-17148	areas	_	
115-46	17149-17150	(	_	
115-47	17150-17156	Figure	_	
115-48	17157-17159	6B	_	
115-49	17159-17160	,	_	
115-50	17161-17166	right	_	
115-51	17166-17167	)	_	
115-52	17167-17168	.	_	

#Text=AUD also had lower CA between nodes in the middle temporal gyrus and inferior insula (Figure 6C).
116-1	17169-17172	AUD	_	
116-2	17173-17177	also	_	
116-3	17178-17181	had	_	
116-4	17182-17187	lower	_	
116-5	17188-17190	CA	_	
116-6	17191-17198	between	_	
116-7	17199-17204	nodes	_	
116-8	17205-17207	in	_	
116-9	17208-17211	the	_	
116-10	17212-17218	middle	_	
116-11	17219-17227	temporal	_	
116-12	17228-17233	gyrus	_	
116-13	17234-17237	and	_	
116-14	17238-17246	inferior	_	
116-15	17247-17253	insula	_	
116-16	17254-17255	(	_	
116-17	17255-17261	Figure	_	
116-18	17262-17264	6C	_	
116-19	17264-17265	)	_	
116-20	17265-17266	.	_	

#Text=Discussion
#Text=Studies employing DWI frequently focus on alcoholism in detoxified/abstinent older adults, but few DWI studies have investigated the WM differences in currently-drinking young adults with AUD.
117-1	17267-17277	Discussion	_	
117-2	17278-17285	Studies	_	
117-3	17286-17295	employing	_	
117-4	17296-17299	DWI	_	
117-5	17300-17310	frequently	_	
117-6	17311-17316	focus	_	
117-7	17317-17319	on	_	
117-8	17320-17330	alcoholism	_	
117-9	17331-17333	in	_	
117-10	17334-17344	detoxified	_	
117-11	17344-17345	/	_	
117-12	17345-17354	abstinent	_	
117-13	17355-17360	older	_	
117-14	17361-17367	adults	_	
117-15	17367-17368	,	_	
117-16	17369-17372	but	_	
117-17	17373-17376	few	_	
117-18	17377-17380	DWI	_	
117-19	17381-17388	studies	_	
117-20	17389-17393	have	_	
117-21	17394-17406	investigated	_	
117-22	17407-17410	the	_	
117-23	17411-17413	WM	_	
117-24	17414-17425	differences	_	
117-25	17426-17428	in	_	
117-26	17429-17447	currently-drinking	_	
117-27	17448-17453	young	_	
117-28	17454-17460	adults	_	
117-29	17461-17465	with	_	
117-30	17466-17469	AUD	_	
117-31	17469-17470	.	_	

#Text=Emerging adulthood is a critical period for alcohol use as it represents the time period when one reaches the legal drinking age with greater access to alcohol use.
118-1	17471-17479	Emerging	_	
118-2	17480-17489	adulthood	_	
118-3	17490-17492	is	_	
118-4	17493-17494	a	_	
118-5	17495-17503	critical	_	
118-6	17504-17510	period	_	
118-7	17511-17514	for	_	
118-8	17515-17522	alcohol	_	
118-9	17523-17526	use	_	
118-10	17527-17529	as	_	
118-11	17530-17532	it	_	
118-12	17533-17543	represents	_	
118-13	17544-17547	the	_	
118-14	17548-17552	time	_	
118-15	17553-17559	period	_	
118-16	17560-17564	when	_	
118-17	17565-17568	one	_	
118-18	17569-17576	reaches	_	
118-19	17577-17580	the	_	
118-20	17581-17586	legal	_	
118-21	17587-17595	drinking	_	
118-22	17596-17599	age	_	
118-23	17600-17604	with	_	
118-24	17605-17612	greater	_	
118-25	17613-17619	access	_	
118-26	17620-17622	to	_	
118-27	17623-17630	alcohol	_	
118-28	17631-17634	use	_	
118-29	17634-17635	.	_	

#Text=This, coupled with increasing social acceptance of heavy drinking at this age, means that emerging adulthood is likely an important stage for the development and/or maintenance of AUD.
119-1	17636-17640	This	_	
119-2	17640-17641	,	_	
119-3	17642-17649	coupled	_	
119-4	17650-17654	with	_	
119-5	17655-17665	increasing	_	
119-6	17666-17672	social	_	
119-7	17673-17683	acceptance	_	
119-8	17684-17686	of	_	
119-9	17687-17692	heavy	_	
119-10	17693-17701	drinking	_	
119-11	17702-17704	at	_	
119-12	17705-17709	this	_	
119-13	17710-17713	age	_	
119-14	17713-17714	,	_	
119-15	17715-17720	means	_	
119-16	17721-17725	that	_	
119-17	17726-17734	emerging	_	
119-18	17735-17744	adulthood	_	
119-19	17745-17747	is	_	
119-20	17748-17754	likely	_	
119-21	17755-17757	an	_	
119-22	17758-17767	important	_	
119-23	17768-17773	stage	_	
119-24	17774-17777	for	_	
119-25	17778-17781	the	_	
119-26	17782-17793	development	_	
119-27	17794-17797	and	_	
119-28	17797-17798	/	_	
119-29	17798-17800	or	_	
119-30	17801-17812	maintenance	_	
119-31	17813-17815	of	_	
119-32	17816-17819	AUD	_	
119-33	17819-17820	.	_	

#Text=The present study demonstrates that there are alterations in WM microstructure in young adults with AUD.
120-1	17821-17824	The	_	
120-2	17825-17832	present	_	
120-3	17833-17838	study	_	
120-4	17839-17851	demonstrates	_	
120-5	17852-17856	that	_	
120-6	17857-17862	there	_	
120-7	17863-17866	are	_	
120-8	17867-17878	alterations	_	
120-9	17879-17881	in	_	
120-10	17882-17884	WM	_	
120-11	17885-17899	microstructure	_	
120-12	17900-17902	in	_	
120-13	17903-17908	young	_	
120-14	17909-17915	adults	_	
120-15	17916-17920	with	_	
120-16	17921-17924	AUD	_	
120-17	17924-17925	.	_	

#Text=Additionally, our investigation of structural network modularity utilizing a novel connectomics based approach yielded differences in community structure in the brains of young AUD subjects.
121-1	17926-17938	Additionally	_	
121-2	17938-17939	,	_	
121-3	17940-17943	our	_	
121-4	17944-17957	investigation	_	
121-5	17958-17960	of	_	
121-6	17961-17971	structural	_	
121-7	17972-17979	network	_	
121-8	17980-17990	modularity	_	
121-9	17991-18000	utilizing	_	
121-10	18001-18002	a	_	
121-11	18003-18008	novel	_	
121-12	18009-18021	connectomics	_	
121-13	18022-18027	based	_	
121-14	18028-18036	approach	_	
121-15	18037-18044	yielded	_	
121-16	18045-18056	differences	_	
121-17	18057-18059	in	_	
121-18	18060-18069	community	_	
121-19	18070-18079	structure	_	
121-20	18080-18082	in	_	
121-21	18083-18086	the	_	
121-22	18087-18093	brains	_	
121-23	18094-18096	of	_	
121-24	18097-18102	young	_	
121-25	18103-18106	AUD	_	
121-26	18107-18115	subjects	_	
121-27	18115-18116	.	_	

#Text=This study represents one of the first investigations of WM differences in an emerging adulthood AUD sample using a network science based analysis in addition to traditional DWI metrics.
122-1	18117-18121	This	_	
122-2	18122-18127	study	_	
122-3	18128-18138	represents	_	
122-4	18139-18142	one	_	
122-5	18143-18145	of	_	
122-6	18146-18149	the	_	
122-7	18150-18155	first	_	
122-8	18156-18170	investigations	_	
122-9	18171-18173	of	_	
122-10	18174-18176	WM	_	
122-11	18177-18188	differences	_	
122-12	18189-18191	in	_	
122-13	18192-18194	an	_	
122-14	18195-18203	emerging	_	
122-15	18204-18213	adulthood	_	
122-16	18214-18217	AUD	_	
122-17	18218-18224	sample	_	
122-18	18225-18230	using	_	
122-19	18231-18232	a	_	
122-20	18233-18240	network	_	
122-21	18241-18248	science	_	
122-22	18249-18254	based	_	
122-23	18255-18263	analysis	_	
122-24	18264-18266	in	_	
122-25	18267-18275	addition	_	
122-26	18276-18278	to	_	
122-27	18279-18290	traditional	_	
122-28	18291-18294	DWI	_	
122-29	18295-18302	metrics	_	
122-30	18302-18303	.	_	

#Text=Alterations in FA, MD, AD, and RD values reflect differences in axonal diameters, density, and myelination.
123-1	18304-18315	Alterations	_	
123-2	18316-18318	in	_	
123-3	18319-18321	FA	_	
123-4	18321-18322	,	_	
123-5	18323-18325	MD	_	
123-6	18325-18326	,	_	
123-7	18327-18329	AD	_	
123-8	18329-18330	,	_	
123-9	18331-18334	and	_	
123-10	18335-18337	RD	_	
123-11	18338-18344	values	_	
123-12	18345-18352	reflect	_	
123-13	18353-18364	differences	_	
123-14	18365-18367	in	_	
123-15	18368-18374	axonal	_	
123-16	18375-18384	diameters	_	
123-17	18384-18385	,	_	
123-18	18386-18393	density	_	
123-19	18393-18394	,	_	
123-20	18395-18398	and	_	
123-21	18399-18410	myelination	_	
123-22	18410-18411	.	_	

#Text=Consistently, the literature has reported that decrements in WM integrity are associated with alcohol use (for review see) and higher WM integrity is associated with better cognitive functioning.
124-1	18412-18424	Consistently	_	
124-2	18424-18425	,	_	
124-3	18426-18429	the	_	
124-4	18430-18440	literature	_	
124-5	18441-18444	has	_	
124-6	18445-18453	reported	_	
124-7	18454-18458	that	_	
124-8	18459-18469	decrements	_	
124-9	18470-18472	in	_	
124-10	18473-18475	WM	_	
124-11	18476-18485	integrity	_	
124-12	18486-18489	are	_	
124-13	18490-18500	associated	_	
124-14	18501-18505	with	_	
124-15	18506-18513	alcohol	_	
124-16	18514-18517	use	_	
124-17	18518-18519	(	_	
124-18	18519-18522	for	_	
124-19	18523-18529	review	_	
124-20	18530-18533	see	_	
124-21	18533-18534	)	_	
124-22	18535-18538	and	_	
124-23	18539-18545	higher	_	
124-24	18546-18548	WM	_	
124-25	18549-18558	integrity	_	
124-26	18559-18561	is	_	
124-27	18562-18572	associated	_	
124-28	18573-18577	with	_	
124-29	18578-18584	better	_	
124-30	18585-18594	cognitive	_	
124-31	18595-18606	functioning	_	
124-32	18606-18607	.	_	

#Text=However, our results show that young AUD subjects have elevated FA, with lower MD, RD, and AD throughout major WM tracts of the TBSS FA-skeleton.
125-1	18608-18615	However	_	
125-2	18615-18616	,	_	
125-3	18617-18620	our	_	
125-4	18621-18628	results	_	
125-5	18629-18633	show	_	
125-6	18634-18638	that	_	
125-7	18639-18644	young	_	
125-8	18645-18648	AUD	_	
125-9	18649-18657	subjects	_	
125-10	18658-18662	have	_	
125-11	18663-18671	elevated	_	
125-12	18672-18674	FA	_	
125-13	18674-18675	,	_	
125-14	18676-18680	with	_	
125-15	18681-18686	lower	_	
125-16	18687-18689	MD	_	
125-17	18689-18690	,	_	
125-18	18691-18693	RD	_	
125-19	18693-18694	,	_	
125-20	18695-18698	and	_	
125-21	18699-18701	AD	_	
125-22	18702-18712	throughout	_	
125-23	18713-18718	major	_	
125-24	18719-18721	WM	_	
125-25	18722-18728	tracts	_	
125-26	18729-18731	of	_	
125-27	18732-18735	the	_	
125-28	18736-18740	TBSS	_	
125-29	18741-18752	FA-skeleton	_	
125-30	18752-18753	.	_	

#Text=This suggests that young AUD may have differential axonal diameters, density, and/or myelination compared to CON subjects.
126-1	18754-18758	This	_	
126-2	18759-18767	suggests	_	
126-3	18768-18772	that	_	
126-4	18773-18778	young	_	
126-5	18779-18782	AUD	_	
126-6	18783-18786	may	_	
126-7	18787-18791	have	_	
126-8	18792-18804	differential	_	
126-9	18805-18811	axonal	_	
126-10	18812-18821	diameters	_	
126-11	18821-18822	,	_	
126-12	18823-18830	density	_	
126-13	18830-18831	,	_	
126-14	18832-18835	and	_	
126-15	18835-18836	/	_	
126-16	18836-18838	or	_	
126-17	18839-18850	myelination	_	
126-18	18851-18859	compared	_	
126-19	18860-18862	to	_	
126-20	18863-18866	CON	_	
126-21	18867-18875	subjects	_	
126-22	18875-18876	.	_	

#Text=The present findings are consistent with several reports that observed higher FA in at-risk adolescent populations and adolescent-onset AUD.
127-1	18877-18880	The	_	
127-2	18881-18888	present	_	
127-3	18889-18897	findings	_	
127-4	18898-18901	are	_	
127-5	18902-18912	consistent	_	
127-6	18913-18917	with	_	
127-7	18918-18925	several	_	
127-8	18926-18933	reports	_	
127-9	18934-18938	that	_	
127-10	18939-18947	observed	_	
127-11	18948-18954	higher	_	
127-12	18955-18957	FA	_	
127-13	18958-18960	in	_	
127-14	18961-18968	at-risk	_	
127-15	18969-18979	adolescent	_	
127-16	18980-18991	populations	_	
127-17	18992-18995	and	_	
127-18	18996-19012	adolescent-onset	_	
127-19	19013-19016	AUD	_	
127-20	19016-19017	.	_	

#Text=There are several potential explanations for these unexpected results.
128-1	19018-19023	There	_	
128-2	19024-19027	are	_	
128-3	19028-19035	several	_	
128-4	19036-19045	potential	_	
128-5	19046-19058	explanations	_	
128-6	19059-19062	for	_	
128-7	19063-19068	these	_	
128-8	19069-19079	unexpected	_	
128-9	19080-19087	results	_	
128-10	19087-19088	.	_	

#Text=It is possible that accelerated myelination of callosal tracts may present a vulnerability for adolescent AUD.
129-1	19089-19091	It	_	
129-2	19092-19094	is	_	
129-3	19095-19103	possible	_	
129-4	19104-19108	that	_	
129-5	19109-19120	accelerated	_	
129-6	19121-19132	myelination	_	
129-7	19133-19135	of	_	
129-8	19136-19144	callosal	_	
129-9	19145-19151	tracts	_	
129-10	19152-19155	may	_	
129-11	19156-19163	present	_	
129-12	19164-19165	a	_	
129-13	19166-19179	vulnerability	_	
129-14	19180-19183	for	_	
129-15	19184-19194	adolescent	_	
129-16	19195-19198	AUD	_	
129-17	19198-19199	.	_	

#Text=Alternatively, such WM changes might reflect compensatory responses that occur during the early progression of AUD.
130-1	19200-19213	Alternatively	_	
130-2	19213-19214	,	_	
130-3	19215-19219	such	_	
130-4	19220-19222	WM	_	
130-5	19223-19230	changes	_	
130-6	19231-19236	might	_	
130-7	19237-19244	reflect	_	
130-8	19245-19257	compensatory	_	
130-9	19258-19267	responses	_	
130-10	19268-19272	that	_	
130-11	19273-19278	occur	_	
130-12	19279-19285	during	_	
130-13	19286-19289	the	_	
130-14	19290-19295	early	_	
130-15	19296-19307	progression	_	
130-16	19308-19310	of	_	
130-17	19311-19314	AUD	_	
130-18	19314-19315	.	_	

#Text=Indeed, fMRI studies have shown that subtle reorganization of functional activation may occur during the progression of AUD with increasing use.
131-1	19316-19322	Indeed	_	
131-2	19322-19323	,	_	
131-3	19324-19328	fMRI	_	
131-4	19329-19336	studies	_	
131-5	19337-19341	have	_	
131-6	19342-19347	shown	_	
131-7	19348-19352	that	_	
131-8	19353-19359	subtle	_	
131-9	19360-19374	reorganization	_	
131-10	19375-19377	of	_	
131-11	19378-19388	functional	_	
131-12	19389-19399	activation	_	
131-13	19400-19403	may	_	
131-14	19404-19409	occur	_	
131-15	19410-19416	during	_	
131-16	19417-19420	the	_	
131-17	19421-19432	progression	_	
131-18	19433-19435	of	_	
131-19	19436-19439	AUD	_	
131-20	19440-19444	with	_	
131-21	19445-19455	increasing	_	
131-22	19456-19459	use	_	
131-23	19459-19460	.	_	

#Text=Taken together, these findings could suggest that the early stages of AUD may be associated with higher FA in many regions, either as a function of predisposition to AUD or as a result of the effects of extensive alcohol exposure during the early stages of AUD.
132-1	19461-19466	Taken	_	
132-2	19467-19475	together	_	
132-3	19475-19476	,	_	
132-4	19477-19482	these	_	
132-5	19483-19491	findings	_	
132-6	19492-19497	could	_	
132-7	19498-19505	suggest	_	
132-8	19506-19510	that	_	
132-9	19511-19514	the	_	
132-10	19515-19520	early	_	
132-11	19521-19527	stages	_	
132-12	19528-19530	of	_	
132-13	19531-19534	AUD	_	
132-14	19535-19538	may	_	
132-15	19539-19541	be	_	
132-16	19542-19552	associated	_	
132-17	19553-19557	with	_	
132-18	19558-19564	higher	_	
132-19	19565-19567	FA	_	
132-20	19568-19570	in	_	
132-21	19571-19575	many	_	
132-22	19576-19583	regions	_	
132-23	19583-19584	,	_	
132-24	19585-19591	either	_	
132-25	19592-19594	as	_	
132-26	19595-19596	a	_	
132-27	19597-19605	function	_	
132-28	19606-19608	of	_	
132-29	19609-19623	predisposition	_	
132-30	19624-19626	to	_	
132-31	19627-19630	AUD	_	
132-32	19631-19633	or	_	
132-33	19634-19636	as	_	
132-34	19637-19638	a	_	
132-35	19639-19645	result	_	
132-36	19646-19648	of	_	
132-37	19649-19652	the	_	
132-38	19653-19660	effects	_	
132-39	19661-19663	of	_	
132-40	19664-19673	extensive	_	
132-41	19674-19681	alcohol	_	
132-42	19682-19690	exposure	_	
132-43	19691-19697	during	_	
132-44	19698-19701	the	_	
132-45	19702-19707	early	_	
132-46	19708-19714	stages	_	
132-47	19715-19717	of	_	
132-48	19718-19721	AUD	_	
132-49	19721-19722	.	_	

#Text=Further work is needed to understand whether or not these neurophysiological signatures are related to behavioral and cognitive endophenotypes in early-stage AUD, and whether they are predictive of sustained alcohol use disorders throughout adulthood.
133-1	19723-19730	Further	_	
133-2	19731-19735	work	_	
133-3	19736-19738	is	_	
133-4	19739-19745	needed	_	
133-5	19746-19748	to	_	
133-6	19749-19759	understand	_	
133-7	19760-19767	whether	_	
133-8	19768-19770	or	_	
133-9	19771-19774	not	_	
133-10	19775-19780	these	_	
133-11	19781-19799	neurophysiological	_	
133-12	19800-19810	signatures	_	
133-13	19811-19814	are	_	
133-14	19815-19822	related	_	
133-15	19823-19825	to	_	
133-16	19826-19836	behavioral	_	
133-17	19837-19840	and	_	
133-18	19841-19850	cognitive	_	
133-19	19851-19865	endophenotypes	_	
133-20	19866-19868	in	_	
133-21	19869-19880	early-stage	_	
133-22	19881-19884	AUD	_	
133-23	19884-19885	,	_	
133-24	19886-19889	and	_	
133-25	19890-19897	whether	_	
133-26	19898-19902	they	_	
133-27	19903-19906	are	_	
133-28	19907-19917	predictive	_	
133-29	19918-19920	of	_	
133-30	19921-19930	sustained	_	
133-31	19931-19938	alcohol	_	
133-32	19939-19942	use	_	
133-33	19943-19952	disorders	_	
133-34	19953-19963	throughout	_	
133-35	19964-19973	adulthood	_	
133-36	19973-19974	.	_	

#Text=The lower FA values in WM tracts near the insula indicate potential demyelination or damage in tracts that connect with the insula.
134-1	19975-19978	The	_	
134-2	19979-19984	lower	_	
134-3	19985-19987	FA	_	
134-4	19988-19994	values	_	
134-5	19995-19997	in	_	
134-6	19998-20000	WM	_	
134-7	20001-20007	tracts	_	
134-8	20008-20012	near	_	
134-9	20013-20016	the	_	
134-10	20017-20023	insula	_	
134-11	20024-20032	indicate	_	
134-12	20033-20042	potential	_	
134-13	20043-20056	demyelination	_	
134-14	20057-20059	or	_	
134-15	20060-20066	damage	_	
134-16	20067-20069	in	_	
134-17	20070-20076	tracts	_	
134-18	20077-20081	that	_	
134-19	20082-20089	connect	_	
134-20	20090-20094	with	_	
134-21	20095-20098	the	_	
134-22	20099-20105	insula	_	
134-23	20105-20106	.	_	

#Text=The insula is an important neural substrate for reward and addiction, and is critical for mediating cue-induced craving that can drive drug use.
135-1	20107-20110	The	_	
135-2	20111-20117	insula	_	
135-3	20118-20120	is	_	
135-4	20121-20123	an	_	
135-5	20124-20133	important	_	
135-6	20134-20140	neural	_	
135-7	20141-20150	substrate	_	
135-8	20151-20154	for	_	
135-9	20155-20161	reward	_	
135-10	20162-20165	and	_	
135-11	20166-20175	addiction	_	
135-12	20175-20176	,	_	
135-13	20177-20180	and	_	
135-14	20181-20183	is	_	
135-15	20184-20192	critical	_	
135-16	20193-20196	for	_	
135-17	20197-20206	mediating	_	
135-18	20207-20218	cue-induced	_	
135-19	20219-20226	craving	_	
135-20	20227-20231	that	_	
135-21	20232-20235	can	_	
135-22	20236-20241	drive	_	
135-23	20242-20246	drug	_	
135-24	20247-20250	use	_	
135-25	20250-20251	.	_	

#Text=This is supported by rodent models of alcohol addiction, which have shown that disrupting excitatory insular-striatal circuitry decreases alcohol self-administration and increases sensitivity to alcohol.
136-1	20252-20256	This	_	
136-2	20257-20259	is	_	
136-3	20260-20269	supported	_	
136-4	20270-20272	by	_	
136-5	20273-20279	rodent	_	
136-6	20280-20286	models	_	
136-7	20287-20289	of	_	
136-8	20290-20297	alcohol	_	
136-9	20298-20307	addiction	_	
136-10	20307-20308	,	_	
136-11	20309-20314	which	_	
136-12	20315-20319	have	_	
136-13	20320-20325	shown	_	
136-14	20326-20330	that	_	
136-15	20331-20341	disrupting	_	
136-16	20342-20352	excitatory	_	
136-17	20353-20369	insular-striatal	_	
136-18	20370-20379	circuitry	_	
136-19	20380-20389	decreases	_	
136-20	20390-20397	alcohol	_	
136-21	20398-20417	self-administration	_	
136-22	20418-20421	and	_	
136-23	20422-20431	increases	_	
136-24	20432-20443	sensitivity	_	
136-25	20444-20446	to	_	
136-26	20447-20454	alcohol	_	
136-27	20454-20455	.	_	

#Text=Decrements in FA in the vicinity of the insula in our young adult AUD sample may lead to impaired ability to detect changes in internal states such as alcohol intoxication.
137-1	20456-20466	Decrements	_	
137-2	20467-20469	in	_	
137-3	20470-20472	FA	_	
137-4	20473-20475	in	_	
137-5	20476-20479	the	_	
137-6	20480-20488	vicinity	_	
137-7	20489-20491	of	_	
137-8	20492-20495	the	_	
137-9	20496-20502	insula	_	
137-10	20503-20505	in	_	
137-11	20506-20509	our	_	
137-12	20510-20515	young	_	
137-13	20516-20521	adult	_	
137-14	20522-20525	AUD	_	
137-15	20526-20532	sample	_	
137-16	20533-20536	may	_	
137-17	20537-20541	lead	_	
137-18	20542-20544	to	_	
137-19	20545-20553	impaired	_	
137-20	20554-20561	ability	_	
137-21	20562-20564	to	_	
137-22	20565-20571	detect	_	
137-23	20572-20579	changes	_	
137-24	20580-20582	in	_	
137-25	20583-20591	internal	_	
137-26	20592-20598	states	_	
137-27	20599-20603	such	_	
137-28	20604-20606	as	_	
137-29	20607-20614	alcohol	_	
137-30	20615-20627	intoxication	_	
137-31	20627-20628	.	_	

#Text=Additionally, the key role of the insula in salience attribution to the effects of alcohol intoxication could also be altered with deficits of WM adjacent to the insula.
138-1	20629-20641	Additionally	_	
138-2	20641-20642	,	_	
138-3	20643-20646	the	_	
138-4	20647-20650	key	_	
138-5	20651-20655	role	_	
138-6	20656-20658	of	_	
138-7	20659-20662	the	_	
138-8	20663-20669	insula	_	
138-9	20670-20672	in	_	
138-10	20673-20681	salience	_	
138-11	20682-20693	attribution	_	
138-12	20694-20696	to	_	
138-13	20697-20700	the	_	
138-14	20701-20708	effects	_	
138-15	20709-20711	of	_	
138-16	20712-20719	alcohol	_	
138-17	20720-20732	intoxication	_	
138-18	20733-20738	could	_	
138-19	20739-20743	also	_	
138-20	20744-20746	be	_	
138-21	20747-20754	altered	_	
138-22	20755-20759	with	_	
138-23	20760-20768	deficits	_	
138-24	20769-20771	of	_	
138-25	20772-20774	WM	_	
138-26	20775-20783	adjacent	_	
138-27	20784-20786	to	_	
138-28	20787-20790	the	_	
138-29	20791-20797	insula	_	
138-30	20797-20798	.	_	

#Text=In support of this, a recent resting state fMRI study demonstrated that alcohol disrupted the connectivity between the anterior insular cortex and dorsal cingulate cortex (key nodes in the salience network), and that this disrupted connectivity was associated with greater “relaxing” effects of alcohol.
139-1	20799-20801	In	_	
139-2	20802-20809	support	_	
139-3	20810-20812	of	_	
139-4	20813-20817	this	_	
139-5	20817-20818	,	_	
139-6	20819-20820	a	_	
139-7	20821-20827	recent	_	
139-8	20828-20835	resting	_	
139-9	20836-20841	state	_	
139-10	20842-20846	fMRI	_	
139-11	20847-20852	study	_	
139-12	20853-20865	demonstrated	_	
139-13	20866-20870	that	_	
139-14	20871-20878	alcohol	_	
139-15	20879-20888	disrupted	_	
139-16	20889-20892	the	_	
139-17	20893-20905	connectivity	_	
139-18	20906-20913	between	_	
139-19	20914-20917	the	_	
139-20	20918-20926	anterior	_	
139-21	20927-20934	insular	_	
139-22	20935-20941	cortex	_	
139-23	20942-20945	and	_	
139-24	20946-20952	dorsal	_	
139-25	20953-20962	cingulate	_	
139-26	20963-20969	cortex	_	
139-27	20970-20971	(	_	
139-28	20971-20974	key	_	
139-29	20975-20980	nodes	_	
139-30	20981-20983	in	_	
139-31	20984-20987	the	_	
139-32	20988-20996	salience	_	
139-33	20997-21004	network	_	
139-34	21004-21005	)	_	
139-35	21005-21006	,	_	
139-36	21007-21010	and	_	
139-37	21011-21015	that	_	
139-38	21016-21020	this	_	
139-39	21021-21030	disrupted	_	
139-40	21031-21043	connectivity	_	
139-41	21044-21047	was	_	
139-42	21048-21058	associated	_	
139-43	21059-21063	with	_	
139-44	21064-21071	greater	_	
139-45	21072-21073	“	_	
139-46	21073-21081	relaxing	_	
139-47	21081-21082	”	_	
139-48	21083-21090	effects	_	
139-49	21091-21093	of	_	
139-50	21094-21101	alcohol	_	
139-51	21101-21102	.	_	

#Text=To our knowledge, only one other structural connectivity study used graph theory analyses in AUD and demonstrated that the AUD group had significantly weaker connectivity, primarily in the right hemisphere.
140-1	21103-21105	To	_	
140-2	21106-21109	our	_	
140-3	21110-21119	knowledge	_	
140-4	21119-21120	,	_	
140-5	21121-21125	only	_	
140-6	21126-21129	one	_	
140-7	21130-21135	other	_	
140-8	21136-21146	structural	_	
140-9	21147-21159	connectivity	_	
140-10	21160-21165	study	_	
140-11	21166-21170	used	_	
140-12	21171-21176	graph	_	
140-13	21177-21183	theory	_	
140-14	21184-21192	analyses	_	
140-15	21193-21195	in	_	
140-16	21196-21199	AUD	_	
140-17	21200-21203	and	_	
140-18	21204-21216	demonstrated	_	
140-19	21217-21221	that	_	
140-20	21222-21225	the	_	
140-21	21226-21229	AUD	_	
140-22	21230-21235	group	_	
140-23	21236-21239	had	_	
140-24	21240-21253	significantly	_	
140-25	21254-21260	weaker	_	
140-26	21261-21273	connectivity	_	
140-27	21273-21274	,	_	
140-28	21275-21284	primarily	_	
140-29	21285-21287	in	_	
140-30	21288-21291	the	_	
140-31	21292-21297	right	_	
140-32	21298-21308	hemisphere	_	
140-33	21308-21309	.	_	

#Text=The edges or tracts of significance included connections of the putamen and hippocampus with other brain regions.
141-1	21310-21313	The	_	
141-2	21314-21319	edges	_	
141-3	21320-21322	or	_	
141-4	21323-21329	tracts	_	
141-5	21330-21332	of	_	
141-6	21333-21345	significance	_	
141-7	21346-21354	included	_	
141-8	21355-21366	connections	_	
141-9	21367-21369	of	_	
141-10	21370-21373	the	_	
141-11	21374-21381	putamen	_	
141-12	21382-21385	and	_	
141-13	21386-21397	hippocampus	_	
141-14	21398-21402	with	_	
141-15	21403-21408	other	_	
141-16	21409-21414	brain	_	
141-17	21415-21422	regions	_	
141-18	21422-21423	.	_	

#Text=We add to these findings by reporting AUD had lower co-classification of nodes between ventral attention (supplementary motor and inferior insula/superior temporal areas) and default mode (superior middle temporal gyrus) networks and higher co-classification between nodes of visual (middle occipital/temporal areas) and somatomotor (supplementary motor area) networks.
142-1	21424-21426	We	_	
142-2	21427-21430	add	_	
142-3	21431-21433	to	_	
142-4	21434-21439	these	_	
142-5	21440-21448	findings	_	
142-6	21449-21451	by	_	
142-7	21452-21461	reporting	_	
142-8	21462-21465	AUD	_	
142-9	21466-21469	had	_	
142-10	21470-21475	lower	_	
142-11	21476-21493	co-classification	_	
142-12	21494-21496	of	_	
142-13	21497-21502	nodes	_	
142-14	21503-21510	between	_	
142-15	21511-21518	ventral	_	
142-16	21519-21528	attention	_	
142-17	21529-21530	(	_	
142-18	21530-21543	supplementary	_	
142-19	21544-21549	motor	_	
142-20	21550-21553	and	_	
142-21	21554-21562	inferior	_	
142-22	21563-21569	insula	_	
142-23	21569-21570	/	_	
142-24	21570-21578	superior	_	
142-25	21579-21587	temporal	_	
142-26	21588-21593	areas	_	
142-27	21593-21594	)	_	
142-28	21595-21598	and	_	
142-29	21599-21606	default	_	
142-30	21607-21611	mode	_	
142-31	21612-21613	(	_	
142-32	21613-21621	superior	_	
142-33	21622-21628	middle	_	
142-34	21629-21637	temporal	_	
142-35	21638-21643	gyrus	_	
142-36	21643-21644	)	_	
142-37	21645-21653	networks	_	
142-38	21654-21657	and	_	
142-39	21658-21664	higher	_	
142-40	21665-21682	co-classification	_	
142-41	21683-21690	between	_	
142-42	21691-21696	nodes	_	
142-43	21697-21699	of	_	
142-44	21700-21706	visual	_	
142-45	21707-21708	(	_	
142-46	21708-21714	middle	_	
142-47	21715-21724	occipital	_	
142-48	21724-21725	/	_	
142-49	21725-21733	temporal	_	
142-50	21734-21739	areas	_	
142-51	21739-21740	)	_	
142-52	21741-21744	and	_	
142-53	21745-21756	somatomotor	_	
142-54	21757-21758	(	_	
142-55	21758-21771	supplementary	_	
142-56	21772-21777	motor	_	
142-57	21778-21782	area	_	
142-58	21782-21783	)	_	
142-59	21784-21792	networks	_	
142-60	21792-21793	.	_	

#Text=Additionally, AUD had higher fiber density between a pair of nodes within the default mode (middle frontal and superior frontal areas) network and a pair of nodes between the dorsal attention (precentral/middle frontal area) and somatomotor (precentral/postcentral area) networks.
143-1	21794-21806	Additionally	_	
143-2	21806-21807	,	_	
143-3	21808-21811	AUD	_	
143-4	21812-21815	had	_	
143-5	21816-21822	higher	_	
143-6	21823-21828	fiber	_	
143-7	21829-21836	density	_	
143-8	21837-21844	between	_	
143-9	21845-21846	a	_	
143-10	21847-21851	pair	_	
143-11	21852-21854	of	_	
143-12	21855-21860	nodes	_	
143-13	21861-21867	within	_	
143-14	21868-21871	the	_	
143-15	21872-21879	default	_	
143-16	21880-21884	mode	_	
143-17	21885-21886	(	_	
143-18	21886-21892	middle	_	
143-19	21893-21900	frontal	_	
143-20	21901-21904	and	_	
143-21	21905-21913	superior	_	
143-22	21914-21921	frontal	_	
143-23	21922-21927	areas	_	
143-24	21927-21928	)	_	
143-25	21929-21936	network	_	
143-26	21937-21940	and	_	
143-27	21941-21942	a	_	
143-28	21943-21947	pair	_	
143-29	21948-21950	of	_	
143-30	21951-21956	nodes	_	
143-31	21957-21964	between	_	
143-32	21965-21968	the	_	
143-33	21969-21975	dorsal	_	
143-34	21976-21985	attention	_	
143-35	21986-21987	(	_	
143-36	21987-21997	precentral	_	
143-37	21997-21998	/	_	
143-38	21998-22004	middle	_	
143-39	22005-22012	frontal	_	
143-40	22013-22017	area	_	
143-41	22017-22018	)	_	
143-42	22019-22022	and	_	
143-43	22023-22034	somatomotor	_	
143-44	22035-22036	(	_	
143-45	22036-22046	precentral	_	
143-46	22046-22047	/	_	
143-47	22047-22058	postcentral	_	
143-48	22059-22063	area	_	
143-49	22063-22064	)	_	
143-50	22065-22073	networks	_	
143-51	22073-22074	.	_	

#Text=We recently reported structural connectivity differences in the ventral and dorsal attention networks, frontoparietal network, and default mode network in adult nontreatment-seeking AUD subjects.
144-1	22075-22077	We	_	
144-2	22078-22086	recently	_	
144-3	22087-22095	reported	_	
144-4	22096-22106	structural	_	
144-5	22107-22119	connectivity	_	
144-6	22120-22131	differences	_	
144-7	22132-22134	in	_	
144-8	22135-22138	the	_	
144-9	22139-22146	ventral	_	
144-10	22147-22150	and	_	
144-11	22151-22157	dorsal	_	
144-12	22158-22167	attention	_	
144-13	22168-22176	networks	_	
144-14	22176-22177	,	_	
144-15	22178-22192	frontoparietal	_	
144-16	22193-22200	network	_	
144-17	22200-22201	,	_	
144-18	22202-22205	and	_	
144-19	22206-22213	default	_	
144-20	22214-22218	mode	_	
144-21	22219-22226	network	_	
144-22	22227-22229	in	_	
144-23	22230-22235	adult	_	
144-24	22236-22256	nontreatment-seeking	_	
144-25	22257-22260	AUD	_	
144-26	22261-22269	subjects	_	
144-27	22269-22270	.	_	

#Text=In agreement with our previous findings, here we demonstrate that younger AUD subjects have altered connectivity in the ventral and dorsal attention networks and default mode network in addition to differences in the visual and somatomotor networks.
145-1	22271-22273	In	_	
145-2	22274-22283	agreement	_	
145-3	22284-22288	with	_	
145-4	22289-22292	our	_	
145-5	22293-22301	previous	_	
145-6	22302-22310	findings	_	
145-7	22310-22311	,	_	
145-8	22312-22316	here	_	
145-9	22317-22319	we	_	
145-10	22320-22331	demonstrate	_	
145-11	22332-22336	that	_	
145-12	22337-22344	younger	_	
145-13	22345-22348	AUD	_	
145-14	22349-22357	subjects	_	
145-15	22358-22362	have	_	
145-16	22363-22370	altered	_	
145-17	22371-22383	connectivity	_	
145-18	22384-22386	in	_	
145-19	22387-22390	the	_	
145-20	22391-22398	ventral	_	
145-21	22399-22402	and	_	
145-22	22403-22409	dorsal	_	
145-23	22410-22419	attention	_	
145-24	22420-22428	networks	_	
145-25	22429-22432	and	_	
145-26	22433-22440	default	_	
145-27	22441-22445	mode	_	
145-28	22446-22453	network	_	
145-29	22454-22456	in	_	
145-30	22457-22465	addition	_	
145-31	22466-22468	to	_	
145-32	22469-22480	differences	_	
145-33	22481-22483	in	_	
145-34	22484-22487	the	_	
145-35	22488-22494	visual	_	
145-36	22495-22498	and	_	
145-37	22499-22510	somatomotor	_	
145-38	22511-22519	networks	_	
145-39	22519-22520	.	_	

#Text=Structural networks generally correspond to functional networks; therefore, alterations to structural networks likely result in disrupted function.
146-1	22521-22531	Structural	_	
146-2	22532-22540	networks	_	
146-3	22541-22550	generally	_	
146-4	22551-22561	correspond	_	
146-5	22562-22564	to	_	
146-6	22565-22575	functional	_	
146-7	22576-22584	networks	_	
146-8	22584-22585	;	_	
146-9	22586-22595	therefore	_	
146-10	22595-22596	,	_	
146-11	22597-22608	alterations	_	
146-12	22609-22611	to	_	
146-13	22612-22622	structural	_	
146-14	22623-22631	networks	_	
146-15	22632-22638	likely	_	
146-16	22639-22645	result	_	
146-17	22646-22648	in	_	
146-18	22649-22658	disrupted	_	
146-19	22659-22667	function	_	
146-20	22667-22668	.	_	

#Text=Respectively, the dorsal and ventral attention networks mediate voluntary shifts in attention, and detect unexpected, behaviorally-relevant stimuli.
147-1	22669-22681	Respectively	_	
147-2	22681-22682	,	_	
147-3	22683-22686	the	_	
147-4	22687-22693	dorsal	_	
147-5	22694-22697	and	_	
147-6	22698-22705	ventral	_	
147-7	22706-22715	attention	_	
147-8	22716-22724	networks	_	
147-9	22725-22732	mediate	_	
147-10	22733-22742	voluntary	_	
147-11	22743-22749	shifts	_	
147-12	22750-22752	in	_	
147-13	22753-22762	attention	_	
147-14	22762-22763	,	_	
147-15	22764-22767	and	_	
147-16	22768-22774	detect	_	
147-17	22775-22785	unexpected	_	
147-18	22785-22786	,	_	
147-19	22787-22808	behaviorally-relevant	_	
147-20	22809-22816	stimuli	_	
147-21	22816-22817	.	_	

#Text=The default mode network is a set of nodes broadly thought to be active during rest and silent during cognitive activities.
148-1	22818-22821	The	_	
148-2	22822-22829	default	_	
148-3	22830-22834	mode	_	
148-4	22835-22842	network	_	
148-5	22843-22845	is	_	
148-6	22846-22847	a	_	
148-7	22848-22851	set	_	
148-8	22852-22854	of	_	
148-9	22855-22860	nodes	_	
148-10	22861-22868	broadly	_	
148-11	22869-22876	thought	_	
148-12	22877-22879	to	_	
148-13	22880-22882	be	_	
148-14	22883-22889	active	_	
148-15	22890-22896	during	_	
148-16	22897-22901	rest	_	
148-17	22902-22905	and	_	
148-18	22906-22912	silent	_	
148-19	22913-22919	during	_	
148-20	22920-22929	cognitive	_	
148-21	22930-22940	activities	_	
148-22	22940-22941	.	_	

#Text=Importantly, the functions of the dorsal and ventral attention network and default mode network are relevant to alcohol abuse and dependence.
149-1	22942-22953	Importantly	_	
149-2	22953-22954	,	_	
149-3	22955-22958	the	_	
149-4	22959-22968	functions	_	
149-5	22969-22971	of	_	
149-6	22972-22975	the	_	
149-7	22976-22982	dorsal	_	
149-8	22983-22986	and	_	
149-9	22987-22994	ventral	_	
149-10	22995-23004	attention	_	
149-11	23005-23012	network	_	
149-12	23013-23016	and	_	
149-13	23017-23024	default	_	
149-14	23025-23029	mode	_	
149-15	23030-23037	network	_	
149-16	23038-23041	are	_	
149-17	23042-23050	relevant	_	
149-18	23051-23053	to	_	
149-19	23054-23061	alcohol	_	
149-20	23062-23067	abuse	_	
149-21	23068-23071	and	_	
149-22	23072-23082	dependence	_	
149-23	23082-23083	.	_	

#Text=Disrupted functional connectivity in the default mode has been reported in heavy drinking populations.
150-1	23084-23093	Disrupted	_	
150-2	23094-23104	functional	_	
150-3	23105-23117	connectivity	_	
150-4	23118-23120	in	_	
150-5	23121-23124	the	_	
150-6	23125-23132	default	_	
150-7	23133-23137	mode	_	
150-8	23138-23141	has	_	
150-9	23142-23146	been	_	
150-10	23147-23155	reported	_	
150-11	23156-23158	in	_	
150-12	23159-23164	heavy	_	
150-13	23165-23173	drinking	_	
150-14	23174-23185	populations	_	
150-15	23185-23186	.	_	

#Text=Attentional bias and deficits are also frequently observed in AUD patients.
151-1	23187-23198	Attentional	_	
151-2	23199-23203	bias	_	
151-3	23204-23207	and	_	
151-4	23208-23216	deficits	_	
151-5	23217-23220	are	_	
151-6	23221-23225	also	_	
151-7	23226-23236	frequently	_	
151-8	23237-23245	observed	_	
151-9	23246-23248	in	_	
151-10	23249-23252	AUD	_	
151-11	23253-23261	patients	_	
151-12	23261-23262	.	_	

#Text=Disruptions in the somatomotor and visual networks are less frequently associated with AUD; however, altered functional connectivity has been observed in the somatomotor and visual networks during alcohol intoxication.
152-1	23263-23274	Disruptions	_	
152-2	23275-23277	in	_	
152-3	23278-23281	the	_	
152-4	23282-23293	somatomotor	_	
152-5	23294-23297	and	_	
152-6	23298-23304	visual	_	
152-7	23305-23313	networks	_	
152-8	23314-23317	are	_	
152-9	23318-23322	less	_	
152-10	23323-23333	frequently	_	
152-11	23334-23344	associated	_	
152-12	23345-23349	with	_	
152-13	23350-23353	AUD	_	
152-14	23353-23354	;	_	
152-15	23355-23362	however	_	
152-16	23362-23363	,	_	
152-17	23364-23371	altered	_	
152-18	23372-23382	functional	_	
152-19	23383-23395	connectivity	_	
152-20	23396-23399	has	_	
152-21	23400-23404	been	_	
152-22	23405-23413	observed	_	
152-23	23414-23416	in	_	
152-24	23417-23420	the	_	
152-25	23421-23432	somatomotor	_	
152-26	23433-23436	and	_	
152-27	23437-23443	visual	_	
152-28	23444-23452	networks	_	
152-29	23453-23459	during	_	
152-30	23460-23467	alcohol	_	
152-31	23468-23480	intoxication	_	
152-32	23480-23481	.	_	

#Text=Thus, the functional findings in the literature are consistent with our present structural connectivity data in young adult AUD.
153-1	23482-23486	Thus	_	
153-2	23486-23487	,	_	
153-3	23488-23491	the	_	
153-4	23492-23502	functional	_	
153-5	23503-23511	findings	_	
153-6	23512-23514	in	_	
153-7	23515-23518	the	_	
153-8	23519-23529	literature	_	
153-9	23530-23533	are	_	
153-10	23534-23544	consistent	_	
153-11	23545-23549	with	_	
153-12	23550-23553	our	_	
153-13	23554-23561	present	_	
153-14	23562-23572	structural	_	
153-15	23573-23585	connectivity	_	
153-16	23586-23590	data	_	
153-17	23591-23593	in	_	
153-18	23594-23599	young	_	
153-19	23600-23605	adult	_	
153-20	23606-23609	AUD	_	
153-21	23609-23610	.	_	

#Text=Nodes within the networks referred to above, including the superior frontal cortex, insular cortex, temporal cortex and lateral parietal cortex, have been shown to be highly connected regions with a central position in the overall network.
154-1	23611-23616	Nodes	_	
154-2	23617-23623	within	_	
154-3	23624-23627	the	_	
154-4	23628-23636	networks	_	
154-5	23637-23645	referred	_	
154-6	23646-23648	to	_	
154-7	23649-23654	above	_	
154-8	23654-23655	,	_	
154-9	23656-23665	including	_	
154-10	23666-23669	the	_	
154-11	23670-23678	superior	_	
154-12	23679-23686	frontal	_	
154-13	23687-23693	cortex	_	
154-14	23693-23694	,	_	
154-15	23695-23702	insular	_	
154-16	23703-23709	cortex	_	
154-17	23709-23710	,	_	
154-18	23711-23719	temporal	_	
154-19	23720-23726	cortex	_	
154-20	23727-23730	and	_	
154-21	23731-23738	lateral	_	
154-22	23739-23747	parietal	_	
154-23	23748-23754	cortex	_	
154-24	23754-23755	,	_	
154-25	23756-23760	have	_	
154-26	23761-23765	been	_	
154-27	23766-23771	shown	_	
154-28	23772-23774	to	_	
154-29	23775-23777	be	_	
154-30	23778-23784	highly	_	
154-31	23785-23794	connected	_	
154-32	23795-23802	regions	_	
154-33	23803-23807	with	_	
154-34	23808-23809	a	_	
154-35	23810-23817	central	_	
154-36	23818-23826	position	_	
154-37	23827-23829	in	_	
154-38	23830-23833	the	_	
154-39	23834-23841	overall	_	
154-40	23842-23849	network	_	
154-41	23849-23850	.	_	

#Text=These densely connected “hubs” or “rich clubs” play key roles in integrating information between segregated parts of the brain.
155-1	23851-23856	These	_	
155-2	23857-23864	densely	_	
155-3	23865-23874	connected	_	
155-4	23875-23876	“	_	
155-5	23876-23880	hubs	_	
155-6	23880-23881	”	_	
155-7	23882-23884	or	_	
155-8	23885-23886	“	_	
155-9	23886-23890	rich	_	
155-10	23891-23896	clubs	_	
155-11	23896-23897	”	_	
155-12	23898-23902	play	_	
155-13	23903-23906	key	_	
155-14	23907-23912	roles	_	
155-15	23913-23915	in	_	
155-16	23916-23927	integrating	_	
155-17	23928-23939	information	_	
155-18	23940-23947	between	_	
155-19	23948-23958	segregated	_	
155-20	23959-23964	parts	_	
155-21	23965-23967	of	_	
155-22	23968-23971	the	_	
155-23	23972-23977	brain	_	
155-24	23977-23978	.	_	

#Text=It has been suggested that alterations in these hubs or interconnections could likely lead to severe impairments because of their roles in whole-brain integrative processes.
156-1	23979-23981	It	_	
156-2	23982-23985	has	_	
156-3	23986-23990	been	_	
156-4	23991-24000	suggested	_	
156-5	24001-24005	that	_	
156-6	24006-24017	alterations	_	
156-7	24018-24020	in	_	
156-8	24021-24026	these	_	
156-9	24027-24031	hubs	_	
156-10	24032-24034	or	_	
156-11	24035-24051	interconnections	_	
156-12	24052-24057	could	_	
156-13	24058-24064	likely	_	
156-14	24065-24069	lead	_	
156-15	24070-24072	to	_	
156-16	24073-24079	severe	_	
156-17	24080-24091	impairments	_	
156-18	24092-24099	because	_	
156-19	24100-24102	of	_	
156-20	24103-24108	their	_	
156-21	24109-24114	roles	_	
156-22	24115-24117	in	_	
156-23	24118-24129	whole-brain	_	
156-24	24130-24141	integrative	_	
156-25	24142-24151	processes	_	
156-26	24151-24152	.	_	

#Text=For instance, abnormal rich club organization has been reported in structural connectivity analysis of patients with AUD.
157-1	24153-24156	For	_	
157-2	24157-24165	instance	_	
157-3	24165-24166	,	_	
157-4	24167-24175	abnormal	_	
157-5	24176-24180	rich	_	
157-6	24181-24185	club	_	
157-7	24186-24198	organization	_	
157-8	24199-24202	has	_	
157-9	24203-24207	been	_	
157-10	24208-24216	reported	_	
157-11	24217-24219	in	_	
157-12	24220-24230	structural	_	
157-13	24231-24243	connectivity	_	
157-14	24244-24252	analysis	_	
157-15	24253-24255	of	_	
157-16	24256-24264	patients	_	
157-17	24265-24269	with	_	
157-18	24270-24273	AUD	_	
157-19	24273-24274	.	_	

#Text=The differences seen here may represent a network phenotype associated with a predisposition to develop AUD.
158-1	24275-24278	The	_	
158-2	24279-24290	differences	_	
158-3	24291-24295	seen	_	
158-4	24296-24300	here	_	
158-5	24301-24304	may	_	
158-6	24305-24314	represent	_	
158-7	24315-24316	a	_	
158-8	24317-24324	network	_	
158-9	24325-24334	phenotype	_	
158-10	24335-24345	associated	_	
158-11	24346-24350	with	_	
158-12	24351-24352	a	_	
158-13	24353-24367	predisposition	_	
158-14	24368-24370	to	_	
158-15	24371-24378	develop	_	
158-16	24379-24382	AUD	_	
158-17	24382-24383	.	_	

#Text=However, it should be noted that the neurophysiological and cognitive/behavioral relevance of alterations in hubs and their interconnectedness are not fully understood.
159-1	24384-24391	However	_	
159-2	24391-24392	,	_	
159-3	24393-24395	it	_	
159-4	24396-24402	should	_	
159-5	24403-24405	be	_	
159-6	24406-24411	noted	_	
159-7	24412-24416	that	_	
159-8	24417-24420	the	_	
159-9	24421-24439	neurophysiological	_	
159-10	24440-24443	and	_	
159-11	24444-24453	cognitive	_	
159-12	24453-24454	/	_	
159-13	24454-24464	behavioral	_	
159-14	24465-24474	relevance	_	
159-15	24475-24477	of	_	
159-16	24478-24489	alterations	_	
159-17	24490-24492	in	_	
159-18	24493-24497	hubs	_	
159-19	24498-24501	and	_	
159-20	24502-24507	their	_	
159-21	24508-24526	interconnectedness	_	
159-22	24527-24530	are	_	
159-23	24531-24534	not	_	
159-24	24535-24540	fully	_	
159-25	24541-24551	understood	_	
159-26	24551-24552	.	_	

#Text=The present study contains some limitations that should be considered.
160-1	24553-24556	The	_	
160-2	24557-24564	present	_	
160-3	24565-24570	study	_	
160-4	24571-24579	contains	_	
160-5	24580-24584	some	_	
160-6	24585-24596	limitations	_	
160-7	24597-24601	that	_	
160-8	24602-24608	should	_	
160-9	24609-24611	be	_	
160-10	24612-24622	considered	_	
160-11	24622-24623	.	_	

#Text=Not all individuals with hazardous drinking behavior in emerging adulthood will continue on to AUD as they age (for review see).
161-1	24624-24627	Not	_	
161-2	24628-24631	all	_	
161-3	24632-24643	individuals	_	
161-4	24644-24648	with	_	
161-5	24649-24658	hazardous	_	
161-6	24659-24667	drinking	_	
161-7	24668-24676	behavior	_	
161-8	24677-24679	in	_	
161-9	24680-24688	emerging	_	
161-10	24689-24698	adulthood	_	
161-11	24699-24703	will	_	
161-12	24704-24712	continue	_	
161-13	24713-24715	on	_	
161-14	24716-24718	to	_	
161-15	24719-24722	AUD	_	
161-16	24723-24725	as	_	
161-17	24726-24730	they	_	
161-18	24731-24734	age	_	
161-19	24735-24736	(	_	
161-20	24736-24739	for	_	
161-21	24740-24746	review	_	
161-22	24747-24750	see	_	
161-23	24750-24751	)	_	
161-24	24751-24752	.	_	

#Text=It is possible that subjects meeting the criteria for AUD in our study may “grow out” or “age out” of the AUD status as they progress through adulthood.
162-1	24753-24755	It	_	
162-2	24756-24758	is	_	
162-3	24759-24767	possible	_	
162-4	24768-24772	that	_	
162-5	24773-24781	subjects	_	
162-6	24782-24789	meeting	_	
162-7	24790-24793	the	_	
162-8	24794-24802	criteria	_	
162-9	24803-24806	for	_	
162-10	24807-24810	AUD	_	
162-11	24811-24813	in	_	
162-12	24814-24817	our	_	
162-13	24818-24823	study	_	
162-14	24824-24827	may	_	
162-15	24828-24829	“	_	
162-16	24829-24833	grow	_	
162-17	24834-24837	out	_	
162-18	24837-24838	”	_	
162-19	24839-24841	or	_	
162-20	24842-24843	“	_	
162-21	24843-24846	age	_	
162-22	24847-24850	out	_	
162-23	24850-24851	”	_	
162-24	24852-24854	of	_	
162-25	24855-24858	the	_	
162-26	24859-24862	AUD	_	
162-27	24863-24869	status	_	
162-28	24870-24872	as	_	
162-29	24873-24877	they	_	
162-30	24878-24886	progress	_	
162-31	24887-24894	through	_	
162-32	24895-24904	adulthood	_	
162-33	24904-24905	.	_	

#Text=Nonetheless, identifying differences in WM integrity and structural connectivity in young adult subjects currently meeting AUD criteria and experiencing the burden of heavy alcohol use is necessary, as these differences could represent areas of lasting neuroanatomical changes that continue regardless of the retention of AUD status.
163-1	24906-24917	Nonetheless	_	
163-2	24917-24918	,	_	
163-3	24919-24930	identifying	_	
163-4	24931-24942	differences	_	
163-5	24943-24945	in	_	
163-6	24946-24948	WM	_	
163-7	24949-24958	integrity	_	
163-8	24959-24962	and	_	
163-9	24963-24973	structural	_	
163-10	24974-24986	connectivity	_	
163-11	24987-24989	in	_	
163-12	24990-24995	young	_	
163-13	24996-25001	adult	_	
163-14	25002-25010	subjects	_	
163-15	25011-25020	currently	_	
163-16	25021-25028	meeting	_	
163-17	25029-25032	AUD	_	
163-18	25033-25041	criteria	_	
163-19	25042-25045	and	_	
163-20	25046-25058	experiencing	_	
163-21	25059-25062	the	_	
163-22	25063-25069	burden	_	
163-23	25070-25072	of	_	
163-24	25073-25078	heavy	_	
163-25	25079-25086	alcohol	_	
163-26	25087-25090	use	_	
163-27	25091-25093	is	_	
163-28	25094-25103	necessary	_	
163-29	25103-25104	,	_	
163-30	25105-25107	as	_	
163-31	25108-25113	these	_	
163-32	25114-25125	differences	_	
163-33	25126-25131	could	_	
163-34	25132-25141	represent	_	
163-35	25142-25147	areas	_	
163-36	25148-25150	of	_	
163-37	25151-25158	lasting	_	
163-38	25159-25174	neuroanatomical	_	
163-39	25175-25182	changes	_	
163-40	25183-25187	that	_	
163-41	25188-25196	continue	_	
163-42	25197-25207	regardless	_	
163-43	25208-25210	of	_	
163-44	25211-25214	the	_	
163-45	25215-25224	retention	_	
163-46	25225-25227	of	_	
163-47	25228-25231	AUD	_	
163-48	25232-25238	status	_	
163-49	25238-25239	.	_	

#Text=In addition, information on family history of AUD, which is a strong predictor for eventual development of AUD, was not available for this sample, and may be a contributing predisposing factor toward alterations of DWI scalar metrics (for review see).
164-1	25240-25242	In	_	
164-2	25243-25251	addition	_	
164-3	25251-25252	,	_	
164-4	25253-25264	information	_	
164-5	25265-25267	on	_	
164-6	25268-25274	family	_	
164-7	25275-25282	history	_	
164-8	25283-25285	of	_	
164-9	25286-25289	AUD	_	
164-10	25289-25290	,	_	
164-11	25291-25296	which	_	
164-12	25297-25299	is	_	
164-13	25300-25301	a	_	
164-14	25302-25308	strong	_	
164-15	25309-25318	predictor	_	
164-16	25319-25322	for	_	
164-17	25323-25331	eventual	_	
164-18	25332-25343	development	_	
164-19	25344-25346	of	_	
164-20	25347-25350	AUD	_	
164-21	25350-25351	,	_	
164-22	25352-25355	was	_	
164-23	25356-25359	not	_	
164-24	25360-25369	available	_	
164-25	25370-25373	for	_	
164-26	25374-25378	this	_	
164-27	25379-25385	sample	_	
164-28	25385-25386	,	_	
164-29	25387-25390	and	_	
164-30	25391-25394	may	_	
164-31	25395-25397	be	_	
164-32	25398-25399	a	_	
164-33	25400-25412	contributing	_	
164-34	25413-25425	predisposing	_	
164-35	25426-25432	factor	_	
164-36	25433-25439	toward	_	
164-37	25440-25451	alterations	_	
164-38	25452-25454	of	_	
164-39	25455-25458	DWI	_	
164-40	25459-25465	scalar	_	
164-41	25466-25473	metrics	_	
164-42	25474-25475	(	_	
164-43	25475-25478	for	_	
164-44	25479-25485	review	_	
164-45	25486-25489	see	_	
164-46	25489-25490	)	_	
164-47	25490-25491	.	_	

#Text=Finally, this study utilized a relatively small, retrospective sample; longitudinal research with larger sample sizes is necessary to determine whether differences in scalar DWI metrics, fiber densities, and node associations contribute to the development of AUD, or are a consequence of the early stages of AUD.
165-1	25492-25499	Finally	_	
165-2	25499-25500	,	_	
165-3	25501-25505	this	_	
165-4	25506-25511	study	_	
165-5	25512-25520	utilized	_	
165-6	25521-25522	a	_	
165-7	25523-25533	relatively	_	
165-8	25534-25539	small	_	
165-9	25539-25540	,	_	
165-10	25541-25554	retrospective	_	
165-11	25555-25561	sample	_	
165-12	25561-25562	;	_	
165-13	25563-25575	longitudinal	_	
165-14	25576-25584	research	_	
165-15	25585-25589	with	_	
165-16	25590-25596	larger	_	
165-17	25597-25603	sample	_	
165-18	25604-25609	sizes	_	
165-19	25610-25612	is	_	
165-20	25613-25622	necessary	_	
165-21	25623-25625	to	_	
165-22	25626-25635	determine	_	
165-23	25636-25643	whether	_	
165-24	25644-25655	differences	_	
165-25	25656-25658	in	_	
165-26	25659-25665	scalar	_	
165-27	25666-25669	DWI	_	
165-28	25670-25677	metrics	_	
165-29	25677-25678	,	_	
165-30	25679-25684	fiber	_	
165-31	25685-25694	densities	_	
165-32	25694-25695	,	_	
165-33	25696-25699	and	_	
165-34	25700-25704	node	_	
165-35	25705-25717	associations	_	
165-36	25718-25728	contribute	_	
165-37	25729-25731	to	_	
165-38	25732-25735	the	_	
165-39	25736-25747	development	_	
165-40	25748-25750	of	_	
165-41	25751-25754	AUD	_	
165-42	25754-25755	,	_	
165-43	25756-25758	or	_	
165-44	25759-25762	are	_	
165-45	25763-25764	a	_	
165-46	25765-25776	consequence	_	
165-47	25777-25779	of	_	
165-48	25780-25783	the	_	
165-49	25784-25789	early	_	
165-50	25790-25796	stages	_	
165-51	25797-25799	of	_	
165-52	25800-25803	AUD	_	
165-53	25803-25804	.	_	

#Text=In summary, we utilized traditional DWI metrics and a novel connectomics-based approach to examine WM differences in young adult AUD subjects.
166-1	25805-25807	In	_	
166-2	25808-25815	summary	_	
166-3	25815-25816	,	_	
166-4	25817-25819	we	_	
166-5	25820-25828	utilized	_	
166-6	25829-25840	traditional	_	
166-7	25841-25844	DWI	_	
166-8	25845-25852	metrics	_	
166-9	25853-25856	and	_	
166-10	25857-25858	a	_	
166-11	25859-25864	novel	_	
166-12	25865-25883	connectomics-based	_	
166-13	25884-25892	approach	_	
166-14	25893-25895	to	_	
166-15	25896-25903	examine	_	
166-16	25904-25906	WM	_	
166-17	25907-25918	differences	_	
166-18	25919-25921	in	_	
166-19	25922-25927	young	_	
166-20	25928-25933	adult	_	
166-21	25934-25937	AUD	_	
166-22	25938-25946	subjects	_	
166-23	25946-25947	.	_	

#Text=We demonstrated that young AUD subjects had distinct differences in microstructure with both higher WM integrity in many tracts and lower WM integrity in others.
167-1	25948-25950	We	_	
167-2	25951-25963	demonstrated	_	
167-3	25964-25968	that	_	
167-4	25969-25974	young	_	
167-5	25975-25978	AUD	_	
167-6	25979-25987	subjects	_	
167-7	25988-25991	had	_	
167-8	25992-26000	distinct	_	
167-9	26001-26012	differences	_	
167-10	26013-26015	in	_	
167-11	26016-26030	microstructure	_	
167-12	26031-26035	with	_	
167-13	26036-26040	both	_	
167-14	26041-26047	higher	_	
167-15	26048-26050	WM	_	
167-16	26051-26060	integrity	_	
167-17	26061-26063	in	_	
167-18	26064-26068	many	_	
167-19	26069-26075	tracts	_	
167-20	26076-26079	and	_	
167-21	26080-26085	lower	_	
167-22	26086-26088	WM	_	
167-23	26089-26098	integrity	_	
167-24	26099-26101	in	_	
167-25	26102-26108	others	_	
167-26	26108-26109	.	_	

#Text=The connectomics analysis also revealed altered structural connectivity in this young adult AUD sample.
168-1	26110-26113	The	_	
168-2	26114-26126	connectomics	_	
168-3	26127-26135	analysis	_	
168-4	26136-26140	also	_	
168-5	26141-26149	revealed	_	
168-6	26150-26157	altered	_	
168-7	26158-26168	structural	_	
168-8	26169-26181	connectivity	_	
168-9	26182-26184	in	_	
168-10	26185-26189	this	_	
168-11	26190-26195	young	_	
168-12	26196-26201	adult	_	
168-13	26202-26205	AUD	_	
168-14	26206-26212	sample	_	
168-15	26212-26213	.	_	

#Text=The presence of these differences indicates that alterations in WM may not only appear after years of chronic alcohol abuse, but may in fact emerge during the early stages of AUD.
169-1	26214-26217	The	_	
169-2	26218-26226	presence	_	
169-3	26227-26229	of	_	
169-4	26230-26235	these	_	
169-5	26236-26247	differences	_	
169-6	26248-26257	indicates	_	
169-7	26258-26262	that	_	
169-8	26263-26274	alterations	_	
169-9	26275-26277	in	_	
169-10	26278-26280	WM	_	
169-11	26281-26284	may	_	
169-12	26285-26288	not	_	
169-13	26289-26293	only	_	
169-14	26294-26300	appear	_	
169-15	26301-26306	after	_	
169-16	26307-26312	years	_	
169-17	26313-26315	of	_	
169-18	26316-26323	chronic	_	
169-19	26324-26331	alcohol	_	
169-20	26332-26337	abuse	_	
169-21	26337-26338	,	_	
169-22	26339-26342	but	_	
169-23	26343-26346	may	_	
169-24	26347-26349	in	_	
169-25	26350-26354	fact	_	
169-26	26355-26361	emerge	_	
169-27	26362-26368	during	_	
169-28	26369-26372	the	_	
169-29	26373-26378	early	_	
169-30	26379-26385	stages	_	
169-31	26386-26388	of	_	
169-32	26389-26392	AUD	_	
169-33	26392-26393	.	_	

#Text=The connectomics approach also detected structural connectivity differences in regional and global network connectivity measures in these emerging adulthood AUD subjects, and suggests that DWI studies investigating WM microstructure in AUD populations may benefit from utilizing this complementary, network science-based approaches.
170-1	26394-26397	The	_	
170-2	26398-26410	connectomics	_	
170-3	26411-26419	approach	_	
170-4	26420-26424	also	_	
170-5	26425-26433	detected	_	
170-6	26434-26444	structural	_	
170-7	26445-26457	connectivity	_	
170-8	26458-26469	differences	_	
170-9	26470-26472	in	_	
170-10	26473-26481	regional	_	
170-11	26482-26485	and	_	
170-12	26486-26492	global	_	
170-13	26493-26500	network	_	
170-14	26501-26513	connectivity	_	
170-15	26514-26522	measures	_	
170-16	26523-26525	in	_	
170-17	26526-26531	these	_	
170-18	26532-26540	emerging	_	
170-19	26541-26550	adulthood	_	
170-20	26551-26554	AUD	_	
170-21	26555-26563	subjects	_	
170-22	26563-26564	,	_	
170-23	26565-26568	and	_	
170-24	26569-26577	suggests	_	
170-25	26578-26582	that	_	
170-26	26583-26586	DWI	_	
170-27	26587-26594	studies	_	
170-28	26595-26608	investigating	_	
170-29	26609-26611	WM	_	
170-30	26612-26626	microstructure	_	
170-31	26627-26629	in	_	
170-32	26630-26633	AUD	_	
170-33	26634-26645	populations	_	
170-34	26646-26649	may	_	
170-35	26650-26657	benefit	_	
170-36	26658-26662	from	_	
170-37	26663-26672	utilizing	_	
170-38	26673-26677	this	_	
170-39	26678-26691	complementary	_	
170-40	26691-26692	,	_	
170-41	26693-26700	network	_	
170-42	26701-26714	science-based	_	
170-43	26715-26725	approaches	_	
170-44	26725-26726	.	_	

#Text=The present findings demonstrate WM microstructural structural connectome patterns that may be important for further understanding the early stages of AUD.
171-1	26727-26730	The	_	
171-2	26731-26738	present	_	
171-3	26739-26747	findings	_	
171-4	26748-26759	demonstrate	_	
171-5	26760-26762	WM	_	
171-6	26763-26778	microstructural	_	
171-7	26779-26789	structural	_	
171-8	26790-26800	connectome	_	
171-9	26801-26809	patterns	_	
171-10	26810-26814	that	_	
171-11	26815-26818	may	_	
171-12	26819-26821	be	_	
171-13	26822-26831	important	_	
171-14	26832-26835	for	_	
171-15	26836-26843	further	_	
171-16	26844-26857	understanding	_	
171-17	26858-26861	the	_	
171-18	26862-26867	early	_	
171-19	26868-26874	stages	_	
171-20	26875-26877	of	_	
171-21	26878-26881	AUD	_	
171-22	26881-26882	.	_	

#Text=This is clinically relevant, as young adult AUD represents a crucial time period for intervention to prevent maintenance of AUD throughout adulthood and subsequent potentially damaging changes to brain tissue.
172-1	26883-26887	This	_	
172-2	26888-26890	is	_	
172-3	26891-26901	clinically	_	
172-4	26902-26910	relevant	_	
172-5	26910-26911	,	_	
172-6	26912-26914	as	_	
172-7	26915-26920	young	_	
172-8	26921-26926	adult	_	
172-9	26927-26930	AUD	_	
172-10	26931-26941	represents	_	
172-11	26942-26943	a	_	
172-12	26944-26951	crucial	_	
172-13	26952-26956	time	_	
172-14	26957-26963	period	_	
172-15	26964-26967	for	_	
172-16	26968-26980	intervention	_	
172-17	26981-26983	to	_	
172-18	26984-26991	prevent	_	
172-19	26992-27003	maintenance	_	
172-20	27004-27006	of	_	
172-21	27007-27010	AUD	_	
172-22	27011-27021	throughout	_	
172-23	27022-27031	adulthood	_	
172-24	27032-27035	and	_	
172-25	27036-27046	subsequent	_	
172-26	27047-27058	potentially	_	
172-27	27059-27067	damaging	_	
172-28	27068-27075	changes	_	
172-29	27076-27078	to	_	
172-30	27079-27084	brain	_	
172-31	27085-27091	tissue	_	
172-32	27091-27092	.	_	

#Text=Supplementary Material
#Text=Conflict of Interest
#Text=The authors declare that they have no conflicts of interest.
173-1	27093-27106	Supplementary	_	
173-2	27107-27115	Material	_	
173-3	27116-27124	Conflict	_	
173-4	27125-27127	of	_	
173-5	27128-27136	Interest	_	
173-6	27137-27140	The	_	
173-7	27141-27148	authors	_	
173-8	27149-27156	declare	_	
173-9	27157-27161	that	_	
173-10	27162-27166	they	_	
173-11	27167-27171	have	_	
173-12	27172-27174	no	_	
173-13	27175-27184	conflicts	_	
173-14	27185-27187	of	_	
173-15	27188-27196	interest	_	
173-16	27196-27197	.	_	

#Text=References
#Text=Characterization of Cerebral White Matter Properties Using Quantitative Magnetic Resonance Imaging Stains
#Text=Diffusion Tensor Imaging of the Brain
#Text=Callosal white matter microstructural recovery in abstinent alcoholics: a longitudinal diffusion tensor imaging study
#Text=Altered white matter microstructure in adolescent substance users
#Text=Adolescent Brain Development and the Risk for Alcohol and Other Drug Problems
#Text=Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging
#Text=Under pressure: adolescent substance users show exaggerated neural processing of aversive interoceptive stimuli
#Text=Mental Health of College Students and Their Non-college-attending Peers: Results from the National Epidemiologic Study on Alcohol and Related Conditions
#Text=A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA
#Text=Alcohol and the human brain: a systematic review of different neuroimaging methods
#Text=Complex brain networks: graph theoretical analysis of structural and functional systems
#Text=Not lesser but Greater fractional anisotropy in adolescents with alcohol use disorders
#Text=
#Text=Disruption of Functional Connectivity of the Default-Mode Network in Alcoholism
#Text=Effects of Alcohol Cues on MRS Glutamate Levels in the Anterior Cingulate
#Text=Differences in White Matter Microstructure and Connectivity in Nontreatment-Seeking Individuals with Alcohol Use Disorder
#Text=
#Text=Functional and structural brain connectivity of young binge drinkers: a follow-up study
#Text=An Optimized Blockwise Nonlocal Means Denoising Filter for 3-D Magnetic Resonance Images
#Text=Neurobiological phenotypes associated with a family history of alcoholism
#Text=Diffusion tensor measures of the corpus callosum in adolescents with adolescent onset alcohol use disorders
#Text=Activity Dependent Degeneration Explains Hub Vulnerability in Alzheimer’s Disease
#Text=Revisiting the role of the insula in addiction
#Text=Alcohol Use and Cerebral White Matter Compromise in Adolescence
#Text=Alcohol increases spontaneous BOLD signal fluctuations in the visual network
#Text=Diffusion Tensor Imaging: A Review for Pediatric Researchers and Clinicians
#Text=Attentional bias in addictive behaviors: a review of its development, causes, and consequences
#Text=The Effects of a Working Memory Load on Delay Discounting in Those with Externalizing Psychopathology
#Text=Differential brain response to alcohol cue distractors across stages of alcohol dependence
#Text=Acute calming effects of alcohol are associated with disruption of the salience network
#Text=Functional connectivity in the resting brain: A network analysis of the default mode hypothesis
#Text=Mapping the Structural Core of Human Cerebral Cortex
#Text=White matter integrity in adolescents with histories of marijuana use and binge drinking
#Text=Functional role for cortical-striatal circuitry in modulating alcohol self-administration
#Text=Silencing the insular-striatal circuit decreases alcohol self-administration and increases sensitivity to alcohol
#Text=
#Text=The Short‐Term Effects and Unintended Long‐Term Consequences of Binge Drinking in College: A 10‐Year Follow‐Up Study
#Text=Multiresolution Consensus Clustering in Networks
#Text=Effects of morphine and alcohol on functional brain connectivity during “resting state”: a placebo-controlled crossover study in healthy young men
#Text=Broad disruption of brain white matter microstructure and relationship with neuropsychological performance in male patients with severe alcohol dependence
#Text=Executive Functions, Memory, and Social Cognitive Deficits and Recovery in Chronic Alcoholism: A Critical Review to Inform Future Research
#Text=The challenge of mapping the human connectome based on diffusion tractography
#Text=Diffusion Weighted Image Denoising Using Overcomplete Local PCA
#Text=Imaging Human Mesolimbic Dopamine Transmission With Positron Emission Tomography: I.
174-1	27198-27208	References	_	
174-2	27209-27225	Characterization	_	
174-3	27226-27228	of	_	
174-4	27229-27237	Cerebral	_	
174-5	27238-27243	White	_	
174-6	27244-27250	Matter	_	
174-7	27251-27261	Properties	_	
174-8	27262-27267	Using	_	
174-9	27268-27280	Quantitative	_	
174-10	27281-27289	Magnetic	_	
174-11	27290-27299	Resonance	_	
174-12	27300-27307	Imaging	_	
174-13	27308-27314	Stains	_	
174-14	27315-27324	Diffusion	_	
174-15	27325-27331	Tensor	_	
174-16	27332-27339	Imaging	_	
174-17	27340-27342	of	_	
174-18	27343-27346	the	_	
174-19	27347-27352	Brain	_	
174-20	27353-27361	Callosal	_	
174-21	27362-27367	white	_	
174-22	27368-27374	matter	_	
174-23	27375-27390	microstructural	_	
174-24	27391-27399	recovery	_	
174-25	27400-27402	in	_	
174-26	27403-27412	abstinent	_	
174-27	27413-27423	alcoholics	_	
174-28	27423-27424	:	_	
174-29	27425-27426	a	_	
174-30	27427-27439	longitudinal	_	
174-31	27440-27449	diffusion	_	
174-32	27450-27456	tensor	_	
174-33	27457-27464	imaging	_	
174-34	27465-27470	study	_	
174-35	27471-27478	Altered	_	
174-36	27479-27484	white	_	
174-37	27485-27491	matter	_	
174-38	27492-27506	microstructure	_	
174-39	27507-27509	in	_	
174-40	27510-27520	adolescent	_	
174-41	27521-27530	substance	_	
174-42	27531-27536	users	_	
174-43	27537-27547	Adolescent	_	
174-44	27548-27553	Brain	_	
174-45	27554-27565	Development	_	
174-46	27566-27569	and	_	
174-47	27570-27573	the	_	
174-48	27574-27578	Risk	_	
174-49	27579-27582	for	_	
174-50	27583-27590	Alcohol	_	
174-51	27591-27594	and	_	
174-52	27595-27600	Other	_	
174-53	27601-27605	Drug	_	
174-54	27606-27614	Problems	_	
174-55	27615-27627	Non-invasive	_	
174-56	27628-27635	mapping	_	
174-57	27636-27638	of	_	
174-58	27639-27650	connections	_	
174-59	27651-27658	between	_	
174-60	27659-27664	human	_	
174-61	27665-27673	thalamus	_	
174-62	27674-27677	and	_	
174-63	27678-27684	cortex	_	
174-64	27685-27690	using	_	
174-65	27691-27700	diffusion	_	
174-66	27701-27708	imaging	_	
174-67	27709-27714	Under	_	
174-68	27715-27723	pressure	_	
174-69	27723-27724	:	_	
174-70	27725-27735	adolescent	_	
174-71	27736-27745	substance	_	
174-72	27746-27751	users	_	
174-73	27752-27756	show	_	
174-74	27757-27768	exaggerated	_	
174-75	27769-27775	neural	_	
174-76	27776-27786	processing	_	
174-77	27787-27789	of	_	
174-78	27790-27798	aversive	_	
174-79	27799-27812	interoceptive	_	
174-80	27813-27820	stimuli	_	
174-81	27821-27827	Mental	_	
174-82	27828-27834	Health	_	
174-83	27835-27837	of	_	
174-84	27838-27845	College	_	
174-85	27846-27854	Students	_	
174-86	27855-27858	and	_	
174-87	27859-27864	Their	_	
174-88	27865-27886	Non-college-attending	_	
174-89	27887-27892	Peers	_	
174-90	27892-27893	:	_	
174-91	27894-27901	Results	_	
174-92	27902-27906	from	_	
174-93	27907-27910	the	_	
174-94	27911-27919	National	_	
174-95	27920-27933	Epidemiologic	_	
174-96	27934-27939	Study	_	
174-97	27940-27942	on	_	
174-98	27943-27950	Alcohol	_	
174-99	27951-27954	and	_	
174-100	27955-27962	Related	_	
174-101	27963-27973	Conditions	_	
174-102	27974-27975	A	_	
174-103	27976-27979	new	_	
174-104	27979-27980	,	_	
174-105	27981-27996	semi-structured	_	
174-106	27997-28008	psychiatric	_	
174-107	28009-28018	interview	_	
174-108	28019-28022	for	_	
174-109	28023-28026	use	_	
174-110	28027-28029	in	_	
174-111	28030-28037	genetic	_	
174-112	28038-28045	linkage	_	
174-113	28046-28053	studies	_	
174-114	28053-28054	:	_	
174-115	28055-28056	a	_	
174-116	28057-28063	report	_	
174-117	28064-28066	on	_	
174-118	28067-28070	the	_	
174-119	28071-28082	reliability	_	
174-120	28083-28085	of	_	
174-121	28086-28089	the	_	
174-122	28090-28095	SSAGA	_	
174-123	28096-28103	Alcohol	_	
174-124	28104-28107	and	_	
174-125	28108-28111	the	_	
174-126	28112-28117	human	_	
174-127	28118-28123	brain	_	
174-128	28123-28124	:	_	
174-129	28125-28126	a	_	
174-130	28127-28137	systematic	_	
174-131	28138-28144	review	_	
174-132	28145-28147	of	_	
174-133	28148-28157	different	_	
174-134	28158-28170	neuroimaging	_	
174-135	28171-28178	methods	_	
174-136	28179-28186	Complex	_	
174-137	28187-28192	brain	_	
174-138	28193-28201	networks	_	
174-139	28201-28202	:	_	
174-140	28203-28208	graph	_	
174-141	28209-28220	theoretical	_	
174-142	28221-28229	analysis	_	
174-143	28230-28232	of	_	
174-144	28233-28243	structural	_	
174-145	28244-28247	and	_	
174-146	28248-28258	functional	_	
174-147	28259-28266	systems	_	
174-148	28267-28270	Not	_	
174-149	28271-28277	lesser	_	
174-150	28278-28281	but	_	
174-151	28282-28289	Greater	_	
174-152	28290-28300	fractional	_	
174-153	28301-28311	anisotropy	_	
174-154	28312-28314	in	_	
174-155	28315-28326	adolescents	_	
174-156	28327-28331	with	_	
174-157	28332-28339	alcohol	_	
174-158	28340-28343	use	_	
174-159	28344-28353	disorders	_	
174-160	28355-28365	Disruption	_	
174-161	28366-28368	of	_	
174-162	28369-28379	Functional	_	
174-163	28380-28392	Connectivity	_	
174-164	28393-28395	of	_	
174-165	28396-28399	the	_	
174-166	28400-28412	Default-Mode	_	
174-167	28413-28420	Network	_	
174-168	28421-28423	in	_	
174-169	28424-28434	Alcoholism	_	
174-170	28435-28442	Effects	_	
174-171	28443-28445	of	_	
174-172	28446-28453	Alcohol	_	
174-173	28454-28458	Cues	_	
174-174	28459-28461	on	_	
174-175	28462-28465	MRS	_	
174-176	28466-28475	Glutamate	_	
174-177	28476-28482	Levels	_	
174-178	28483-28485	in	_	
174-179	28486-28489	the	_	
174-180	28490-28498	Anterior	_	
174-181	28499-28508	Cingulate	_	
174-182	28509-28520	Differences	_	
174-183	28521-28523	in	_	
174-184	28524-28529	White	_	
174-185	28530-28536	Matter	_	
174-186	28537-28551	Microstructure	_	
174-187	28552-28555	and	_	
174-188	28556-28568	Connectivity	_	
174-189	28569-28571	in	_	
174-190	28572-28592	Nontreatment-Seeking	_	
174-191	28593-28604	Individuals	_	
174-192	28605-28609	with	_	
174-193	28610-28617	Alcohol	_	
174-194	28618-28621	Use	_	
174-195	28622-28630	Disorder	_	
174-196	28632-28642	Functional	_	
174-197	28643-28646	and	_	
174-198	28647-28657	structural	_	
174-199	28658-28663	brain	_	
174-200	28664-28676	connectivity	_	
174-201	28677-28679	of	_	
174-202	28680-28685	young	_	
174-203	28686-28691	binge	_	
174-204	28692-28700	drinkers	_	
174-205	28700-28701	:	_	
174-206	28702-28703	a	_	
174-207	28704-28713	follow-up	_	
174-208	28714-28719	study	_	
174-209	28720-28722	An	_	
174-210	28723-28732	Optimized	_	
174-211	28733-28742	Blockwise	_	
174-212	28743-28751	Nonlocal	_	
174-213	28752-28757	Means	_	
174-214	28758-28767	Denoising	_	
174-215	28768-28774	Filter	_	
174-216	28775-28778	for	_	
174-217	28779-28780	3	_	
174-218	28780-28781	-	_	
174-219	28781-28782	D	_	
174-220	28783-28791	Magnetic	_	
174-221	28792-28801	Resonance	_	
174-222	28802-28808	Images	_	
174-223	28809-28824	Neurobiological	_	
174-224	28825-28835	phenotypes	_	
174-225	28836-28846	associated	_	
174-226	28847-28851	with	_	
174-227	28852-28853	a	_	
174-228	28854-28860	family	_	
174-229	28861-28868	history	_	
174-230	28869-28871	of	_	
174-231	28872-28882	alcoholism	_	
174-232	28883-28892	Diffusion	_	
174-233	28893-28899	tensor	_	
174-234	28900-28908	measures	_	
174-235	28909-28911	of	_	
174-236	28912-28915	the	_	
174-237	28916-28922	corpus	_	
174-238	28923-28931	callosum	_	
174-239	28932-28934	in	_	
174-240	28935-28946	adolescents	_	
174-241	28947-28951	with	_	
174-242	28952-28962	adolescent	_	
174-243	28963-28968	onset	_	
174-244	28969-28976	alcohol	_	
174-245	28977-28980	use	_	
174-246	28981-28990	disorders	_	
174-247	28991-28999	Activity	_	
174-248	29000-29009	Dependent	_	
174-249	29010-29022	Degeneration	_	
174-250	29023-29031	Explains	_	
174-251	29032-29035	Hub	_	
174-252	29036-29049	Vulnerability	_	
174-253	29050-29052	in	_	
174-254	29053-29062	Alzheimer	_	
174-255	29062-29063	’	_	
174-256	29063-29064	s	_	
174-257	29065-29072	Disease	_	
174-258	29073-29083	Revisiting	_	
174-259	29084-29087	the	_	
174-260	29088-29092	role	_	
174-261	29093-29095	of	_	
174-262	29096-29099	the	_	
174-263	29100-29106	insula	_	
174-264	29107-29109	in	_	
174-265	29110-29119	addiction	_	
174-266	29120-29127	Alcohol	_	
174-267	29128-29131	Use	_	
174-268	29132-29135	and	_	
174-269	29136-29144	Cerebral	_	
174-270	29145-29150	White	_	
174-271	29151-29157	Matter	_	
174-272	29158-29168	Compromise	_	
174-273	29169-29171	in	_	
174-274	29172-29183	Adolescence	_	
174-275	29184-29191	Alcohol	_	
174-276	29192-29201	increases	_	
174-277	29202-29213	spontaneous	_	
174-278	29214-29218	BOLD	_	
174-279	29219-29225	signal	_	
174-280	29226-29238	fluctuations	_	
174-281	29239-29241	in	_	
174-282	29242-29245	the	_	
174-283	29246-29252	visual	_	
174-284	29253-29260	network	_	
174-285	29261-29270	Diffusion	_	
174-286	29271-29277	Tensor	_	
174-287	29278-29285	Imaging	_	
174-288	29285-29286	:	_	
174-289	29287-29288	A	_	
174-290	29289-29295	Review	_	
174-291	29296-29299	for	_	
174-292	29300-29309	Pediatric	_	
174-293	29310-29321	Researchers	_	
174-294	29322-29325	and	_	
174-295	29326-29336	Clinicians	_	
174-296	29337-29348	Attentional	_	
174-297	29349-29353	bias	_	
174-298	29354-29356	in	_	
174-299	29357-29366	addictive	_	
174-300	29367-29376	behaviors	_	
174-301	29376-29377	:	_	
174-302	29378-29379	a	_	
174-303	29380-29386	review	_	
174-304	29387-29389	of	_	
174-305	29390-29393	its	_	
174-306	29394-29405	development	_	
174-307	29405-29406	,	_	
174-308	29407-29413	causes	_	
174-309	29413-29414	,	_	
174-310	29415-29418	and	_	
174-311	29419-29431	consequences	_	
174-312	29432-29435	The	_	
174-313	29436-29443	Effects	_	
174-314	29444-29446	of	_	
174-315	29447-29448	a	_	
174-316	29449-29456	Working	_	
174-317	29457-29463	Memory	_	
174-318	29464-29468	Load	_	
174-319	29469-29471	on	_	
174-320	29472-29477	Delay	_	
174-321	29478-29489	Discounting	_	
174-322	29490-29492	in	_	
174-323	29493-29498	Those	_	
174-324	29499-29503	with	_	
174-325	29504-29517	Externalizing	_	
174-326	29518-29533	Psychopathology	_	
174-327	29534-29546	Differential	_	
174-328	29547-29552	brain	_	
174-329	29553-29561	response	_	
174-330	29562-29564	to	_	
174-331	29565-29572	alcohol	_	
174-332	29573-29576	cue	_	
174-333	29577-29588	distractors	_	
174-334	29589-29595	across	_	
174-335	29596-29602	stages	_	
174-336	29603-29605	of	_	
174-337	29606-29613	alcohol	_	
174-338	29614-29624	dependence	_	
174-339	29625-29630	Acute	_	
174-340	29631-29638	calming	_	
174-341	29639-29646	effects	_	
174-342	29647-29649	of	_	
174-343	29650-29657	alcohol	_	
174-344	29658-29661	are	_	
174-345	29662-29672	associated	_	
174-346	29673-29677	with	_	
174-347	29678-29688	disruption	_	
174-348	29689-29691	of	_	
174-349	29692-29695	the	_	
174-350	29696-29704	salience	_	
174-351	29705-29712	network	_	
174-352	29713-29723	Functional	_	
174-353	29724-29736	connectivity	_	
174-354	29737-29739	in	_	
174-355	29740-29743	the	_	
174-356	29744-29751	resting	_	
174-357	29752-29757	brain	_	
174-358	29757-29758	:	_	
174-359	29759-29760	A	_	
174-360	29761-29768	network	_	
174-361	29769-29777	analysis	_	
174-362	29778-29780	of	_	
174-363	29781-29784	the	_	
174-364	29785-29792	default	_	
174-365	29793-29797	mode	_	
174-366	29798-29808	hypothesis	_	
174-367	29809-29816	Mapping	_	
174-368	29817-29820	the	_	
174-369	29821-29831	Structural	_	
174-370	29832-29836	Core	_	
174-371	29837-29839	of	_	
174-372	29840-29845	Human	_	
174-373	29846-29854	Cerebral	_	
174-374	29855-29861	Cortex	_	
174-375	29862-29867	White	_	
174-376	29868-29874	matter	_	
174-377	29875-29884	integrity	_	
174-378	29885-29887	in	_	
174-379	29888-29899	adolescents	_	
174-380	29900-29904	with	_	
174-381	29905-29914	histories	_	
174-382	29915-29917	of	_	
174-383	29918-29927	marijuana	_	
174-384	29928-29931	use	_	
174-385	29932-29935	and	_	
174-386	29936-29941	binge	_	
174-387	29942-29950	drinking	_	
174-388	29951-29961	Functional	_	
174-389	29962-29966	role	_	
174-390	29967-29970	for	_	
174-391	29971-29988	cortical-striatal	_	
174-392	29989-29998	circuitry	_	
174-393	29999-30001	in	_	
174-394	30002-30012	modulating	_	
174-395	30013-30020	alcohol	_	
174-396	30021-30040	self-administration	_	
174-397	30041-30050	Silencing	_	
174-398	30051-30054	the	_	
174-399	30055-30071	insular-striatal	_	
174-400	30072-30079	circuit	_	
174-401	30080-30089	decreases	_	
174-402	30090-30097	alcohol	_	
174-403	30098-30117	self-administration	_	
174-404	30118-30121	and	_	
174-405	30122-30131	increases	_	
174-406	30132-30143	sensitivity	_	
174-407	30144-30146	to	_	
174-408	30147-30154	alcohol	_	
174-409	30156-30159	The	_	
174-410	30160-30170	Short‐Term	_	
174-411	30171-30178	Effects	_	
174-412	30179-30182	and	_	
174-413	30183-30193	Unintended	_	
174-414	30194-30203	Long‐Term	_	
174-415	30204-30216	Consequences	_	
174-416	30217-30219	of	_	
174-417	30220-30225	Binge	_	
174-418	30226-30234	Drinking	_	
174-419	30235-30237	in	_	
174-420	30238-30245	College	_	
174-421	30245-30246	:	_	
174-422	30247-30248	A	_	
174-423	30249-30251	10	_	
174-424	30251-30252	‐	_	
174-425	30252-30256	Year	_	
174-426	30257-30266	Follow‐Up	_	
174-427	30267-30272	Study	_	
174-428	30273-30288	Multiresolution	_	
174-429	30289-30298	Consensus	_	
174-430	30299-30309	Clustering	_	
174-431	30310-30312	in	_	
174-432	30313-30321	Networks	_	
174-433	30322-30329	Effects	_	
174-434	30330-30332	of	_	
174-435	30333-30341	morphine	_	
174-436	30342-30345	and	_	
174-437	30346-30353	alcohol	_	
174-438	30354-30356	on	_	
174-439	30357-30367	functional	_	
174-440	30368-30373	brain	_	
174-441	30374-30386	connectivity	_	
174-442	30387-30393	during	_	
174-443	30394-30395	“	_	
174-444	30395-30402	resting	_	
174-445	30403-30408	state	_	
174-446	30408-30409	”	_	
174-447	30409-30410	:	_	
174-448	30411-30412	a	_	
174-449	30413-30431	placebo-controlled	_	
174-450	30432-30441	crossover	_	
174-451	30442-30447	study	_	
174-452	30448-30450	in	_	
174-453	30451-30458	healthy	_	
174-454	30459-30464	young	_	
174-455	30465-30468	men	_	
174-456	30469-30474	Broad	_	
174-457	30475-30485	disruption	_	
174-458	30486-30488	of	_	
174-459	30489-30494	brain	_	
174-460	30495-30500	white	_	
174-461	30501-30507	matter	_	
174-462	30508-30522	microstructure	_	
174-463	30523-30526	and	_	
174-464	30527-30539	relationship	_	
174-465	30540-30544	with	_	
174-466	30545-30563	neuropsychological	_	
174-467	30564-30575	performance	_	
174-468	30576-30578	in	_	
174-469	30579-30583	male	_	
174-470	30584-30592	patients	_	
174-471	30593-30597	with	_	
174-472	30598-30604	severe	_	
174-473	30605-30612	alcohol	_	
174-474	30613-30623	dependence	_	
174-475	30624-30633	Executive	_	
174-476	30634-30643	Functions	_	
174-477	30643-30644	,	_	
174-478	30645-30651	Memory	_	
174-479	30651-30652	,	_	
174-480	30653-30656	and	_	
174-481	30657-30663	Social	_	
174-482	30664-30673	Cognitive	_	
174-483	30674-30682	Deficits	_	
174-484	30683-30686	and	_	
174-485	30687-30695	Recovery	_	
174-486	30696-30698	in	_	
174-487	30699-30706	Chronic	_	
174-488	30707-30717	Alcoholism	_	
174-489	30717-30718	:	_	
174-490	30719-30720	A	_	
174-491	30721-30729	Critical	_	
174-492	30730-30736	Review	_	
174-493	30737-30739	to	_	
174-494	30740-30746	Inform	_	
174-495	30747-30753	Future	_	
174-496	30754-30762	Research	_	
174-497	30763-30766	The	_	
174-498	30767-30776	challenge	_	
174-499	30777-30779	of	_	
174-500	30780-30787	mapping	_	
174-501	30788-30791	the	_	
174-502	30792-30797	human	_	
174-503	30798-30808	connectome	_	
174-504	30809-30814	based	_	
174-505	30815-30817	on	_	
174-506	30818-30827	diffusion	_	
174-507	30828-30840	tractography	_	
174-508	30841-30850	Diffusion	_	
174-509	30851-30859	Weighted	_	
174-510	30860-30865	Image	_	
174-511	30866-30875	Denoising	_	
174-512	30876-30881	Using	_	
174-513	30882-30894	Overcomplete	_	
174-514	30895-30900	Local	_	
174-515	30901-30904	PCA	_	
174-516	30905-30912	Imaging	_	
174-517	30913-30918	Human	_	
174-518	30919-30929	Mesolimbic	_	
174-519	30930-30938	Dopamine	_	
174-520	30939-30951	Transmission	_	
174-521	30952-30956	With	_	
174-522	30957-30965	Positron	_	
174-523	30966-30974	Emission	_	
174-524	30975-30985	Tomography	_	
174-525	30985-30986	:	_	
174-526	30987-30988	I	_	
174-527	30988-30989	.	_	

#Text=Accuracy and Precision of D2 Receptor Parameter Measurements in Ventral Striatum
#Text=What do you feel?
175-1	30990-30998	Accuracy	_	
175-2	30999-31002	and	_	
175-3	31003-31012	Precision	_	
175-4	31013-31015	of	_	
175-5	31016-31018	D2	_	
175-6	31019-31027	Receptor	_	
175-7	31028-31037	Parameter	_	
175-8	31038-31050	Measurements	_	
175-9	31051-31053	in	_	
175-10	31054-31061	Ventral	_	
175-11	31062-31070	Striatum	_	
175-12	31071-31075	What	_	
175-13	31076-31078	do	_	
175-14	31079-31082	you	_	
175-15	31083-31087	feel	_	
175-16	31087-31088	?	_	

#Text=Adolescent drug and alcohol users show altered brain response to pleasant interoceptive stimuli
#Text=The insula: a critical neural substrate for craving and drug seeking under conflict and risk
#Text=Modularity and community structure in networks
#Text=Earlier alcohol use onset prospectively predicts changes in functional connectivity
#Text=Maturing out of problematic alcohol use
#Text=Degradation of association and projection white matter systems in alcoholism detected with quantitative fiber tracking
#Text=White Matter Microstructural Recovery with Abstinence and Decline with Relapse in Alcoholism: Interaction with Normal Aging Revealed with Longitudinal DTI
#Text=Complex network measures of brain connectivity: Uses and interpretations
#Text=Dissociable Intrinsic Connectivity Networks for Salience Processing and Executive Control
#Text=Groupwise whole-brain parcellation from resting-state fMRI data for network node identification
#Text=Altered Modular Organization of Structural Cortical Networks in Children with Autism
#Text=Alcohol affects brain functional connectivity and its coupling with behavior: greater effects in male heavy drinkers
#Text=Neurobiological signatures associated with alcohol and drug use in the human adolescent brain
#Text=Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data
#Text=Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference
#Text=A hitchhiker’s guide to diffusion tensor imaging
#Text=Modular Brain Networks
#Text=Neural response to alcohol stimuli in adolescents with alcohol use disorder
#Text=The human adolescent brain and alcohol use disorders
#Text=Blood oxygen level dependent response and spatial working memory in adolescents with alcohol use disorders
#Text=Network hubs in the human brain
#Text=Dorsal and Ventral Attention Systems: Distinct Neural Circuits but Collaborative Roles
#Text=
#Text=Tract-Based Spatial Statistics (TBSS) of diffusion tensor imaging data in alcohol dependence: abnormalities of the motivational neurocircuitry
#Text=Alcohol’s Effects on the Brain: Neuroimaging Results in Humans and Animal Models
#Text=Network-based statistic: Identifying differences in brain networks
#Text=Rich club and reward network connectivity as endophenotypes for alcohol dependence: a diffusion tensor imaging study
#Text=TBSS results for fractional anisotropy (FA).
176-1	31089-31099	Adolescent	_	
176-2	31100-31104	drug	_	
176-3	31105-31108	and	_	
176-4	31109-31116	alcohol	_	
176-5	31117-31122	users	_	
176-6	31123-31127	show	_	
176-7	31128-31135	altered	_	
176-8	31136-31141	brain	_	
176-9	31142-31150	response	_	
176-10	31151-31153	to	_	
176-11	31154-31162	pleasant	_	
176-12	31163-31176	interoceptive	_	
176-13	31177-31184	stimuli	_	
176-14	31185-31188	The	_	
176-15	31189-31195	insula	_	
176-16	31195-31196	:	_	
176-17	31197-31198	a	_	
176-18	31199-31207	critical	_	
176-19	31208-31214	neural	_	
176-20	31215-31224	substrate	_	
176-21	31225-31228	for	_	
176-22	31229-31236	craving	_	
176-23	31237-31240	and	_	
176-24	31241-31245	drug	_	
176-25	31246-31253	seeking	_	
176-26	31254-31259	under	_	
176-27	31260-31268	conflict	_	
176-28	31269-31272	and	_	
176-29	31273-31277	risk	_	
176-30	31278-31288	Modularity	_	
176-31	31289-31292	and	_	
176-32	31293-31302	community	_	
176-33	31303-31312	structure	_	
176-34	31313-31315	in	_	
176-35	31316-31324	networks	_	
176-36	31325-31332	Earlier	_	
176-37	31333-31340	alcohol	_	
176-38	31341-31344	use	_	
176-39	31345-31350	onset	_	
176-40	31351-31364	prospectively	_	
176-41	31365-31373	predicts	_	
176-42	31374-31381	changes	_	
176-43	31382-31384	in	_	
176-44	31385-31395	functional	_	
176-45	31396-31408	connectivity	_	
176-46	31409-31417	Maturing	_	
176-47	31418-31421	out	_	
176-48	31422-31424	of	_	
176-49	31425-31436	problematic	_	
176-50	31437-31444	alcohol	_	
176-51	31445-31448	use	_	
176-52	31449-31460	Degradation	_	
176-53	31461-31463	of	_	
176-54	31464-31475	association	_	
176-55	31476-31479	and	_	
176-56	31480-31490	projection	_	
176-57	31491-31496	white	_	
176-58	31497-31503	matter	_	
176-59	31504-31511	systems	_	
176-60	31512-31514	in	_	
176-61	31515-31525	alcoholism	_	
176-62	31526-31534	detected	_	
176-63	31535-31539	with	_	
176-64	31540-31552	quantitative	_	
176-65	31553-31558	fiber	_	
176-66	31559-31567	tracking	_	
176-67	31568-31573	White	_	
176-68	31574-31580	Matter	_	
176-69	31581-31596	Microstructural	_	
176-70	31597-31605	Recovery	_	
176-71	31606-31610	with	_	
176-72	31611-31621	Abstinence	_	
176-73	31622-31625	and	_	
176-74	31626-31633	Decline	_	
176-75	31634-31638	with	_	
176-76	31639-31646	Relapse	_	
176-77	31647-31649	in	_	
176-78	31650-31660	Alcoholism	_	
176-79	31660-31661	:	_	
176-80	31662-31673	Interaction	_	
176-81	31674-31678	with	_	
176-82	31679-31685	Normal	_	
176-83	31686-31691	Aging	_	
176-84	31692-31700	Revealed	_	
176-85	31701-31705	with	_	
176-86	31706-31718	Longitudinal	_	
176-87	31719-31722	DTI	_	
176-88	31723-31730	Complex	_	
176-89	31731-31738	network	_	
176-90	31739-31747	measures	_	
176-91	31748-31750	of	_	
176-92	31751-31756	brain	_	
176-93	31757-31769	connectivity	_	
176-94	31769-31770	:	_	
176-95	31771-31775	Uses	_	
176-96	31776-31779	and	_	
176-97	31780-31795	interpretations	_	
176-98	31796-31807	Dissociable	_	
176-99	31808-31817	Intrinsic	_	
176-100	31818-31830	Connectivity	_	
176-101	31831-31839	Networks	_	
176-102	31840-31843	for	_	
176-103	31844-31852	Salience	_	
176-104	31853-31863	Processing	_	
176-105	31864-31867	and	_	
176-106	31868-31877	Executive	_	
176-107	31878-31885	Control	_	
176-108	31886-31895	Groupwise	_	
176-109	31896-31907	whole-brain	_	
176-110	31908-31920	parcellation	_	
176-111	31921-31925	from	_	
176-112	31926-31939	resting-state	_	
176-113	31940-31944	fMRI	_	
176-114	31945-31949	data	_	
176-115	31950-31953	for	_	
176-116	31954-31961	network	_	
176-117	31962-31966	node	_	
176-118	31967-31981	identification	_	
176-119	31982-31989	Altered	_	
176-120	31990-31997	Modular	_	
176-121	31998-32010	Organization	_	
176-122	32011-32013	of	_	
176-123	32014-32024	Structural	_	
176-124	32025-32033	Cortical	_	
176-125	32034-32042	Networks	_	
176-126	32043-32045	in	_	
176-127	32046-32054	Children	_	
176-128	32055-32059	with	_	
176-129	32060-32066	Autism	_	
176-130	32067-32074	Alcohol	_	
176-131	32075-32082	affects	_	
176-132	32083-32088	brain	_	
176-133	32089-32099	functional	_	
176-134	32100-32112	connectivity	_	
176-135	32113-32116	and	_	
176-136	32117-32120	its	_	
176-137	32121-32129	coupling	_	
176-138	32130-32134	with	_	
176-139	32135-32143	behavior	_	
176-140	32143-32144	:	_	
176-141	32145-32152	greater	_	
176-142	32153-32160	effects	_	
176-143	32161-32163	in	_	
176-144	32164-32168	male	_	
176-145	32169-32174	heavy	_	
176-146	32175-32183	drinkers	_	
176-147	32184-32199	Neurobiological	_	
176-148	32200-32210	signatures	_	
176-149	32211-32221	associated	_	
176-150	32222-32226	with	_	
176-151	32227-32234	alcohol	_	
176-152	32235-32238	and	_	
176-153	32239-32243	drug	_	
176-154	32244-32247	use	_	
176-155	32248-32250	in	_	
176-156	32251-32254	the	_	
176-157	32255-32260	human	_	
176-158	32261-32271	adolescent	_	
176-159	32272-32277	brain	_	
176-160	32278-32289	Tract-based	_	
176-161	32290-32297	spatial	_	
176-162	32298-32308	statistics	_	
176-163	32308-32309	:	_	
176-164	32310-32319	Voxelwise	_	
176-165	32320-32328	analysis	_	
176-166	32329-32331	of	_	
176-167	32332-32345	multi-subject	_	
176-168	32346-32355	diffusion	_	
176-169	32356-32360	data	_	
176-170	32361-32375	Threshold-free	_	
176-171	32376-32383	cluster	_	
176-172	32384-32395	enhancement	_	
176-173	32395-32396	:	_	
176-174	32397-32407	Addressing	_	
176-175	32408-32416	problems	_	
176-176	32417-32419	of	_	
176-177	32420-32429	smoothing	_	
176-178	32429-32430	,	_	
176-179	32431-32440	threshold	_	
176-180	32441-32451	dependence	_	
176-181	32452-32455	and	_	
176-182	32456-32468	localisation	_	
176-183	32469-32471	in	_	
176-184	32472-32479	cluster	_	
176-185	32480-32489	inference	_	
176-186	32490-32491	A	_	
176-187	32492-32502	hitchhiker	_	
176-188	32502-32503	’	_	
176-189	32503-32504	s	_	
176-190	32505-32510	guide	_	
176-191	32511-32513	to	_	
176-192	32514-32523	diffusion	_	
176-193	32524-32530	tensor	_	
176-194	32531-32538	imaging	_	
176-195	32539-32546	Modular	_	
176-196	32547-32552	Brain	_	
176-197	32553-32561	Networks	_	
176-198	32562-32568	Neural	_	
176-199	32569-32577	response	_	
176-200	32578-32580	to	_	
176-201	32581-32588	alcohol	_	
176-202	32589-32596	stimuli	_	
176-203	32597-32599	in	_	
176-204	32600-32611	adolescents	_	
176-205	32612-32616	with	_	
176-206	32617-32624	alcohol	_	
176-207	32625-32628	use	_	
176-208	32629-32637	disorder	_	
176-209	32638-32641	The	_	
176-210	32642-32647	human	_	
176-211	32648-32658	adolescent	_	
176-212	32659-32664	brain	_	
176-213	32665-32668	and	_	
176-214	32669-32676	alcohol	_	
176-215	32677-32680	use	_	
176-216	32681-32690	disorders	_	
176-217	32691-32696	Blood	_	
176-218	32697-32703	oxygen	_	
176-219	32704-32709	level	_	
176-220	32710-32719	dependent	_	
176-221	32720-32728	response	_	
176-222	32729-32732	and	_	
176-223	32733-32740	spatial	_	
176-224	32741-32748	working	_	
176-225	32749-32755	memory	_	
176-226	32756-32758	in	_	
176-227	32759-32770	adolescents	_	
176-228	32771-32775	with	_	
176-229	32776-32783	alcohol	_	
176-230	32784-32787	use	_	
176-231	32788-32797	disorders	_	
176-232	32798-32805	Network	_	
176-233	32806-32810	hubs	_	
176-234	32811-32813	in	_	
176-235	32814-32817	the	_	
176-236	32818-32823	human	_	
176-237	32824-32829	brain	_	
176-238	32830-32836	Dorsal	_	
176-239	32837-32840	and	_	
176-240	32841-32848	Ventral	_	
176-241	32849-32858	Attention	_	
176-242	32859-32866	Systems	_	
176-243	32866-32867	:	_	
176-244	32868-32876	Distinct	_	
176-245	32877-32883	Neural	_	
176-246	32884-32892	Circuits	_	
176-247	32893-32896	but	_	
176-248	32897-32910	Collaborative	_	
176-249	32911-32916	Roles	_	
176-250	32918-32929	Tract-Based	_	
176-251	32930-32937	Spatial	_	
176-252	32938-32948	Statistics	_	
176-253	32949-32950	(	_	
176-254	32950-32954	TBSS	_	
176-255	32954-32955	)	_	
176-256	32956-32958	of	_	
176-257	32959-32968	diffusion	_	
176-258	32969-32975	tensor	_	
176-259	32976-32983	imaging	_	
176-260	32984-32988	data	_	
176-261	32989-32991	in	_	
176-262	32992-32999	alcohol	_	
176-263	33000-33010	dependence	_	
176-264	33010-33011	:	_	
176-265	33012-33025	abnormalities	_	
176-266	33026-33028	of	_	
176-267	33029-33032	the	_	
176-268	33033-33045	motivational	_	
176-269	33046-33060	neurocircuitry	_	
176-270	33061-33068	Alcohol	_	
176-271	33068-33069	’	_	
176-272	33069-33070	s	_	
176-273	33071-33078	Effects	_	
176-274	33079-33081	on	_	
176-275	33082-33085	the	_	
176-276	33086-33091	Brain	_	
176-277	33091-33092	:	_	
176-278	33093-33105	Neuroimaging	_	
176-279	33106-33113	Results	_	
176-280	33114-33116	in	_	
176-281	33117-33123	Humans	_	
176-282	33124-33127	and	_	
176-283	33128-33134	Animal	_	
176-284	33135-33141	Models	_	
176-285	33142-33155	Network-based	_	
176-286	33156-33165	statistic	_	
176-287	33165-33166	:	_	
176-288	33167-33178	Identifying	_	
176-289	33179-33190	differences	_	
176-290	33191-33193	in	_	
176-291	33194-33199	brain	_	
176-292	33200-33208	networks	_	
176-293	33209-33213	Rich	_	
176-294	33214-33218	club	_	
176-295	33219-33222	and	_	
176-296	33223-33229	reward	_	
176-297	33230-33237	network	_	
176-298	33238-33250	connectivity	_	
176-299	33251-33253	as	_	
176-300	33254-33268	endophenotypes	_	
176-301	33269-33272	for	_	
176-302	33273-33280	alcohol	_	
176-303	33281-33291	dependence	_	
176-304	33291-33292	:	_	
176-305	33293-33294	a	_	
176-306	33295-33304	diffusion	_	
176-307	33305-33311	tensor	_	
176-308	33312-33319	imaging	_	
176-309	33320-33325	study	_	
176-310	33326-33330	TBSS	_	
176-311	33331-33338	results	_	
176-312	33339-33342	for	_	
176-313	33343-33353	fractional	_	
176-314	33354-33364	anisotropy	_	
176-315	33365-33366	(	_	
176-316	33366-33368	FA	_	
176-317	33368-33369	)	_	
176-318	33369-33370	.	_	

#Text=Areas where young adult alcohol use disorder (AUD) subjects had either higher (red-yellow) or lower (blue) FA compared to controls (CON) (pTFCE < 0.05).
177-1	33371-33376	Areas	_	
177-2	33377-33382	where	_	
177-3	33383-33388	young	_	
177-4	33389-33394	adult	_	
177-5	33395-33402	alcohol	_	
177-6	33403-33406	use	_	
177-7	33407-33415	disorder	_	
177-8	33416-33417	(	_	
177-9	33417-33420	AUD	_	
177-10	33420-33421	)	_	
177-11	33422-33430	subjects	_	
177-12	33431-33434	had	_	
177-13	33435-33441	either	_	
177-14	33442-33448	higher	_	
177-15	33449-33450	(	_	
177-16	33450-33460	red-yellow	_	
177-17	33460-33461	)	_	
177-18	33462-33464	or	_	
177-19	33465-33470	lower	_	
177-20	33471-33472	(	_	
177-21	33472-33476	blue	_	
177-22	33476-33477	)	_	
177-23	33478-33480	FA	_	
177-24	33481-33489	compared	_	
177-25	33490-33492	to	_	
177-26	33493-33501	controls	_	
177-27	33502-33503	(	_	
177-28	33503-33506	CON	_	
177-29	33506-33507	)	_	
177-30	33508-33509	(	_	
177-31	33509-33514	pTFCE	_	
177-32	33515-33516	<	_	
177-33	33517-33521	0.05	_	
177-34	33521-33522	)	_	
177-35	33522-33523	.	_	

#Text=Group differences are superimposed on the mean FA skeleton (green); the mean FA image of the sample is the underlay.
178-1	33524-33529	Group	_	
178-2	33530-33541	differences	_	
178-3	33542-33545	are	_	
178-4	33546-33558	superimposed	_	
178-5	33559-33561	on	_	
178-6	33562-33565	the	_	
178-7	33566-33570	mean	_	
178-8	33571-33573	FA	_	
178-9	33574-33582	skeleton	_	
178-10	33583-33584	(	_	
178-11	33584-33589	green	_	
178-12	33589-33590	)	_	
178-13	33590-33591	;	_	
178-14	33592-33595	the	_	
178-15	33596-33600	mean	_	
178-16	33601-33603	FA	_	
178-17	33604-33609	image	_	
178-18	33610-33612	of	_	
178-19	33613-33616	the	_	
178-20	33617-33623	sample	_	
178-21	33624-33626	is	_	
178-22	33627-33630	the	_	
178-23	33631-33639	underlay	_	
178-24	33639-33640	.	_	

#Text=For visualization purposes, significant voxels within the WM skeleton were thickened with tbss_fill.
179-1	33641-33644	For	_	
179-2	33645-33658	visualization	_	
179-3	33659-33667	purposes	_	
179-4	33667-33668	,	_	
179-5	33669-33680	significant	_	
179-6	33681-33687	voxels	_	
179-7	33688-33694	within	_	
179-8	33695-33698	the	_	
179-9	33699-33701	WM	_	
179-10	33702-33710	skeleton	_	
179-11	33711-33715	were	_	
179-12	33716-33725	thickened	_	
179-13	33726-33730	with	_	
179-14	33731-33740	tbss_fill	_	
179-15	33740-33741	.	_	

#Text=TBSS results for (A) mean diffusivity (MD), (B) axial diffusivity (AD), and (C) radial diffusivity (RD).
180-1	33742-33746	TBSS	_	
180-2	33747-33754	results	_	
180-3	33755-33758	for	_	
180-4	33759-33760	(	_	
180-5	33760-33761	A	_	
180-6	33761-33762	)	_	
180-7	33763-33767	mean	_	
180-8	33768-33779	diffusivity	_	
180-9	33780-33781	(	_	
180-10	33781-33783	MD	_	
180-11	33783-33784	)	_	
180-12	33784-33785	,	_	
180-13	33786-33787	(	_	
180-14	33787-33788	B	_	
180-15	33788-33789	)	_	
180-16	33790-33795	axial	_	
180-17	33796-33807	diffusivity	_	
180-18	33808-33809	(	_	
180-19	33809-33811	AD	_	
180-20	33811-33812	)	_	
180-21	33812-33813	,	_	
180-22	33814-33817	and	_	
180-23	33818-33819	(	_	
180-24	33819-33820	C	_	
180-25	33820-33821	)	_	
180-26	33822-33828	radial	_	
180-27	33829-33840	diffusivity	_	
180-28	33841-33842	(	_	
180-29	33842-33844	RD	_	
180-30	33844-33845	)	_	
180-31	33845-33846	.	_	

#Text=Areas where alcohol use disorder (AUD) subjects had either higher (red-yellow) or lower (blue) scalar diffusion measures compared to controls (CON) (pTFCE < 0.05).
181-1	33847-33852	Areas	_	
181-2	33853-33858	where	_	
181-3	33859-33866	alcohol	_	
181-4	33867-33870	use	_	
181-5	33871-33879	disorder	_	
181-6	33880-33881	(	_	
181-7	33881-33884	AUD	_	
181-8	33884-33885	)	_	
181-9	33886-33894	subjects	_	
181-10	33895-33898	had	_	
181-11	33899-33905	either	_	
181-12	33906-33912	higher	_	
181-13	33913-33914	(	_	
181-14	33914-33924	red-yellow	_	
181-15	33924-33925	)	_	
181-16	33926-33928	or	_	
181-17	33929-33934	lower	_	
181-18	33935-33936	(	_	
181-19	33936-33940	blue	_	
181-20	33940-33941	)	_	
181-21	33942-33948	scalar	_	
181-22	33949-33958	diffusion	_	
181-23	33959-33967	measures	_	
181-24	33968-33976	compared	_	
181-25	33977-33979	to	_	
181-26	33980-33988	controls	_	
181-27	33989-33990	(	_	
181-28	33990-33993	CON	_	
181-29	33993-33994	)	_	
181-30	33995-33996	(	_	
181-31	33996-34001	pTFCE	_	
181-32	34002-34003	<	_	
181-33	34004-34008	0.05	_	
181-34	34008-34009	)	_	
181-35	34009-34010	.	_	

#Text=Group differences are superimposed on the mean FA skeleton (green); the mean FA image of the sample is the underlay.
182-1	34011-34016	Group	_	
182-2	34017-34028	differences	_	
182-3	34029-34032	are	_	
182-4	34033-34045	superimposed	_	
182-5	34046-34048	on	_	
182-6	34049-34052	the	_	
182-7	34053-34057	mean	_	
182-8	34058-34060	FA	_	
182-9	34061-34069	skeleton	_	
182-10	34070-34071	(	_	
182-11	34071-34076	green	_	
182-12	34076-34077	)	_	
182-13	34077-34078	;	_	
182-14	34079-34082	the	_	
182-15	34083-34087	mean	_	
182-16	34088-34090	FA	_	
182-17	34091-34096	image	_	
182-18	34097-34099	of	_	
182-19	34100-34103	the	_	
182-20	34104-34110	sample	_	
182-21	34111-34113	is	_	
182-22	34114-34117	the	_	
182-23	34118-34126	underlay	_	
182-24	34126-34127	.	_	

#Text=For visualization purposes, significant voxels within the WM skeleton were thickened with tbss_fill.
183-1	34128-34131	For	_	
183-2	34132-34145	visualization	_	
183-3	34146-34154	purposes	_	
183-4	34154-34155	,	_	
183-5	34156-34167	significant	_	
183-6	34168-34174	voxels	_	
183-7	34175-34181	within	_	
183-8	34182-34185	the	_	
183-9	34186-34188	WM	_	
183-10	34189-34197	skeleton	_	
183-11	34198-34202	were	_	
183-12	34203-34212	thickened	_	
183-13	34213-34217	with	_	
183-14	34218-34227	tbss_fill	_	
183-15	34227-34228	.	_	

#Text=Comparisons of mean fractional anisotropy (FA) for largest 1% of clusters (> 500 voxels).
184-1	34229-34240	Comparisons	_	
184-2	34241-34243	of	_	
184-3	34244-34248	mean	_	
184-4	34249-34259	fractional	_	
184-5	34260-34270	anisotropy	_	
184-6	34271-34272	(	_	
184-7	34272-34274	FA	_	
184-8	34274-34275	)	_	
184-9	34276-34279	for	_	
184-10	34280-34287	largest	_	
184-11	34288-34290	1%	_	
184-12	34291-34293	of	_	
184-13	34294-34302	clusters	_	
184-14	34303-34304	(	_	
184-15	34304-34305	>	_	
184-16	34306-34309	500	_	
184-17	34310-34316	voxels	_	
184-18	34316-34317	)	_	
184-19	34317-34318	.	_	

#Text=TBSS results (pTFCE < 0.05) showed higher FA in alcohol use disorder (AUD) subjects compared to controls (CON) in clusters encompassing the (A) posterior internal capsule, (B) inferior fronto-occipital, (C) cingulum, (D) callosal, (E) superior longitudinal, and (F) inferior longitudinal tracts.
185-1	34319-34323	TBSS	_	
185-2	34324-34331	results	_	
185-3	34332-34333	(	_	
185-4	34333-34338	pTFCE	_	
185-5	34339-34340	<	_	
185-6	34341-34345	0.05	_	
185-7	34345-34346	)	_	
185-8	34347-34353	showed	_	
185-9	34354-34360	higher	_	
185-10	34361-34363	FA	_	
185-11	34364-34366	in	_	
185-12	34367-34374	alcohol	_	
185-13	34375-34378	use	_	
185-14	34379-34387	disorder	_	
185-15	34388-34389	(	_	
185-16	34389-34392	AUD	_	
185-17	34392-34393	)	_	
185-18	34394-34402	subjects	_	
185-19	34403-34411	compared	_	
185-20	34412-34414	to	_	
185-21	34415-34423	controls	_	
185-22	34424-34425	(	_	
185-23	34425-34428	CON	_	
185-24	34428-34429	)	_	
185-25	34430-34432	in	_	
185-26	34433-34441	clusters	_	
185-27	34442-34454	encompassing	_	
185-28	34455-34458	the	_	
185-29	34459-34460	(	_	
185-30	34460-34461	A	_	
185-31	34461-34462	)	_	
185-32	34463-34472	posterior	_	
185-33	34473-34481	internal	_	
185-34	34482-34489	capsule	_	
185-35	34489-34490	,	_	
185-36	34491-34492	(	_	
185-37	34492-34493	B	_	
185-38	34493-34494	)	_	
185-39	34495-34503	inferior	_	
185-40	34504-34520	fronto-occipital	_	
185-41	34520-34521	,	_	
185-42	34522-34523	(	_	
185-43	34523-34524	C	_	
185-44	34524-34525	)	_	
185-45	34526-34534	cingulum	_	
185-46	34534-34535	,	_	
185-47	34536-34537	(	_	
185-48	34537-34538	D	_	
185-49	34538-34539	)	_	
185-50	34540-34548	callosal	_	
185-51	34548-34549	,	_	
185-52	34550-34551	(	_	
185-53	34551-34552	E	_	
185-54	34552-34553	)	_	
185-55	34554-34562	superior	_	
185-56	34563-34575	longitudinal	_	
185-57	34575-34576	,	_	
185-58	34577-34580	and	_	
185-59	34581-34582	(	_	
185-60	34582-34583	F	_	
185-61	34583-34584	)	_	
185-62	34585-34593	inferior	_	
185-63	34594-34606	longitudinal	_	
185-64	34607-34613	tracts	_	
185-65	34613-34614	.	_	

#Text=Mean FA images show the anatomic position of each cluster.
186-1	34615-34619	Mean	_	
186-2	34620-34622	FA	_	
186-3	34623-34629	images	_	
186-4	34630-34634	show	_	
186-5	34635-34638	the	_	
186-6	34639-34647	anatomic	_	
186-7	34648-34656	position	_	
186-8	34657-34659	of	_	
186-9	34660-34664	each	_	
186-10	34665-34672	cluster	_	
186-11	34672-34673	.	_	

#Text=Data are mean ± standard deviation (black), with individual data points in gray filled circles.
187-1	34674-34678	Data	_	
187-2	34679-34682	are	_	
187-3	34683-34687	mean	_	
187-4	34688-34689	±	_	
187-5	34690-34698	standard	_	
187-6	34699-34708	deviation	_	
187-7	34709-34710	(	_	
187-8	34710-34715	black	_	
187-9	34715-34716	)	_	
187-10	34716-34717	,	_	
187-11	34718-34722	with	_	
187-12	34723-34733	individual	_	
187-13	34734-34738	data	_	
187-14	34739-34745	points	_	
187-15	34746-34748	in	_	
187-16	34749-34753	gray	_	
187-17	34754-34760	filled	_	
187-18	34761-34768	circles	_	
187-19	34768-34769	.	_	

#Text=Tract labels were obtained from the Johns Hopkins University white-matter tractography atlas available in FSL.
188-1	34770-34775	Tract	_	
188-2	34776-34782	labels	_	
188-3	34783-34787	were	_	
188-4	34788-34796	obtained	_	
188-5	34797-34801	from	_	
188-6	34802-34805	the	_	
188-7	34806-34811	Johns	_	
188-8	34812-34819	Hopkins	_	
188-9	34820-34830	University	_	
188-10	34831-34843	white-matter	_	
188-11	34844-34856	tractography	_	
188-12	34857-34862	atlas	_	
188-13	34863-34872	available	_	
188-14	34873-34875	in	_	
188-15	34876-34879	FSL	_	
188-16	34879-34880	.	_	

#Text=Comparisons of mean diffusivity (MD) for largest 1% of clusters (> 500 voxels).
189-1	34881-34892	Comparisons	_	
189-2	34893-34895	of	_	
189-3	34896-34900	mean	_	
189-4	34901-34912	diffusivity	_	
189-5	34913-34914	(	_	
189-6	34914-34916	MD	_	
189-7	34916-34917	)	_	
189-8	34918-34921	for	_	
189-9	34922-34929	largest	_	
189-10	34930-34932	1%	_	
189-11	34933-34935	of	_	
189-12	34936-34944	clusters	_	
189-13	34945-34946	(	_	
189-14	34946-34947	>	_	
189-15	34948-34951	500	_	
189-16	34952-34958	voxels	_	
189-17	34958-34959	)	_	
189-18	34959-34960	.	_	

#Text=TBSS results (pTFCE < 0.05) showed reduced MD in portions of the (A) superior longitudinal, (B) inferior longitudinal and internal capsule, as well as (C) thalamic white matter.
190-1	34961-34965	TBSS	_	
190-2	34966-34973	results	_	
190-3	34974-34975	(	_	
190-4	34975-34980	pTFCE	_	
190-5	34981-34982	<	_	
190-6	34983-34987	0.05	_	
190-7	34987-34988	)	_	
190-8	34989-34995	showed	_	
190-9	34996-35003	reduced	_	
190-10	35004-35006	MD	_	
190-11	35007-35009	in	_	
190-12	35010-35018	portions	_	
190-13	35019-35021	of	_	
190-14	35022-35025	the	_	
190-15	35026-35027	(	_	
190-16	35027-35028	A	_	
190-17	35028-35029	)	_	
190-18	35030-35038	superior	_	
190-19	35039-35051	longitudinal	_	
190-20	35051-35052	,	_	
190-21	35053-35054	(	_	
190-22	35054-35055	B	_	
190-23	35055-35056	)	_	
190-24	35057-35065	inferior	_	
190-25	35066-35078	longitudinal	_	
190-26	35079-35082	and	_	
190-27	35083-35091	internal	_	
190-28	35092-35099	capsule	_	
190-29	35099-35100	,	_	
190-30	35101-35103	as	_	
190-31	35104-35108	well	_	
190-32	35109-35111	as	_	
190-33	35112-35113	(	_	
190-34	35113-35114	C	_	
190-35	35114-35115	)	_	
190-36	35116-35124	thalamic	_	
190-37	35125-35130	white	_	
190-38	35131-35137	matter	_	
190-39	35137-35138	.	_	

#Text=Mean FA images from the sample show the anatomic position of each cluster in red.
191-1	35139-35143	Mean	_	
191-2	35144-35146	FA	_	
191-3	35147-35153	images	_	
191-4	35154-35158	from	_	
191-5	35159-35162	the	_	
191-6	35163-35169	sample	_	
191-7	35170-35174	show	_	
191-8	35175-35178	the	_	
191-9	35179-35187	anatomic	_	
191-10	35188-35196	position	_	
191-11	35197-35199	of	_	
191-12	35200-35204	each	_	
191-13	35205-35212	cluster	_	
191-14	35213-35215	in	_	
191-15	35216-35219	red	_	
191-16	35219-35220	.	_	

#Text=Data are mean ± standard deviation (black), with individual data points in gray filled circles.
192-1	35221-35225	Data	_	
192-2	35226-35229	are	_	
192-3	35230-35234	mean	_	
192-4	35235-35236	±	_	
192-5	35237-35245	standard	_	
192-6	35246-35255	deviation	_	
192-7	35256-35257	(	_	
192-8	35257-35262	black	_	
192-9	35262-35263	)	_	
192-10	35263-35264	,	_	
192-11	35265-35269	with	_	
192-12	35270-35280	individual	_	
192-13	35281-35285	data	_	
192-14	35286-35292	points	_	
192-15	35293-35295	in	_	
192-16	35296-35300	gray	_	
192-17	35301-35307	filled	_	
192-18	35308-35315	circles	_	
192-19	35315-35316	.	_	

#Text=Tract labels were obtained from the Johns Hopkins University white-matter tractography atlas in FSL.
193-1	35317-35322	Tract	_	
193-2	35323-35329	labels	_	
193-3	35330-35334	were	_	
193-4	35335-35343	obtained	_	
193-5	35344-35348	from	_	
193-6	35349-35352	the	_	
193-7	35353-35358	Johns	_	
193-8	35359-35366	Hopkins	_	
193-9	35367-35377	University	_	
193-10	35378-35390	white-matter	_	
193-11	35391-35403	tractography	_	
193-12	35404-35409	atlas	_	
193-13	35410-35412	in	_	
193-14	35413-35416	FSL	_	
193-15	35416-35417	.	_	

#Text=Characterization of networks from tractography-based structural connectomes (A,B,C) and comparisons of measures of network segregation and integration (D,E).
194-1	35418-35434	Characterization	_	
194-2	35435-35437	of	_	
194-3	35438-35446	networks	_	
194-4	35447-35451	from	_	
194-5	35452-35470	tractography-based	_	
194-6	35471-35481	structural	_	
194-7	35482-35493	connectomes	_	
194-8	35494-35495	(	_	
194-9	35495-35496	A	_	
194-10	35496-35497	,	_	
194-11	35497-35498	B	_	
194-12	35498-35499	,	_	
194-13	35499-35500	C	_	
194-14	35500-35501	)	_	
194-15	35502-35505	and	_	
194-16	35506-35517	comparisons	_	
194-17	35518-35520	of	_	
194-18	35521-35529	measures	_	
194-19	35530-35532	of	_	
194-20	35533-35540	network	_	
194-21	35541-35552	segregation	_	
194-22	35553-35556	and	_	
194-23	35557-35568	integration	_	
194-24	35569-35570	(	_	
194-25	35570-35571	D	_	
194-26	35571-35572	,	_	
194-27	35572-35573	E	_	
194-28	35573-35574	)	_	
194-29	35574-35575	.	_	

#Text=Structural networks of CON and AUD groups were similar in density (A) and mean degree (B), while mean strength of edges was significantly (p = 0.0248) higher in the AUD group.
195-1	35576-35586	Structural	_	
195-2	35587-35595	networks	_	
195-3	35596-35598	of	_	
195-4	35599-35602	CON	_	
195-5	35603-35606	and	_	
195-6	35607-35610	AUD	_	
195-7	35611-35617	groups	_	
195-8	35618-35622	were	_	
195-9	35623-35630	similar	_	
195-10	35631-35633	in	_	
195-11	35634-35641	density	_	
195-12	35642-35643	(	_	
195-13	35643-35644	A	_	
195-14	35644-35645	)	_	
195-15	35646-35649	and	_	
195-16	35650-35654	mean	_	
195-17	35655-35661	degree	_	
195-18	35662-35663	(	_	
195-19	35663-35664	B	_	
195-20	35664-35665	)	_	
195-21	35665-35666	,	_	
195-22	35667-35672	while	_	
195-23	35673-35677	mean	_	
195-24	35678-35686	strength	_	
195-25	35687-35689	of	_	
195-26	35690-35695	edges	_	
195-27	35696-35699	was	_	
195-28	35700-35713	significantly	_	
195-29	35714-35715	(	_	
195-30	35715-35716	p	_	
195-31	35717-35718	=	_	
195-32	35719-35725	0.0248	_	
195-33	35725-35726	)	_	
195-34	35727-35733	higher	_	
195-35	35734-35736	in	_	
195-36	35737-35740	the	_	
195-37	35741-35744	AUD	_	
195-38	35745-35750	group	_	
195-39	35750-35751	.	_	

#Text=Clustering coefficient, a measure of network segregation did not differ between groups, while global efficiency, a network integration metric, was significantly (p = 0.0354) higher in the AUD group.
196-1	35752-35762	Clustering	_	
196-2	35763-35774	coefficient	_	
196-3	35774-35775	,	_	
196-4	35776-35777	a	_	
196-5	35778-35785	measure	_	
196-6	35786-35788	of	_	
196-7	35789-35796	network	_	
196-8	35797-35808	segregation	_	
196-9	35809-35812	did	_	
196-10	35813-35816	not	_	
196-11	35817-35823	differ	_	
196-12	35824-35831	between	_	
196-13	35832-35838	groups	_	
196-14	35838-35839	,	_	
196-15	35840-35845	while	_	
196-16	35846-35852	global	_	
196-17	35853-35863	efficiency	_	
196-18	35863-35864	,	_	
196-19	35865-35866	a	_	
196-20	35867-35874	network	_	
196-21	35875-35886	integration	_	
196-22	35887-35893	metric	_	
196-23	35893-35894	,	_	
196-24	35895-35898	was	_	
196-25	35899-35912	significantly	_	
196-26	35913-35914	(	_	
196-27	35914-35915	p	_	
196-28	35916-35917	=	_	
196-29	35918-35924	0.0354	_	
196-30	35924-35925	)	_	
196-31	35926-35932	higher	_	
196-32	35933-35935	in	_	
196-33	35936-35939	the	_	
196-34	35940-35943	AUD	_	
196-35	35944-35949	group	_	
196-36	35949-35950	.	_	

#Text=P-values for independent-samples t-test are indicated when significant.
197-1	35951-35959	P-values	_	
197-2	35960-35963	for	_	
197-3	35964-35983	independent-samples	_	
197-4	35984-35990	t-test	_	
197-5	35991-35994	are	_	
197-6	35995-36004	indicated	_	
197-7	36005-36009	when	_	
197-8	36010-36021	significant	_	
197-9	36021-36022	.	_	

#Text=Results from the network based statistics comparison of fiber density and co-classification (pFDR < 0.05).
198-1	36023-36030	Results	_	
198-2	36031-36035	from	_	
198-3	36036-36039	the	_	
198-4	36040-36047	network	_	
198-5	36048-36053	based	_	
198-6	36054-36064	statistics	_	
198-7	36065-36075	comparison	_	
198-8	36076-36078	of	_	
198-9	36079-36084	fiber	_	
198-10	36085-36092	density	_	
198-11	36093-36096	and	_	
198-12	36097-36114	co-classification	_	
198-13	36115-36116	(	_	
198-14	36116-36120	pFDR	_	
198-15	36121-36122	<	_	
198-16	36123-36127	0.05	_	
198-17	36127-36128	)	_	
198-18	36128-36129	.	_	

#Text=(A) Higher fiber density in alcohol use disorder (AUD) subjects compared to controls (CON) was found between nodes located in the middle frontal and superior frontal gyri.
199-1	36130-36131	(	_	
199-2	36131-36132	A	_	
199-3	36132-36133	)	_	
199-4	36134-36140	Higher	_	
199-5	36141-36146	fiber	_	
199-6	36147-36154	density	_	
199-7	36155-36157	in	_	
199-8	36158-36165	alcohol	_	
199-9	36166-36169	use	_	
199-10	36170-36178	disorder	_	
199-11	36179-36180	(	_	
199-12	36180-36183	AUD	_	
199-13	36183-36184	)	_	
199-14	36185-36193	subjects	_	
199-15	36194-36202	compared	_	
199-16	36203-36205	to	_	
199-17	36206-36214	controls	_	
199-18	36215-36216	(	_	
199-19	36216-36219	CON	_	
199-20	36219-36220	)	_	
199-21	36221-36224	was	_	
199-22	36225-36230	found	_	
199-23	36231-36238	between	_	
199-24	36239-36244	nodes	_	
199-25	36245-36252	located	_	
199-26	36253-36255	in	_	
199-27	36256-36259	the	_	
199-28	36260-36266	middle	_	
199-29	36267-36274	frontal	_	
199-30	36275-36278	and	_	
199-31	36279-36287	superior	_	
199-32	36288-36295	frontal	_	
199-33	36296-36300	gyri	_	
199-34	36300-36301	.	_	

#Text=(B) Co-classification index (measure of strength of association of a pair of nodes in an ensemble of community structure partitions obtained from modularity), was higher in AUD compared to CON in edges that connect middle frontal gyrus and pre/postcentral gyrus (left) node pairs, cuneus and middle temporal gyrus (right), and supplementary motor area and middle occipital gyrus (right).
200-1	36302-36303	(	_	
200-2	36303-36304	B	_	
200-3	36304-36305	)	_	
200-4	36306-36323	Co-classification	_	
200-5	36324-36329	index	_	
200-6	36330-36331	(	_	
200-7	36331-36338	measure	_	
200-8	36339-36341	of	_	
200-9	36342-36350	strength	_	
200-10	36351-36353	of	_	
200-11	36354-36365	association	_	
200-12	36366-36368	of	_	
200-13	36369-36370	a	_	
200-14	36371-36375	pair	_	
200-15	36376-36378	of	_	
200-16	36379-36384	nodes	_	
200-17	36385-36387	in	_	
200-18	36388-36390	an	_	
200-19	36391-36399	ensemble	_	
200-20	36400-36402	of	_	
200-21	36403-36412	community	_	
200-22	36413-36422	structure	_	
200-23	36423-36433	partitions	_	
200-24	36434-36442	obtained	_	
200-25	36443-36447	from	_	
200-26	36448-36458	modularity	_	
200-27	36458-36459	)	_	
200-28	36459-36460	,	_	
200-29	36461-36464	was	_	
200-30	36465-36471	higher	_	
200-31	36472-36474	in	_	
200-32	36475-36478	AUD	_	
200-33	36479-36487	compared	_	
200-34	36488-36490	to	_	
200-35	36491-36494	CON	_	
200-36	36495-36497	in	_	
200-37	36498-36503	edges	_	
200-38	36504-36508	that	_	
200-39	36509-36516	connect	_	
200-40	36517-36523	middle	_	
200-41	36524-36531	frontal	_	
200-42	36532-36537	gyrus	_	
200-43	36538-36541	and	_	
200-44	36542-36545	pre	_	
200-45	36545-36546	/	_	
200-46	36546-36557	postcentral	_	
200-47	36558-36563	gyrus	_	
200-48	36564-36565	(	_	
200-49	36565-36569	left	_	
200-50	36569-36570	)	_	
200-51	36571-36575	node	_	
200-52	36576-36581	pairs	_	
200-53	36581-36582	,	_	
200-54	36583-36589	cuneus	_	
200-55	36590-36593	and	_	
200-56	36594-36600	middle	_	
200-57	36601-36609	temporal	_	
200-58	36610-36615	gyrus	_	
200-59	36616-36617	(	_	
200-60	36617-36622	right	_	
200-61	36622-36623	)	_	
200-62	36623-36624	,	_	
200-63	36625-36628	and	_	
200-64	36629-36642	supplementary	_	
200-65	36643-36648	motor	_	
200-66	36649-36653	area	_	
200-67	36654-36657	and	_	
200-68	36658-36664	middle	_	
200-69	36665-36674	occipital	_	
200-70	36675-36680	gyrus	_	
200-71	36681-36682	(	_	
200-72	36682-36687	right	_	
200-73	36687-36688	)	_	
200-74	36688-36689	.	_	

#Text=(C) One edge that connected nodes in the cuneus and inferior insula showed lower co-classification in AUD compared to CON.
201-1	36690-36691	(	_	
201-2	36691-36692	C	_	
201-3	36692-36693	)	_	
201-4	36694-36697	One	_	
201-5	36698-36702	edge	_	
201-6	36703-36707	that	_	
201-7	36708-36717	connected	_	
201-8	36718-36723	nodes	_	
201-9	36724-36726	in	_	
201-10	36727-36730	the	_	
201-11	36731-36737	cuneus	_	
201-12	36738-36741	and	_	
201-13	36742-36750	inferior	_	
201-14	36751-36757	insula	_	
201-15	36758-36764	showed	_	
201-16	36765-36770	lower	_	
201-17	36771-36788	co-classification	_	
201-18	36789-36791	in	_	
201-19	36792-36795	AUD	_	
201-20	36796-36804	compared	_	
201-21	36805-36807	to	_	
201-22	36808-36811	CON	_	
201-23	36811-36812	.	_	

#Text=Renders are on a Montreal Neurological Institute 1mm template included in FSL, visualized with MRIcroGL software.
202-1	36813-36820	Renders	_	
202-2	36821-36824	are	_	
202-3	36825-36827	on	_	
202-4	36828-36829	a	_	
202-5	36830-36838	Montreal	_	
202-6	36839-36851	Neurological	_	
202-7	36852-36861	Institute	_	
202-8	36862-36865	1mm	_	
202-9	36866-36874	template	_	
202-10	36875-36883	included	_	
202-11	36884-36886	in	_	
202-12	36887-36890	FSL	_	
202-13	36890-36891	,	_	
202-14	36892-36902	visualized	_	
202-15	36903-36907	with	_	
202-16	36908-36916	MRIcroGL	_	
202-17	36917-36925	software	_	
202-18	36925-36926	.	_	

#Text=Node pairs with edges that differed between groups are overlaid in shaded gray.
203-1	36927-36931	Node	_	
203-2	36932-36937	pairs	_	
203-3	36938-36942	with	_	
203-4	36943-36948	edges	_	
203-5	36949-36953	that	_	
203-6	36954-36962	differed	_	
203-7	36963-36970	between	_	
203-8	36971-36977	groups	_	
203-9	36978-36981	are	_	
203-10	36982-36990	overlaid	_	
203-11	36991-36993	in	_	
203-12	36994-37000	shaded	_	
203-13	37001-37005	gray	_	
203-14	37005-37006	.	_	

#Text=A black line was used to specify the connected pair, when multiple pairs are presented on a single underlay.
204-1	37007-37008	A	_	
204-2	37009-37014	black	_	
204-3	37015-37019	line	_	
204-4	37020-37023	was	_	
204-5	37024-37028	used	_	
204-6	37029-37031	to	_	
204-7	37032-37039	specify	_	
204-8	37040-37043	the	_	
204-9	37044-37053	connected	_	
204-10	37054-37058	pair	_	
204-11	37058-37059	,	_	
204-12	37060-37064	when	_	
204-13	37065-37073	multiple	_	
204-14	37074-37079	pairs	_	
204-15	37080-37083	are	_	
204-16	37084-37093	presented	_	
204-17	37094-37096	on	_	
204-18	37097-37098	a	_	
204-19	37099-37105	single	_	
204-20	37106-37114	underlay	_	
204-21	37114-37115	.	_	

#Text=R and L represent right and left hemisphere, respectively.
205-1	37116-37117	R	_	
205-2	37118-37121	and	_	
205-3	37122-37123	L	_	
205-4	37124-37133	represent	_	
205-5	37134-37139	right	_	
205-6	37140-37143	and	_	
205-7	37144-37148	left	_	
205-8	37149-37159	hemisphere	_	
205-9	37159-37160	,	_	
205-10	37161-37173	respectively	_	
205-11	37173-37174	.	_	

#Text=Subject Characteristics.
206-1	37175-37182	Subject	_	
206-2	37183-37198	Characteristics	_	
206-3	37198-37199	.	_	

#Text=CON(n = 18)\tAUD(n = 22)\tp-value\t \tAge\t22.39 ± 3.35\t22.73 ± 2.73\t0.73\t \tGender\t9 F\t8 F\t0.36\t \tCigarette use (n)\t4\t8\t0.33\t \tEducation (years)\t14.17 ± 1.65\t14.18 ± 1.22\t0.97\t \tTotal Drinks (Last 2 Weeks)\t6.22 ± 6.75\t66.32 ± 49.49\t9.68 × 10−6\t \tLifetime Alcohol Problems\t2.50 ± 3.19\t48.10 ± 20.93\t3.99 × 10−11\t \tAge at first drink\t18 ± 1.91\t14.82 ± 1.47\t2.15 × 10−6\t \tAge of AUD onset\tn/a\t17.23 ± 1.41\t\t \t
#Text=Data are mean ± standard deviation.
207-1	37201-37204	CON	_	
207-2	37204-37205	(	_	
207-3	37205-37206	n	_	
207-4	37207-37208	=	_	
207-5	37209-37211	18	_	
207-6	37211-37212	)	_	
207-7	37213-37216	AUD	_	
207-8	37216-37217	(	_	
207-9	37217-37218	n	_	
207-10	37219-37220	=	_	
207-11	37221-37223	22	_	
207-12	37223-37224	)	_	
207-13	37225-37232	p-value	_	
207-14	37235-37238	Age	_	
207-15	37239-37244	22.39	_	
207-16	37245-37246	±	_	
207-17	37247-37251	3.35	_	
207-18	37252-37257	22.73	_	
207-19	37258-37259	±	_	
207-20	37260-37264	2.73	_	
207-21	37265-37269	0.73	_	
207-22	37272-37278	Gender	_	
207-23	37279-37280	9	_	
207-24	37281-37282	F	_	
207-25	37283-37284	8	_	
207-26	37285-37286	F	_	
207-27	37287-37291	0.36	_	
207-28	37294-37303	Cigarette	_	
207-29	37304-37307	use	_	
207-30	37308-37309	(	_	
207-31	37309-37310	n	_	
207-32	37310-37311	)	_	
207-33	37312-37313	4	_	
207-34	37314-37315	8	_	
207-35	37316-37320	0.33	_	
207-36	37323-37332	Education	_	
207-37	37333-37334	(	_	
207-38	37334-37339	years	_	
207-39	37339-37340	)	_	
207-40	37341-37346	14.17	_	
207-41	37347-37348	±	_	
207-42	37349-37353	1.65	_	
207-43	37354-37359	14.18	_	
207-44	37360-37361	±	_	
207-45	37362-37366	1.22	_	
207-46	37367-37371	0.97	_	
207-47	37374-37379	Total	_	
207-48	37380-37386	Drinks	_	
207-49	37387-37388	(	_	
207-50	37388-37392	Last	_	
207-51	37393-37394	2	_	
207-52	37395-37400	Weeks	_	
207-53	37400-37401	)	_	
207-54	37402-37406	6.22	_	
207-55	37407-37408	±	_	
207-56	37409-37413	6.75	_	
207-57	37414-37419	66.32	_	
207-58	37420-37421	±	_	
207-59	37422-37427	49.49	_	
207-60	37428-37432	9.68	_	
207-61	37433-37434	×	_	
207-62	37435-37437	10	_	
207-63	37437-37438	−	_	
207-64	37438-37439	6	_	
207-65	37442-37450	Lifetime	_	
207-66	37451-37458	Alcohol	_	
207-67	37459-37467	Problems	_	
207-68	37468-37472	2.50	_	
207-69	37473-37474	±	_	
207-70	37475-37479	3.19	_	
207-71	37480-37485	48.10	_	
207-72	37486-37487	±	_	
207-73	37488-37493	20.93	_	
207-74	37494-37498	3.99	_	
207-75	37499-37500	×	_	
207-76	37501-37503	10	_	
207-77	37503-37504	−	_	
207-78	37504-37506	11	_	
207-79	37509-37512	Age	_	
207-80	37513-37515	at	_	
207-81	37516-37521	first	_	
207-82	37522-37527	drink	_	
207-83	37528-37530	18	_	
207-84	37531-37532	±	_	
207-85	37533-37537	1.91	_	
207-86	37538-37543	14.82	_	
207-87	37544-37545	±	_	
207-88	37546-37550	1.47	_	
207-89	37551-37555	2.15	_	
207-90	37556-37557	×	_	
207-91	37558-37560	10	_	
207-92	37560-37561	−	_	
207-93	37561-37562	6	_	
207-94	37565-37568	Age	_	
207-95	37569-37571	of	_	
207-96	37572-37575	AUD	_	
207-97	37576-37581	onset	_	
207-98	37582-37583	n	_	
207-99	37583-37584	/	_	
207-100	37584-37585	a	_	
207-101	37586-37591	17.23	_	
207-102	37592-37593	±	_	
207-103	37594-37598	1.41	_	
207-104	37603-37607	Data	_	
207-105	37608-37611	are	_	
207-106	37612-37616	mean	_	
207-107	37617-37618	±	_	
207-108	37619-37627	standard	_	
207-109	37628-37637	deviation	_	
207-110	37637-37638	.	_	

#Text=M: Male; F: Female. n/a: not applicable.
208-1	37639-37640	M	_	
208-2	37640-37641	:	_	
208-3	37642-37646	Male	_	
208-4	37646-37647	;	_	
208-5	37648-37649	F	_	
208-6	37649-37650	:	_	
208-7	37651-37657	Female	_	
208-8	37657-37658	.	_	
208-9	37659-37660	n	_	
208-10	37660-37661	/	_	
208-11	37661-37662	a	_	
208-12	37662-37663	:	_	
208-13	37664-37667	not	_	
208-14	37668-37678	applicable	_	
208-15	37678-37679	.	_	
